N-CSR 1 a10-19073_1ncsr.htm N-CSR

 

 

 

OMB APPROVAL

 

 

OMB Number:

3235-0570

 

 

Expires:

August 31, 2011

 

UNITED STATES

Estimated average burden hours per response. . . . . . . . . . . . . . . . .18.9

 

SECURITIES AND EXCHANGE COMMISSION

 

 

Washington, D.C. 20549

 

 

FORM N-CSR

 

CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES

 

Investment Company Act file number

811-01355

 

The Alger Funds

(Exact name of registrant as specified in charter)

 

111 Fifth Avenue New York, New York

 

10003

(Address of principal executive offices)

 

(Zip code)

 

Mr. Hal Liebes

Fred Alger Management, Inc.

111 Fifth Avenue

New York, New York 10003

(Name and address of agent for service)

 

Registrant’s telephone number, including area code:

212-806-8800

 

 

Date of fiscal year end:

October 31

 

 

Date of reporting period:

October 31, 2010

 

 



 

ITEM 1.  REPORTS TO STOCKHOLDERS.

 



 

 

The Alger Funds

 

 

ANNUAL REPORT

 

October 31, 2010

 

 



 

Table of Contents

 

THE ALGER FUNDS

 

Letter to Our Shareholders (Unaudited)

 

1

 

 

 

Fund Highlights (Unaudited)

 

13

 

 

 

Portfolio Summary (Unaudited)

 

22

 

 

 

Schedules of Investments

 

24

 

 

 

Statements of Assets and Liabilities

 

80

 

 

 

Statements of Operations

 

84

 

 

 

Statements of Changes in Net Assets

 

86

 

 

 

Financial Highlights

 

92

 

 

 

Notes to Financial Statements

 

118

 

 

 

Report of Independent Registered Public Accounting Firm

 

147

 

 

 

Additional Information (Unaudited)

 

148

 

Go Paperless With Alger Electronic Delivery Service

 

Alger is pleased to provide you with the ability to access regulatory materials online. When documents such as prospectuses and annual and semi-annual reports are available, we’ll send you an e-mail notification with a convenient link that will take you directly to the fund information on our website. To sign up for this free service, simply enroll at www.icsdelivery.com/alger.

 



 

Dear Shareholders,

December 3, 2010

 

Equities Rally on Corporate Earnings

 

Sometimes the strongest drivers of market performance receive the least amount of media attention.  That was clearly the case during the 12-month period ended October 31, 2010.  As the period progressed, soothsayers of gloom increasingly basked in the limelight of the media to discuss the possibility of the U.S. slipping into a double-dip recession.  Other pundits discussed persistently high unemployment and the possibility of America being hit with deflation.  Yet as the media embraced an increasingly negative economic outlook, corporations continued to announce strong quarterly results, continuing a trend of surprisingly resilient earnings, high levels of free cash flow, and strong incremental profit margins.  The markets, we believe, responded to these fundamentals of investing with the S&P 500 Index posting a 16.52% return for the reporting period.

 

During the 12-month period, mid and small cap equities outperformed large cap stocks while growth stocks outperformed value. The Russell Midcap Index posted a 27.71% return, compared to the 26.58% return of the small cap Russell 2000 Index and to the 17.67% return of the large cap Russell 1000 Index.  Among small caps, the Russell 2000 Growth Index return of 28.67% outpaced the 24.43% return of the Russell 2000 Value Index. In mid caps, growth returned 28.03% as measured by the Russell Midcap Growth Index, outpacing the 27.49% return of the Russell Midcap Value Index.  In the large cap category, the Russell 1000 Growth Index posted a 19.65% return, substantially outperforming the 15.71% return of the Russell 1000 Value Index.

 

Market Volatility Thrives

 

Despite solid market gains for the 12-month period, volatility thrived with the S&P 500 Index declining 11.4% during the second quarter of 2010.  Volatility was driven, in large part, by fears of a slowing U.S. economic recovery. The country’s unemployment rate lingered at or above 9.5% and weakness in real estate persisted, despite mortgage rates dropping to record low levels.  Investors’ concerns over health care reform, proposed regulations of financial firms, and the military conflict in Afghanistan also drove volatility.  In Europe, meanwhile, the sovereign debt crisis lingered, even as countries such as Ireland, Portugal, Greece, and Spain launched austerity programs to improve their ability to make bond payments.

 

The volatility was no surprise to the Alger investment team.  Indeed, in the later portion of 2009 and in August of this year, we conveyed our belief that ongoing market volatility would create opportunities to purchase attractively valued growth companies during market dips and that equities would advance in the foreseeable future.  Our summer observation was timely as the S&P 500 gained 8.92% in September. Our forecast for long-term market gains, meanwhile, is also on track, with the S&P 500 index having gained 80.96% from the market low of March 9, 2009.

 



 

Corporations Produce Strong Earnings

 

Against the backdrop of a challenging economy, corporations generated strong earnings during the 12-month period.  Many companies continued to benefit from cost cutting measures, improvements in operating efficiency, and growing revenues from overseas markets.  In the process, they produced strong levels of free cash flow and they accumulated impressive amounts of cash.  Indeed, by the end of March, non-financial corporations held $1.8 trillion in liquid assets, which is comparable to the combined amount of stimulus spending approved by Congress and the White House in 2008 and 2009.

 

What is even more encouraging is that manufacturers and other corporations started using their cash to make strategic acquisitions, launch share buyback programs, increase dividends, and engage in capital expenditures.  This continuation of increased corporate spending in capital expenditures, sales initiatives, and marketing activities is a strong positive for many industries and a reminder that while the U.S. economy is no longer dominated by manufacturing companies, the sector is far from irrelevant.  Additionally, business spending on PCs, data storage equipment, and software continued to strengthen during the 12-month period. Encouragingly, our analysts’ research suggests that equipment orders for leading machinery, industrial, and engineering companies will continue to be in the “recovery mode.”

 

Throughout the reporting period, we maintained that U.S. equity valuations were highly attractive.  This view was supported by those who would know best: the CEOs and boards of corporate America.  With historically low interest rates and corporations’ deep coffers, U.S. companies have been making investments in something they know better than anyone: their own equities.  So far this year, for example, corporations have announced nearly $243 billion in share buybacks, compared to $125 billion for all of last year, according to data from equity research firm Birinyi Associates, Inc.

 

An increase in merger and acquisition activity also supports our view that equities are attractively valued. Deals announced during the first 11 months of 2010 had a total value of $2.08 trillion, up from $1.70 trillion for the first 11 months of 2009, according to Bloomberg data. Of particular interest was the bidding war between Hewlett-Packard Co. and Dell Inc. for storage specialist 3Par during the third quarter.  Hewlett-Packard won with a bid exceeding $2.35 billion.  Other deals included Intel Corp.’s acquisition of security-software maker McAfee Inc. and consumer-goods company Unilever’s acquisition of hair care products company Alberto-Culver Co.

 

Some analysts have said that deals are being completed at excessively high valuations.  For example, HP paid about 10 times the value of 3Par’s estimated annual sales to acquire the company, according to investment banking firm Kaufman Bros.  By comparison, EMC Corp. and NetApp Inc., two of the leading (but also large) storage specialists, trade at three to four times their sales.

 

Yet, we maintain that viewing recent deal valuations as excessive fails to consider the adverse impacts upon companies that fail to execute in high growth markets. When

 

2



 

considering such adverse impacts of failing to execute, the strategic significance of acquisitions of high growth companies like 3Par becomes clear.  By failing to internally develop capabilities or to make acquisitions, the “missed opportunity” for HP or Dell is not simply slower growth, but the “enhanced risk” that the new high growth market served by 3Par will erode either company’s present business in data storage, for example.  Winners and losers today are created faster than ever, and in this competitive landscape, sitting still is not an option.  While technology as a tool is a primary agent for the transmission of “creative destruction” within an industry at a faster and more devastating pace than ever before, this phenomenon occurs in every industry today. Indeed, retailers like Barnes & Noble, Inc. or Mervyn’s department stores and media giants such as newspaper publishers and radio broadcasters that failed to respond aggressively to the rise of new forms of competition for their goods, services and advertising platforms suffered from a serious decline in their core business and they missed strong growth opportunities. Thus, the value of entry and of position at the table of a high growth market is both future growth opportunities and, likely, the ability to manage (but not avoid) the decline of a core business.

 

Finally, on the financial ledgers, corporate America looks not only strong, but willing to share with stakeholders.  The benefits of large cash balances were reflected in dividends.  Many companies implemented dividends and a flurry of other companies with dividend programs said they will increase the amount that they pay.  In fact, some 37% of S&P 500 companies either started dividend payments in 2010 or announced that they will increase their dividends, according to data from FactSet.  Dividend payments, of course, will help stimulate the economy by increasing income for shareholders.  Perhaps more importantly, dividends will begin to compete for investing dollars with the paltry bond yields in the market today.  Why own a 10-year bond yielding 2.4% when you can own stock with a 2% dividend and earnings or free cash flow yields of 8%, 9%, or 10%?

 

Investors Look to the Fed

 

Strong corporate earnings clearly drove equity gains during the 12-month period, but stocks also received additional support from expectations that the Federal Reserve would roll out additional stimulus. As the 12-month period progressed, continuing weakness in real estate, the labor market and GDP growth caused the expectations to grow, helping the S&P 500 climb 3.7% in October.

 

The Road Ahead

 

Going forward, we believe uncertainty over economic growth will continue to drive equity market volatility, while the sovereign debt crisis in Europe may also provoke angst among investors.  Yet, we are encouraged to observe that European countries are pushing forward with austerity programs to improve their ability to service debt and that the European Financial Stability Facility (the Facility), which was created to assist in the crisis, has received preliminary credit ratings of AAA from Moody’s Investors Service Inc, Standard & Poor’s (a division of McGraw-Hill Companies), and Fitch Inc.  The Facility currently has 440 billion Euros in assets while the International Monetary Fund has earmarked an additional 750 billion Euros to assist governments that may be in danger of defaulting.

 

3



 

Domestically, we also expect investors to remain concerned about high rates of unemployment and weakness in real estate.  We note, however, that job creation and improvements in real estate often occur in the later stages of economic recoveries, so while we would like to see those areas strengthen, we do not believe they point to a decline in the health of the U.S.  At the same time, pockets of improvement in real estate exist.  In Jacksonville, Florida, for example, vacancy rates for office and industrial properties declined during the third quarter, while in Manhattan, residential sales climbed.  We also note that on both sides of the Atlantic, central bankers remain highly vigilant and, we are confident, ready to act to support the recovery today and for quite a while.

 

Robust emerging markets growth, meanwhile, may help lift the U.S. economy and markets.  China may lead the process with its gross domestic product for this year expected to grow 10.5%, according to the International Monetary Fund.  Strong growth won’t be limited to China: The IMF expects overall GDP for emerging markets to grow 6.5% this year.  India, Brazil, and other emerging markets similarly support our long-held view that “global growth” is an investable theme for U.S. equity investors.

 

In closing, we continue to believe that research is the cornerstone of superior portfolio management, regardless of economic conditions.  We believe our proven and disciplined process for identifying companies experiencing Positive Dynamic Change will continue to produce superior long-term investment results for our clients.

 

Portfolio Matters

 

Alger Capital Appreciation Fund

 

The Alger Capital Appreciation Fund returned 17.42% for the 12-month period ended October 31, 2010, compared to the Russell 3000 Growth Index return of 20.31%.

 

During the period, the largest sector weightings for the Fund were in Information Technology and Health Care. The largest sector overweight for the period was in Information Technology and the largest sector underweight for the period was in Consumer Staples. Relative outperformance in the Materials and Information Technology sectors was the most important contributor to performance. Sectors that detracted from performance included Health Care and Consumer Staples.

 

Among the most important contributors to relative performance were Skyworks Solutions Inc., Patriot Coal Corp., Cliffs Natural Resources Inc., Seagate Technology PLC., and Focus Media Holding Ltd. Conversely, detracting from overall results on a relative basis were Hewlett-Packard Co., Brocade Communications Systems Inc., International Business Machines Corp., Baxter International Inc., and Oracle Corp.

 

Alger Large Cap Growth Fund

 

The Alger Large Cap Growth Fund returned 15.86% for the 12-month period ended October 31, 2010, compared to the Russell 1000 Growth Index return of 19.65%.

 

4



 

During the period, the largest portfolio sector weightings for the Fund were in Information Technology and Health Care. The largest sector overweight for the period was in Financials and the largest sector underweight for the period was in Consumer Discretionary. Relative outperformance in the Materials and Utilities sectors was the most important contributor to performance. Sectors that detracted from performance included Financials and Consumer Discretionary.

 

Among the most important relative contributors were Burlington Northern, Potash Corporation of Saskatchewan Inc., Carnival Corp., The Boeing Co., and Cognizant Technology Solutions Corp.  Conversely, detracting from overall results on a relative basis were Exxon Mobil Corp., Transocean Inc., International Business Machines Corp., Caterpillar Inc., and Baxter International Inc.

 

Alger Mid Cap Growth Fund

 

The Alger Mid Cap Growth Fund returned 21.71% for the 12-month period ended October 31, 2010, compared to the Russell Midcap Growth Index, which had a return of 28.03%.

 

During the period, the largest sector weightings in the Alger Mid Cap Growth Fund were in Information Technology and Consumer Discretionary. The largest sector overweight for the period was in Information Technology and the largest sector underweight for the period was in Consumer Staples. Relative outperformance in the Information Technology and Energy sectors was the most important contributor to performance.  Sectors that detracted from the portfolio included Industrials and Health Care.

 

Among the most important contributors to relative performance were NetFlix Inc., Skyworks Solutions Inc., Cliffs Natural Resources Inc., OpenTable Inc., and Human Genome Sciences Inc. Conversely, detracting from relative performance were Duoyuan Global Water Inc., Brocade Communications Systems Inc., NuVasive Inc., Select Medical Holdings Corp., and SmartHeat Inc.

 

Alger SMid Cap Growth Fund

 

The Alger SMid Cap Growth Fund returned 25.15% for the 12-month period ended October 31, 2010, compared to the Russell 2500 Growth Index return of 28.76%.

 

During the period, the largest sector weightings for the Fund were in Information Technology and Health Care. The largest sector overweight for the period was in Industrials and the largest sector underweight for the period was in Consumer Discretionary.  Relative outperformance in the Telecommunication Services and Utilities sectors was the most important contributor to performance. Sectors that detracted from the portfolio included Financials and Information Technology.

 

Among the most important relative contributors were Cliffs Natural Resources Inc., OpenTable Inc., BE Aerospace Inc., Informatica Corp., and Skyworks Solutions Inc. Conversely, detracting from overall results on a relative basis were Sykes Enterprises

 

5



 

Inc., Brocade Communications Systems Inc., PMI Group Inc., Alere Inc., and NetFlix Inc.

 

Alger Small Cap Growth Fund

 

The Alger Small Cap Growth Fund returned 27.13% for the 12-month period ended October 31, 2010, compared to the Russell 2000 Growth Index, which returned 28.67%.

 

During the period, the largest sector weightings for the Fund were in Information Technology and Health Care. The largest sector overweight for the period was in Industrials and the largest sector underweight was in Information Technology. Relative outperformance in the Industrials and Energy sectors was the most important contributor to performance. Sectors that detracted from the portfolio included Financials and Health Care.

 

Among the most important relative contributors were BE Aerospace Inc., Dollar Thrifty Automotive Group Inc., Informatica Corp., VanceInfo Technologies Inc., and OpenTable Inc. Conversely, detracting from relative performance were InterMune Inc., Brocade Communications Systems Inc., Sykes Enterprises Inc., VeriFone Systems Inc., and New York Times Co.

 

Alger Growth Opportunities Fund

 

The Alger Growth Opportunities Fund returned 28.84% for the 12-month period ended October 31, 2010, compared to the Russell 2500 Growth Index return of 28.76%.

 

During the period, the largest sector weightings in the Fund were in the Information Technology and Health Care sectors. The largest sector overweight for the period was in Health Care and the largest sector underweight for the period was in Financials. Relative outperformance in the Information Technology and Energy sectors was the most important contributor to performance. Sectors that detracted from performance included Health Care and Financials.

 

Among the most important contributors to relative performance were VanceInfo Technologies Inc., OpenTable Inc., LogMeIn, Inc., Dollar Thrifty Automotive Group Inc., and Shutterfly Inc. Conversely, detracting from relative performance were Brocade Communications Systems Inc., drugstore.com inc., Grand Canyon Education, Inc., Alpha & Omega Semiconductor Inc., and InterMune Inc.

 

Alger Health Sciences Fund

 

The Alger Health Sciences Fund returned 10.53% for the 12-month period ended October 31, 2010, compared to the S&P 500 Index return of 16.52%.

 

During the period, the largest sector weightings for the Fund were in the Pharmaceuticals and Health Care Equipment & Supplies.  The largest sector overweight for the period was in Pharmaceuticals and the largest sector underweight for the period was in Industrials. Relative outperformance in the Biotechnology and

 

6



 

Life Sciences Tools & Services sectors was the most important contributor to relative performance. Sectors that detracted from relative performance included Industrials and Consumer Staples.

 

Among the most important contributors to relative performance were Human Genome Sciences Inc., PAREXEL International Corp., Medicis Pharmaceutical Corp., AMERIGROUP Corp., and Shire PLC. Conversely, detracting from overall results on a relative basis were Alere Inc., Optimer Pharmaceuticals Inc., NuVasive Inc., Ipsen SA, and Covidien PLC.

 

Alger Balanced Fund

 

The Alger Balanced Fund returned 11.80% for the 12-month period ended October 31, 2010, compared to the Russell 1000 Growth Index return of 19.65% and the 8.48% return of the Barclays Capital U.S. Government/Credit Bond Index.

 

During the period, the largest sector weightings in the equity portion of the Alger Balanced Fund were in Information Technology and Consumer Staples. The largest sector overweight for the period was in Financials and the largest sector underweight for the period was in Information Technology. Relative outperformance in the Consumer Staples sector was the most important contributor to performance. Sectors that detracted from the portfolio included Information Technology and Consumer Discretionary.

 

Among the most important contributors to relative performance were IAC/InterActiveCorp., BE Aerospace Inc., The Boeing Co., The Cheesecake Factory Inc., and UnitedHealth Group Inc. Conversely, detracting from relative performance were Exxon Mobil Corp., Bank of America Corp., Transocean Ltd., International Business Machines Corp., and McDonald’s Corp.

 

Regarding the fixed-income portion of the Fund’s portfolio, 67% was in corporate securities, 11% was in mortgage/asset backed securities, 14% in U.S Treasuries, 5% was in U.S. agency securities and 3% was in cash as of October 31, 2010.

 

After widening in response to sovereign risk exposure in April 2010, the reversal and subsequent tightening of credit spreads has been the major force behind returns.   Despite a lackluster economic backdrop, corporate balance sheets are in great shape.  With the Fed firmly behind maintaining a low rate environment, corporations have been aggressively refinancing debt and reducing leverage while increasing cash balances.  An increase in capital expenditures has also occurred, suggesting that the trough in business spending has passed.

 

Alger Convertible Fund

 

The Alger Convertible Fund returned 22.40% for the 12-month period ended October 31, 2010, compared to the Bank of America Merrill Lynch All US Convertibles Index return of 20.78% and the Lipper Convertible Securities Fund Index return of 19.75%.

 

7



 

Convertibles provided strong returns, outpacing most major asset classes despite significant volatility behind this gain. Speculative grade issuers led the charge within the convertible universe while investment grade issues remained the laggards. Best performing sectors were Transports, Consumer Cyclical and Communications and worst performing sectors were Utilities, Pharmaceuticals and Diversified financials. We believe that convertible securities remain attractive in an ongoing environment of volatility spikes.

 

Alger Money Market Fund

 

The Alger Money Market Fund posted a return of 0.02% for the 12-month period ended October 31, 2010. The Fund invests in U.S. Treasury securities, U.S. agency securities and overnight bank deposits. As of October 31, 2010, the Fund’s portfolio consisted of overnight bank deposits and U.S. agency discount notes. The portfolio’s average days to maturity was 20 days.

 

The Fed reaffirmed its dovish stance and signs of a weakening economy brought the Fed back to the market with plans to buy U.S. Treasuries in hopes of stimulating growth.  With its newest round of quantitative easing, the Fed is in uncharted waters and money market funds remain under pressure from withdrawals as investors seek additional yield.  We expect the Fed to be on hold in terms of its rate policy through 2011.

 

Respectfully submitted,

Daniel C. Chung, CFA

Chief Investment Officer

 

Investors cannot invest directly in an index. Index performance does not reflect the deduction for fees, expenses, or taxes.

 

This report and the financial statements contained herein are submitted for the general information of shareholders of the Fund. This report is not authorized for distribution to prospective investors in the Fund unless proceeded or accompanied by an effective prospectus for the Fund. Fund performance returns represent the fiscal 12-month period return of Class A shares prior to the deduction of any sales charges and include the reinvestment of any dividends or distributions.

 

The performance data quoted represents past performance, which is not an indication or guarantee of future results.

 

Standardized performance results can be found on the following pages. The investment return and principal value of an investment in a fund will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Recent performance has been impacted by an unusually strong period in the U.S. equity market and there is no guarantee that such conditions will be repeated.

 

8



 

Current performance may be lower or higher than the performance quoted. For performance data current to the most recent month-end, visit us at www.alger.com or call us at (800) 992-3863.

 

The views and opinions of the Fund’s management in this report are as of the date of the shareholders letter and are subject to change at any time subsequent to this date. There is no guarantee that any of the assumptions that formed the basis for the opinions stated herein are accurate or that they will materialize. Moreover, the information forming the basis for such assumptions is from sources believed to be reliable; however, there is no guarantee that such information is accurate. Any securities mentioned, whether owned in a fund or otherwise, are considered in the context of the construction of an overall portfolio of securities and therefore reference to them should not be construed as a recommendation or offer to purchase or sell any such security. Inclusion of such securities in a fund and transactions in such securities, if any, may be for a variety of reasons, including without limitation, in response to cash flows, inclusion in a benchmark, and risk control. The reference to a specific security should also be understood in such context and not viewed as a statement that the security is a significant holding in a portfolio. Please refer to the Schedule of Investments for each fund which is included in this report for a complete list of fund holdings as of October 31, 2010. Securities mentioned in the Shareholders letter, if not found in the Schedule of Investments, may have been held by the Funds during the fiscal period.

 

A Word about Risk

 

Growth stocks tend to be more volatile than other stocks as the price of growth stocks tends to be higher in relation to their companies’ earnings and may be more sensitive to market, political and economic developments. Investing in the stock market involves gains and losses and may not be suitable for all investors. Stocks of small- and mid-sized companies are subject to greater risk than stocks of larger, more established companies owing to such factors as limited liquidity, inexperienced management, and limited financial resources. Funds that invest in fixed-income securities, such as the Alger Balanced Fund and Alger Convertible Fund, are subject to the fixed income securities’ sensitivity to interest rate movements; their market values tend to fall when interest rates rise and to rise when interest rates fall. These funds are also subject to the risk of a decline in the value of the Fund’s securities in the event of an issue’s falling credit rating or actual default. The Funds that invest in mortgage and asset backed securities are subject to prepayment risk; thus the average life of the security may be less than maturity. Funds that participate in leveraging, such as the Alger Capital Appreciation, Alger SMid Cap, and Alger Health Sciences Funds, are subject to the risk that the cost of borrowing money to leverage will exceed the returns for securities purchased or that the securities purchased may actually go down in value; thus, the Funds’ net asset value can decrease more quickly than if the Fund had not borrowed. For a more detailed discussion of the risks associated with a Fund, please see the Fund’s Prospectus.

 

Before investing, carefully consider a Fund’s investment objective, risks, charges, and expenses.

 

9



 

For a prospectus or a summary prospectus containing this and other information about the Alger Funds call us at (800) 992-3863 or visit us at www.alger.com.  Read it carefully before investing.

 

Fred Alger & Company, Incorporated, Distributor. Member NYSE Euronext, SIPC.

 

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE.

 

Definitions:

 

·    Standard & Poor’s 500 Index (S&P 500 Index) is an index of 500 leading companies in leading industries in the United States.

·    The Russell 3000 Index measures the performance of the 3,000 largest U.S. companies based on the total market capitalization, which represents 99% of the U.S. Equity Market. The Russell 3000 Growth Index is an unmanaged index designed to measure the performance of those Russell 3000 Index companies with higher price-to-book ratios and higher forecasted growth values.

·    The Russell 1000 Index measures the performance of the large-cap segment of the U.S. equity universe. It is a subset of the Russell 3000 Index and includes approximately 1,000 of the largest securities based on a combination of their market cap and current index membership. The Russell 1000 represents approximately 92% of the Russell 3000 Index. The Russell 1000 Growth Index is an unmanaged index designed to measure the performance of the largest 1,000 companies in the Russell 3000 Index with higher price-to-book ratios and higher forecasted growth values. The Russell 1000 Value Index measures the performance of the large-cap value segment of the U.S. equity universe. It includes those Russell 1000 companies with lower price-to-book ratios and lower expected growth values.

·    The Russell Midcap Index measures the performance of the mid-cap segment of the U.S. equity universe.  The Russell Midcap Index is a subset of the Russell 1000 Index. It includes approximately 800 of the smallest securities based on a combination of their market cap and current index membership. The Russell Midcap Growth Index measures the performance of the mid-cap growth segment of the U.S. equity universe.  It includes those Russell Midcap Index companies with higher price-to-book ratios and higher forecasted growth values. The Russell Midcap Value Index measures the performance of the mid-cap value segment of the U.S. equity universe. It includes those Russell Midcap Index companies with lower price-to-book ratios and lower forecasted growth values.

·    The Russell 2500 Index measures the performance of the small to mid-cap segment of the U.S. equity universe, commonly referred to as “smid” cap. The Russell 2500 Index is a subset of the Russell 3000® Index. The Russell 2500 Growth Index measures the performance of the small to mid-cap growth segment of the U.S. equity universe. It includes those Russell 2500 companies with higher price-to-book ratios and higher forecasted growth values. The

 

10



 

Russell 2500 Growth Index is an unmanaged index designed to measure the performance of the 2,500 smallest companies in the Russell 3000 Index with higher price-to-book ratios and higher forecasted growth values. The Russell 2500 Value Index measures the performance of the small to mid-cap value segment of the U.S. equity universe. It includes those Russell 2500 companies with lower price-to-book ratios and lower forecasted growth values.

·    The Russell 2000 Index measures the performance of the small-cap segment of the U.S. equity universe. The Russell 2000 Index is a subset of the Russell 3000 Index representing approximately 8% of the total market capitalization of that index. The Russell 2000 Growth Index measures the performance of the small-cap growth segment of the U.S. equity universe. It includes those Russell 2000 companies with higher price-to-book ratios and higher forecasted growth values. The Russell 2000 Value Index measures the performance of small-cap value segment of the U.S. equity universe. It includes those Russell 2000 companies with lower price-to-book ratios and lower forecasted growth values.

·    The Merrill Lynch All Convertible Index is an index of convertible securities that is commonly used as a general measure of performance for the convertible securities market.

·    The Barclays Capital U.S. Government/Credit Bond Index tracks the performance of government and corporate bonds.

·    The Lipper Convertible Securities Fund Index is an unmanaged index of the ten largest funds in the Lipper Convertible Securities fund category, which consists of funds that invest primarily in convertible bonds and convertible preferred stock.

·    Bond values are subject to interest rate movements; their market values tend to fall when interest rates rise and to rise when interest rates fall.  Bond values may also decline as a result of an issue’s falling credit rating or actual default, and bonds that are backed by assets are subject to prepayment risk; thus the average life of the security may be less than maturity.

·    Observations of buying opportunities during market dips were provided in the Annual Report to Alger Fund Shareholders, October 31, 2009.

·    Birinyi Associates, Inc. is a stock market research firm.

·    FactSet is a firm that provides market data and analytics to investment firms.

·    Bloomberg is a financial publisher and provider of financial data.

·    Moody’s Investors Service, Standard & Poor’s and Fitch Ratings are credit rating agencies.

·    The following companies represented the stated percentage of firm wide assets as of October 31, 2010: Hewlett-Packard, 2.11%; Dell, 0.00%; 3Par, 0.00%; McAfee, 0.00%; Intel, 0.07%; Unilever, 0.00%; Alberto-Culver, 0.00%; Barnes & Noble, Inc., 0.00%, Mervyn’s, 0.00%; EMC Corp., 0.78% and NetApp Inc., 0.13%.

 

11



 

FUND PERFORMANCE AS OF 9/30/10 (Unaudited)

AVERAGE ANNUAL TOTAL RETURNS

 

 

 

1 YEAR

 

5 YEARS

 

10 YEARS

 

SINCE
INCEPTION

 

Alger Capital Appreciation Class A (Inception 12/31/96)(i)

 

2.38

%

5.52

%

(1.66

)%

10.26

%

Alger Capital Appreciation Class B (Inception 11/1/93)

 

2.05

%

5.47

%

(1.72

)%

10.37

%

Alger Capital Appreciation Class C (Inception 7/31/97)(i)

 

6.23

%

5.87

%

(1.88

)%

9.99

%

 

 

 

 

 

 

 

 

 

 

Alger Large Cap Growth Class A (Inception 12/31/96)(i)

 

3.07

%

(1.10

)%

(2.98

)%

8.76

%

Alger Large Cap Growth Class B (Inception 11/11/86)

 

3.20

%

(1.09

)%

(3.02

)%

9.01

%

Alger Large Cap Growth Class C (Inception 7/31/97)(i)

 

7.10

%

(0.71

)%

(3.17

)%

8.58

%

 

 

 

 

 

 

 

 

 

 

Alger Mid Cap Growth Class A (Inception 12/31/96)(i)

 

5.84

%

(1.81

)%

(0.58

)%

10.00

%

Alger Mid Cap Growth Class B (Inception 5/24/93)

 

5.87

%

(1.80

)%

(0.66

)%

10.13

%

Alger Mid Cap Growth Class C (Inception 7/31/97)(i)

 

9.92

%

(1.56

)%

(0.83

)%

9.65

%

 

 

 

 

 

 

 

 

 

 

Alger SMid Cap Growth Class A (Inception 5/8/02)

 

9.15

%

3.89

%

n/a

 

5.94

%

Alger SMid Cap Growth Class B (Inception 5/8/02)

 

9.16

%

3.84

%

n/a

 

5.85

%

Alger SMid Cap Growth Class C (Inception 5/8/02)

 

13.24

%

4.21

%

n/a

 

5.83

%

Alger SMid Cap Growth Class I (Inception 8/5/07)(ii)

 

15.30

%

5.15

%

n/a

 

6.69

%

 

 

 

 

 

 

 

 

 

 

Alger Small Cap Growth Fund Class A (Inception 12/31/96)(i)

 

9.63

%

2.74

%

(1.53

)%

8.19

%

Alger Small Cap Growth Fund Class B (Inception 11/11/86)

 

9.94

%

2.76

%

(1.56

)%

8.43

%

Alger Small Cap Growth Fund Class C (Inception 7/31/97)(i)

 

13.94

%

3.11

%

(1.72

)%

8.02

%

 

 

 

 

 

 

 

 

 

 

Alger Growth Opportunities Class A (Inception 3/3/08)

 

10.85

%

n/a

 

n/a

 

(2.40

)%

Alger Growth Opportunities Class C (Inception 3/3/08)

 

15.01

%

n/a

 

n/a

 

(1.14

)%

Alger Growth Opportunities Class I (Inception 3/3/08)

 

17.18

%

n/a

 

n/a

 

(0.16

)%

 

 

 

 

 

 

 

 

 

 

Alger Health Sciences Fund Class A (Inception 5/1/02)

 

(2.01

)%

2.42

%

n/a

 

8.66

%

Alger Health Sciences Fund Class B (Inception 5/1/02)

 

(2.42

)%

2.36

%

n/a

 

8.55

%

Alger Health Sciences Fund Class C (Inception 5/1/02)

 

1.64

%

2.74

%

n/a

 

8.54

%

 

 

 

 

 

 

 

 

 

 

Alger Balanced Fund Class A (Inception 12/31/96)(i)

 

2.57

%

0.75

%

0.54

%

6.66

%

Alger Balanced Fund Class B (Inception 6/1/92)

 

2.41

%

0.66

%

0.48

%

6.82

%

Alger Balanced Fund Class C (Inception 7/31/97)(i)

 

6.52

%

1.09

%

0.32

%

6.42

%

 

FUND PERFORMANCE AS OF 9/30/10 (Unaudited)

AVERAGE ANNUAL TOTAL RETURNS

 

 

 

1 YEAR

 

5 YEARS

 

10 YEARS

 

Alger Convertible Fund Class A *

 

11.02

%

0.14

%

2.13

%

 

The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains.

 


(i)

Since inception returns are calculated through Class B inception date. Class A shares and Class C shares returns prior to their commencement of operations are that of the Class B shares adjusted to reflect Class A shares and Class C shares current maximum sales charge.

(ii)

Historical performance prior to August 5, 2007, inception of the class, is that of the Fund’s Class A shares, which has been adjusted to remove the front-end sales charge imposed by Class A shares.

*

Performance prior to January 9, 2009 represents the performance of the common stock of the Fund’s predecessor, Castle Convertible Fund, Inc., a closed-end investment company. The calculation of total return assumes dividends were reinvested at market value.

 

12



 

ALGER CAPITAL APPRECIATION FUND

Fund Highlights Through October 31, 2010 (Unaudited)

 

 

The chart above illustrates the change in value of a hypothetical $10,000 investment made in Alger Capital Appreciation Fund Class A shares, with a maximum sales chare of 5.25%, and the Russell 3000 Growth Index and the Russell 1000 Growth Index (unmanaged indices of common stocks) for the ten years ended October 31, 2010. Figures for the Alger Capital Appreciation Fund Class A shares, Russell 3000 Growth Index and Russell 1000 Growth Index include reinvestment of dividends. Performance for Alger Capital Appreciation Fund Class B and Class C shares will vary from the results shown above due to differences in expenses and sales charges those classes bear.

 

PERFORMANCE COMPARISON AS OF 10/31/10†

AVERAGE ANNUAL TOTAL RETURNS

 

 

 

1 YEAR

 

5 YEARS

 

10 YEARS

 

SINCE
INCEPTION

 

Class A (Inception 12/31/96)(i)

 

11.22

%

6.63

%

(0.17

)%

10.49

%

Class B (Inception 11/1/93)

 

11.44

%

6.60

%

(0.22

)%

10.60

%

Class C (Inception 7/31/97)(i)

 

15.51

%

6.99

%

(0.38

)%

10.22

%

Russell 3000 Growth Index

 

20.31

%

3.28

%

(2.25

)%

6.63

%

Russell 1000 Growth Index

 

19.65

%

3.21

%

(2.52

)%

6.81

%

 

The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For performance current to the most recent month end, visit us at www.alger.com or call us at (800) 992-3863.

 


Returns reflect maximum initial sales charges on Class A shares and applicable contingent deferred sales charges on Class B and Class C shares.

 

 

(i)

Since inception returns are calculated through Class B inception date. Class A shares and Class C shares returns prior to their commencement of operations are that of the Class B shares adjusted to reflect Class A shares and Class C shares current maximum sales charge.

 

13



 

ALGER LARGE CAP GROWTH FUND

Fund Highlights Through October 31, 2010 (Unaudited)

 

 

The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Large Cap Growth Fund Class A shares, with a maximum sales chare of 5.25%, and the Russell 1000 Growth Index (an unmanaged index of common stocks) for the ten years ended October 31, 2010. Figures for the Alger Large Cap Growth Fund Class A shares and the Russell 1000 Growth Index include reinvestment of dividends. Performance for the Alger Large Cap Growth Fund Class B and Class C shares will vary from the results shown above due to differences in expenses and sales charges those classes bear.

 

PERFORMANCE COMPARISON AS OF 10/31/10†

AVERAGE ANNUAL TOTAL RETURNS

 

 

 

1 YEAR

 

5 YEARS

 

10 YEARS

 

SINCE
INCEPTION

 

Class A (Inception 12/31/96)(i)

 

9.76

%

0.36

%

(1.99

)%

8.94

%

Class B (Inception 11/11/86)

 

10.09

%

0.36

%

(2.05

)%

9.18

%

Class C (Inception 7/31/97)(i)

 

14.12

%

0.73

%

(2.18

)%

8.75

%

Russell 1000 Growth Index

 

19.65

%

3.21

%

(2.52

)%

8.65

%

 

The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For performance current to the most recent month end, visit us at www.alger.com or call us at (800) 992-3863.

 


Returns reflect maximum initial sales charges on Class A shares and applicable contingent deferred sales charges on Class B and Class C shares.

 

 

(i)

Since inception returns are calculated through Class B inception date. Class A shares and Class C shares returns prior to their commencement of operations are that of the Class B shares adjusted to reflect Class A shares and Class C shares current maximum sales charge.

 

14



 

ALGER MID CAP GROWTH FUND

Fund Highlights Through October 31, 2010 (Unaudited)

 

 

The chart above illustrates the change in value of a hypothetical $10,000 investment made in Alger Mid Cap Growth Fund Class A shares, with a maximum sales chare of 5.25%, and Russell Midcap Growth Index (an unmanaged index of common stocks) for the ten years ended October 31, 2010. Figures for the Alger Mid Cap Growth Fund Class A shares and Russell Midcap Growth Index include reinvestment of dividends. Performance for the Alger Mid Cap Growth Fund Class B and Class C shares will vary from the results shown above due to differences in expenses and sales charges those classes bear.

 

PERFORMANCE COMPARISON AS OF 10/31/10†

AVERAGE ANNUAL TOTAL RETURNS

 

 

 

1 YEAR

 

5 YEARS

 

10 YEARS

 

SINCE
INCEPTION

 

Class A (Inception 12/31/96)(i)

 

15.34

%

(0.21

)%

0.22

%

10.18

%

Class B (Inception 5/24/93)

 

15.85

%

(0.20

)%

0.13

%

10.31

%

Class C (Inception 7/31/97)(i)

 

19.67

%

0.05

%

(0.03

)%

9.83

%

Russell Midcap Growth Index

 

28.03

%

4.28

%

0.20

%

8.34

%

 

The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For performance current to the most recent month end, visit us at www.alger.com or call us at (800) 992-3863.

 


Returns reflect maximum initial sales charges on Class A shares and applicable contingent deferred sales charges on Class B and Class C shares.

 

 

(i)

Since inception returns are calculated through Class B inception date. Class A shares and Class C shares returns prior to their commencement of operations are that of the Class B shares adjusted to reflect Class A shares and Class C shares current maximum sales charge.

 

15



 

ALGER SMID CAP GROWTH FUND

Fund Highlights Through October 31, 2010 (Unaudited)

 

 

The chart above illustrates the change in value of a hypothetical $10,000 investment made in Alger SMid Cap Growth Fund Class A shares, with a maximum sales chare of 5.25%, and the Russell 2500 Growth Index (an unmanaged index of common stocks) from May 8, 2002, the inception date of the Alger SMid Cap Growth Fund, through October 31, 2010. Figures for both the Alger SMid Cap Growth Fund Class A shares and the Russell 2500 Growth Index include reinvestment of dividends. Performance for the Alger SMid Cap Growth Fund Class B, Class C and Class I shares will vary from the results shown above due to differences in expenses and sales charges those classes bear.

 

PERFORMANCE COMPARISON AS OF 10/31/10†

AVERAGE ANNUAL TOTAL RETURNS

 

 

 

1 YEAR

 

5 YEARS

 

10 YEARS

 

SINCE
INCEPTION

 

Class A (Inception 5/8/02)

 

18.59

%

4.88

%

n/a

 

6.23

%

Class B (Inception 5/8/02)

 

19.08

%

4.84

%

n/a

 

6.14

%

Class C (Inception 5/8/02)

 

23.13

%

5.21

%

n/a

 

6.11

%

Class I (Inception 8/5/07)*

 

25.28

%

6.15

%

n/a

 

6.98

%

Russell 2500 Growth Index

 

28.76

%

4.55

%

n/a

 

5.88

%

 

The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For performance current to the most recent month end, visit us at www.alger.com or call us at (800) 992-3863.

 


Returns reflect maximum initial sales charges on Class A shares and applicable contingent deferred sales charges on Class B and Class C shares.

*

Historical performance prior to August 5, 2007, inception of the class, is that of the Fund’s Class A shares, which has been adjusted to remove the front-end sales charge imposed by Class A shares.

 

16



 

ALGER SMALL CAP GROWTH FUND

Fund Highlights Through October 31, 2010 (Unaudited)

 

 

The chart above illustrates the change in value of a hypothetical $10,000 investment made in the Alger Small Cap Growth Fund Class A shares, with a maximum sales chare of 5.25%, and the Russell 2000 Growth Index (an unmanaged index of common stocks) for the ten years ended October 31, 2010. Figures for both the Alger Small Cap Growth Fund Class A shares and the Russell 2000 Growth Index include reinvestment of dividends. Performance for the Alger Small Cap Growth Fund Class B and Class C shares will vary from the results shown above due to differences in expenses and sales charges those classes bear.

 

PERFORMANCE COMPARISON AS OF 10/31/10†

AVERAGE ANNUAL TOTAL RETURNS

 

 

 

1 YEAR

 

5 YEARS

 

10 YEARS

 

SINCE
INCEPTION

 

Class A (Inception 12/31/96)(i)

 

20.50

%

4.03

%

(0.43

)%

8.30

%

Class B (Inception 11/11/86)

 

21.33

%

4.05

%

(0.44

)%

8.54

%

Class C (Inception 7/31/97)(i)

 

25.06

%

4.35

%

(0.63

)%

8.14

%

Russell 2000 Growth Index

 

28.67

%

3.99

%

1.15

%

6.40

%

 

The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For performance current to the most recent month end, visit us at www.alger.com or call us at (800) 992-3863.

 


Returns reflect maximum initial sales charges on Class A shares and applicable contingent deferred sales charges on Class B and Class C shares.

 

 

(i)

Since inception returns are calculated through Class B inception date. Class A shares and Class C shares returns prior to their commencement of operations are that of the Class B shares adjusted to reflect Class A shares and Class C shares current maximum sales charge.

 

17



 

ALGER GROWTH OPPORTUNITIES FUND

Fund Highlights Through October 31, 2010 (Unaudited)

 

 

The chart above illustrates the change in value of a hypothetical $10,000 investment made in Alger Growth Opportunities Fund Class A shares, with an initial 5.25% maximum sales charge, and the Russell 2500 Growth Index (an unmanaged index of common stocks) from March 3, 2008, the inception date of the Alger Growth Opportunities Fund, through October 31, 2010. Figures for both the Alger Growth Opportunities Fund Class A shares and the Russell 2500 Growth Index include reinvestment of dividends. Performance for the Alger Growth Opportunities Fund Class C and Class I shares will vary from the results shown above due to differences in expenses and sales charges those classes bear.

 

PERFORMANCE COMPARISON AS OF 10/31/10†

AVERAGE ANNUAL TOTAL RETURNS

 

 

 

1 YEAR

 

5 YEARS

 

10 YEARS

 

SINCE
INCEPTION

 

Class A (Inception 3/3/08)

 

22.08

%

n/a

 

n/a

 

(1.15

)%

Class C (Inception 3/3/08)

 

26.81

%

n/a

 

n/a

 

0.08

%

Class I (Inception 3/3/08)

 

29.27

%

n/a

 

n/a

 

1.08

%

Russell 2500 Growth Index

 

28.76

%

n/a

 

n/a

 

2.26

%

 

The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For performance current to the most recent month end, visit us at www.alger.com or call us at (800) 992-3863.

 


Returns reflect maximum initial sales charges on Class A shares and applicable contingent deferred sales charges on Class C shares.

 

18



 

ALGER HEALTH SCIENCES FUND

Fund Highlights Through October 31, 2010 (Unaudited)

 

 

The chart above illustrates the change in value of a hypothetical $10,000 investment made in Alger Health Sciences Fund Class A shares, with a maximum sales chare of 5.25%, and the S&P 500 Index (an unmanaged index of common stocks) from May 1, 2002, the inception date of the Alger Health Sciences Fund, through October 31, 2010. Figures for both the Alger Health Sciences Fund Class A shares and the S&P 500 Index include reinvestment of dividends. Performance for the Alger Health Sciences Fund Class B and Class C shares will vary from the results shown above due to differences in expenses and sales charges those classes bear.

 

PERFORMANCE COMPARISON AS OF 10/31/10†

AVERAGE ANNUAL TOTAL RETURNS

 

 

 

1 YEAR

 

5 YEARS

 

10 YEARS

 

SINCE
INCEPTION

 

Class A (Inception 5/1/02)

 

4.75

%

3.35

%

n/a

 

8.80

%

Class B (Inception 5/1/02)

 

4.74

%

3.30

%

n/a

 

8.70

%

Class C (Inception 5/1/02)

 

8.66

%

3.67

%

n/a

 

8.68

%

S&P 500 Index

 

16.52

%

1.73

%

n/a

 

3.12

%

 

The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For performance current to the most recent month end, visit us at www.alger.com or call us at (800) 992-3863.

 


                  Returns reflect maximum initial sales charges on Class A shares and applicable contingent deferred sales charges on Class B and Class C shares.

 

19



 

ALGER BALANCED FUND

Fund Highlights Through October 31, 2010 (Unaudited)

 

 

The chart above illustrates the change in value of a hypothetical $10,000 investment made in Alger Balanced Fund Class A shares, with a maximum sales chare of 5.25%, the Russell 1000 Growth Index (an unmanaged index of common stocks) and the Barclays Capital U.S. Government/Credit Bond Index (an unmanaged index of government and corporate bonds) for the ten years ended October 31, 2010. Figures for the Alger Balanced Fund Class A shares, the Russell 1000 Growth Index and the Barclays Capital U.S. Government/Credit Bond Index include reinvestment of dividends and/or interest. Performance for the Alger Balanced Fund Class B and Class C shares will vary from the results shown above due to differences in expenses and sales charges those classes bear.

 

PERFORMANCE COMPARISON AS OF 10/31/10†

AVERAGE ANNUAL TOTAL RETURNS

 

 

 

1 YEAR

 

5 YEARS

 

10 YEARS

 

SINCE
INCEPTION

 

Class A (Inception 12/31/96)(i)

 

5.94

%

1.65

%

1.07

%

6.77

%

Class B (Inception 6/1/92)

 

5.94

%

1.57

%

1.01

%

6.93

%

Class C (Inception 7/31/97)(i)

 

10.01

%

1.98

%

0.85

%

6.53

%

Russell 1000 Growth Index

 

19.65

%

3.21

%

(2.52

)%

6.85

%

Barclays Capital U.S. Gov’t/Credit Bond Index

 

8.48

%

6.33

%

6.45

%

6.75

%

 

The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s average annual total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For performance current to the most recent month end, visit us at www.alger.com or call us at (800) 992-3863.

 


Returns reflect maximum initial sales charges on Class A shares and applicable contingent deferred sales charges on Class B and Class C shares.

 

 

(i)

Since inception returns are calculated through Class B inception date. Class A shares and Class C shares returns prior to their commencement of operations are that of the Class B shares adjusted to reflect Class A shares and Class C shares current maximum sales charge.

 

20



 

ALGER CONVERTIBLE FUND

Fund Highlights Through October 31, 2010 (Unaudited)

 

 

The chart above illustrates the change in value of a hypothetical $10,000 investment made in Alger Convertible Fund Class A shares, with an initial 5.25% maximum sales charge, and the Bank of America Merrill Lynch All US Convertibles Index (an unmanaged index of convertible bonds) for the ten years ended October 31, 2010. Figures for both the Alger Convertible Fund Class A shares and the Bank of America Merrill Lynch All US Convertibles Index include reinvestment of dividends.  Performance prior to 1/9/09, inception of the Fund, is that of its predecessor fund, Castle Convertible Fund, Inc, a closed-end investment company.

 

PERFORMANCE COMPARISON AS OF 10/31/10†

AVERAGE ANNUAL TOTAL RETURNS

 

 

 

1 YEAR

 

5 YEARS

 

10 YEARS

 

Class A *

 

15.97

%

1.19

%

2.66

%

Bank of America Merrill Lynch All US Convertibles Index

 

20.78

%

5.39

%

3.60

%

 

The performance data quoted represents past performance, which is not an indication or a guarantee of future results. The Fund’s total returns include changes in share price and reinvestment of dividends and capital gains. The chart and table above do not reflect the deduction of taxes that a shareholder would have paid on Fund distributions or on the redemption of Fund shares. Investment return and principal will fluctuate and the Fund’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. For performance current to the most recent month end, visit us at www.alger.com or call us at (800) 992-3863.

 


Returns reflect maximum initial sales charges on Class A shares.

*

Performance prior to January 9, 2009 represents the performance of the common stock of the Fund’s predecessor, Castle Convertible Fund, Inc. The calculation of total return assumes dividends were reinvested at market value.

 

21



 

PORTFOLIO SUMMARY†

October 31, 2010 (Unaudited)

 

SECTORS

 

Alger Capital
Appreciation Fund

 

Alger Large Cap
Growth Fund

 

Alger Mid Cap
Growth Fund

 

Alger SMid Cap
Growth Fund

 

Alger Small Cap
Growth Fund

 

Consumer Discretionary

 

12.4

%

10.5

%

20.4

%

18.2

%

19.0

%

Consumer Staples

 

4.7

 

9.6

 

1.4

 

2.1

 

2.7

 

Energy

 

10.5

 

8.5

 

8.0

 

3.4

 

4.1

 

Exchange Traded Funds

 

1.0

 

0.0

 

0.0

 

0.0

 

0.0

 

Financials

 

5.2

 

6.6

 

8.5

 

6.3

 

3.5

 

Health Care

 

9.7

 

11.0

 

15.4

 

15.5

 

17.4

 

Industrials

 

15.1

 

11.9

 

15.9

 

19.6

 

19.0

 

Information Technology

 

34.4

 

31.6

 

24.3

 

23.3

 

24.7

 

Materials

 

5.0

 

4.5

 

4.7

 

4.0

 

4.5

 

Telecommunication Services

 

0.0

 

0.5

 

1.2

 

2.3

 

1.4

 

Utilities

 

0.0

 

0.9

 

0.0

 

1.2

 

1.2

 

Short-Term and Net Other Assets

 

2.0

 

4.4

 

0.2

 

4.1

 

2.5

 

 

 

100.0

%

100.0

%

100.0

%

100.0

%

100.0

%

 

SECTORS

 

Alger Growth
Opportunities Fund

 

Alger Health
Sciences Fund

 

Alger Convertible
Fund

 

 

 

 

 

Consumer Discretionary

 

17.8

%

0.0

%

11.7

%

 

 

 

 

Consumer Staples

 

3.3

 

2.5

 

1.2

 

 

 

 

 

Energy

 

3.9

 

0.0

 

12.6

 

 

 

 

 

Financials

 

6.8

 

0.0

 

24.7

 

 

 

 

 

Health Care

 

16.0

 

90.4

 

9.2

 

 

 

 

 

Industrials

 

17.1

 

0.6

 

5.1

 

 

 

 

 

Information Technology

 

25.3

 

0.0

 

17.0

 

 

 

 

 

Materials

 

4.2

 

0.0

 

9.1

 

 

 

 

 

Telecommunication Services

 

1.1

 

0.0

 

1.6

 

 

 

 

 

Utilities

 

0.9

 

0.0

 

4.2

 

 

 

 

 

Short-Term and Net Other Assets

 

3.6

 

6.5

 

3.6

 

 

 

 

 

 

 

100.0

%

100.0

%

100.0

%

 

 

 

 

 

22



 

PORTFOLIO SUMMARY†

October 31, 2010 (Unaudited)

 

SECTORS/SECURITY TYPES

 

Alger Balanced Fund

 

Consumer Discretionary

 

4.9

%

Consumer Staples

 

5.1

 

Energy

 

4.9

 

Exchange Traded Funds

 

1.0

 

Financials

 

7.3

 

Health Care

 

5.0

 

Industrials

 

5.6

 

Information Technology

 

12.3

 

Materials

 

2.2

 

Telecommunication Services

 

0.3

 

Utilities

 

0.3

 

Total Equity Securities

 

48.9

%

Convertible Corporate Bonds

 

3.2

%

Corporate Bonds

 

28.8

 

U.S. Agency Obligations

 

7.0

 

U.S. Governments

 

8.1

 

Total Bonds

 

47.1

%

Short-Term and Net Other Assets

 

4.0

%

 

 

100.0

%

 

DAYS TO MATURITY

 

Alger Money Market
Fund

 

0 to 1

 

46.0

%

2 to 7

 

12.3

 

8 to 30

 

22.1

 

31 to 60

 

19.6

 

 

 

100.0

%

 


Based on net assets for each Fund, except for Alger Money Market Fund which is based on total investments.

 

23



 

THE ALGER FUNDS  |  ALGER CAPITAL APPRECIATION FUND

Schedule of Investments ‡ October 31, 2010

 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—98.0%

 

 

 

 

 

ADVERTISING—1.9%

 

 

 

 

 

Focus Media Holding Ltd.#*

 

631,200

 

$

15,622,200

 

 

 

 

 

 

 

AEROSPACE & DEFENSE—1.1%

 

 

 

 

 

Goodrich Corp.

 

21,600

 

1,772,712

 

United Technologies Corp.

 

95,800

 

7,162,966

 

 

 

 

 

8,935,678

 

AIR FREIGHT & LOGISTICS—2.9%

 

 

 

 

 

FedEx Corp.

 

96,500

 

8,464,980

 

United Parcel Service Inc., Cl. B

 

243,000

 

16,363,620

 

 

 

 

 

24,828,600

 

AIRLINES—0.9%

 

 

 

 

 

United Continental Holdings Inc.*

 

262,900

 

7,634,616

 

 

 

 

 

 

 

APPLICATION SOFTWARE—1.6%

 

 

 

 

 

Adobe Systems Inc. *

 

194,000

 

5,461,100

 

Mentor Graphics Corp. *

 

458,200

 

4,948,560

 

Nice Systems Ltd. #*

 

80,500

 

2,695,945

 

 

 

 

 

13,105,605

 

AUTO PARTS & EQUIPMENT—1.1%

 

 

 

 

 

Johnson Controls Inc.

 

39,800

 

1,397,776

 

Lear Corp. *

 

88,900

 

7,858,760

 

 

 

 

 

9,256,536

 

BIOTECHNOLOGY—1.5%

 

 

 

 

 

Celgene Corp. *

 

43,300

 

2,687,631

 

Cephalon Inc. *

 

66,200

 

4,398,328

 

Human Genome Sciences Inc. *

 

205,600

 

5,526,528

 

 

 

 

 

12,612,487

 

COAL & CONSUMABLE FUELS—1.5%

 

 

 

 

 

Peabody Energy Corp.

 

232,800

 

12,315,120

 

 

 

 

 

 

 

COMMODITY CHEMICALS—0.5%

 

 

 

 

 

Celanese Corp.

 

126,500

 

4,509,725

 

 

 

 

 

 

 

COMMUNICATIONS EQUIPMENT—3.4%

 

 

 

 

 

Cisco Systems Inc. *

 

477,000

 

10,889,910

 

Qualcomm Inc.

 

392,300

 

17,704,499

 

 

 

 

 

28,594,409

 

COMPUTER HARDWARE—10.8%

 

 

 

 

 

Apple Inc. *

 

147,445

 

44,361,777

 

Hewlett-Packard Co.

 

1,112,100

 

46,774,926

 

 

 

 

 

91,136,703

 

COMPUTER STORAGE & PERIPHERALS—1.6%

 

 

 

 

 

EMC Corp.*

 

625,200

 

13,135,452

 

 

 

 

 

 

 

CONSTRUCTION & FARM MACHINERY & HEAVY TRUCKS—2.0%

 

 

 

 

 

ArvinMeritor Inc. *

 

301,600

 

5,000,528

 

Caterpillar Inc.

 

99,200

 

7,797,120

 

Cummins Inc.

 

51,000

 

4,493,100

 

 

 

 

 

17,290,748

 

 

24



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

DATA PROCESSING & OUTSOURCED SERVICES—1.2%

 

 

 

 

 

Mastercard Inc.

 

42,700

 

$

10,250,562

 

 

 

 

 

 

 

DEPARTMENT STORES—0.5%

 

 

 

 

 

Kohl’s Corp.*

 

88,600

 

4,536,320

 

 

 

 

 

 

 

DIVERSIFIED CHEMICALS—0.3%

 

 

 

 

 

Dow Chemical Co., /The

 

82,000

 

2,528,060

 

 

 

 

 

 

 

DIVERSIFIED METALS & MINING—1.9%

 

 

 

 

 

Cliffs Natural Resources Inc.

 

142,100

 

9,264,920

 

Freeport-McMoRan Copper & Gold Inc.

 

68,400

 

6,476,112

 

 

 

 

 

15,741,032

 

DRUG RETAIL—0.5%

 

 

 

 

 

CVS Caremark Corp.

 

134,400

 

4,048,128

 

 

 

 

 

 

 

ELECTRICAL COMPONENTS & EQUIPMENT—0.1%

 

 

 

 

 

Emerson Electric Co.

 

15,800

 

867,420

 

 

 

 

 

 

 

ENVIRONMENTAL & FACILITIES SERVICES—0.5%

 

 

 

 

 

Republic Services Inc.

 

136,000

 

4,054,160

 

 

 

 

 

 

 

FERTILIZERS & AGRICULTURAL CHEMICALS—1.3%

 

 

 

 

 

CF Industries Holdings Inc.

 

39,300

 

4,815,429

 

Mosaic Co., /The

 

86,700

 

6,342,972

 

 

 

 

 

11,158,401

 

FINANCE—1.0%

 

 

 

 

 

SPDR Gold Trust*

 

62,224

 

8,253,391

 

 

 

 

 

 

 

FOOTWEAR—0.5%

 

 

 

 

 

NIKE Inc., Cl. B

 

53,000

 

4,316,320

 

 

 

 

 

 

 

GOLD—0.7%

 

 

 

 

 

Goldcorp Inc.

 

74,700

 

3,330,873

 

Yamana Gold Inc.

 

208,000

 

2,285,920

 

 

 

 

 

5,616,793

 

HEALTH CARE EQUIPMENT—1.6%

 

 

 

 

 

Covidien PLC

 

285,600

 

11,386,872

 

Insulet Corp. *

 

155,300

 

2,477,035

 

 

 

 

 

13,863,907

 

HEALTH CARE FACILITIES—1.0%

 

 

 

 

 

Universal Health Services Inc., Cl. B

 

215,100

 

8,877,177

 

 

 

 

 

 

 

HEALTH CARE SERVICES—1.3%

 

 

 

 

 

Medco Health Solutions Inc.*

 

206,900

 

10,868,457

 

 

 

 

 

 

 

HOME ENTERTAINMENT SOFTWARE—1.0%

 

 

 

 

 

Activision Blizzard Inc.

 

747,300

 

8,571,531

 

 

 

 

 

 

 

HOME IMPROVEMENT RETAIL—1.0%

 

 

 

 

 

Lowe’s Companies, Inc.

 

379,800

 

8,101,134

 

 

 

 

 

 

 

HOTELS RESORTS & CRUISE LINES—1.5%

 

 

 

 

 

Carnival Corp.

 

87,800

 

3,790,326

 

Wyndham Worldwide Corporation

 

318,800

 

9,165,500

 

 

 

 

 

12,955,826

 

 

25



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

HOUSEHOLD APPLIANCES—0.2%

 

 

 

 

 

Stanley Black & Decker Inc.

 

25,100

 

$

1,555,447

 

 

 

 

 

 

 

HUMAN RESOURCE & EMPLOYMENT SERVICES—0.5%

 

 

 

 

 

Towers Watson & Co.

 

75,200

 

3,866,784

 

 

 

 

 

 

 

HYPERMARKETS & SUPER CENTERS—0.9%

 

 

 

 

 

Wal-Mart Stores Inc.

 

144,900

 

7,849,233

 

 

 

 

 

 

 

INDUSTRIAL CONGLOMERATES—1.9%

 

 

 

 

 

3M Co.

 

81,500

 

6,863,930

 

Tyco International Ltd.

 

229,100

 

8,769,948

 

 

 

 

 

15,633,878

 

INDUSTRIAL MACHINERY—2.7%

 

 

 

 

 

Flowserve Corp.

 

59,200

 

5,920,000

 

Illinois Tool Works Inc.

 

104,800

 

4,789,360

 

Ingersoll-Rand PLC

 

300,100

 

11,796,931

 

 

 

 

 

22,506,291

 

INTEGRATED OIL & GAS—2.4%

 

 

 

 

 

Chevron Corp.

 

125,100

 

10,334,511

 

ConocoPhillips

 

160,900

 

9,557,460

 

 

 

 

 

19,891,971

 

INTERNET RETAIL—2.3%

 

 

 

 

 

Amazon.com Inc. *

 

74,100

 

12,236,874

 

Expedia Inc.

 

254,500

 

7,367,775

 

 

 

 

 

19,604,649

 

INTERNET SOFTWARE & SERVICES—6.7%

 

 

 

 

 

Google Inc., Cl. A *

 

37,565

 

23,026,969

 

GSI Commerce Inc. *

 

514,100

 

12,554,322

 

IAC/InterActiveCorp. *

 

129,715

 

3,619,049

 

Sina Corp. *

 

76,400

 

4,301,320

 

VistaPrint Ltd. *

 

130,300

 

5,481,721

 

Yahoo! Inc. *

 

452,300

 

7,467,473

 

 

 

 

 

56,450,854

 

INVESTMENT BANKING & BROKERAGE—0.9%

 

 

 

 

 

Lazard Ltd., Cl. A

 

116,500

 

4,298,850

 

Morgan Stanley

 

111,300

 

2,768,031

 

 

 

 

 

7,066,881

 

IT CONSULTING & OTHER SERVICES—0.7%

 

 

 

 

 

International Business Machines Corp.

 

38,900

 

5,586,040

 

 

 

 

 

 

 

LEISURE PRODUCTS—1.5%

 

 

 

 

 

Phillips-Van Heusen Corp.

 

207,700

 

12,740,318

 

 

 

 

 

 

 

LIFE & HEALTH INSURANCE—0.9%

 

 

 

 

 

MetLife Inc.

 

186,900

 

7,537,677

 

 

 

 

 

 

 

LIFE SCIENCES TOOLS & SERVICES—1.1%

 

 

 

 

 

Thermo Fisher Scientific Inc.*

 

172,700

 

8,880,234

 

 

 

 

 

 

 

MANAGED HEALTH CARE—0.2%

 

 

 

 

 

Aetna Inc.

 

11,700

 

349,362

 

 

26



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

MANAGED HEALTH CARE—(CONT.)

 

 

 

 

 

WellPoint Inc. *

 

28,700

 

$

1,559,558

 

 

 

 

 

1,908,920

 

METAL & GLASS CONTAINERS—0.3%

 

 

 

 

 

Ball Corp.

 

39,900

 

2,567,964

 

 

 

 

 

 

 

MOVIES & ENTERTAINMENT—0.7%

 

 

 

 

 

Walt Disney Co., /The

 

172,500

 

6,228,975

 

 

 

 

 

 

 

OIL & GAS EQUIPMENT & SERVICES—2.5%

 

 

 

 

 

Halliburton Company

 

107,400

 

3,421,764

 

National Oilwell Varco Inc.

 

152,600

 

8,203,776

 

Schlumberger Ltd.

 

140,700

 

9,833,523

 

 

 

 

 

21,459,063

 

OIL & GAS EXPLORATION & PRODUCTION—4.1%

 

 

 

 

 

Concho Resources Inc., /Restricted *,(L2),(a)

 

141,490

 

9,123,435

 

Devon Energy Corp.

 

148,000

 

9,622,960

 

Nexen Inc.

 

450,941

 

9,600,534

 

Plains Exploration & Production Co. *

 

217,100

 

6,050,577

 

 

 

 

 

34,397,506

 

OTHER DIVERSIFIED FINANCIAL SERVICES—1.5%

 

 

 

 

 

BM&F Bovespa SA

 

453,800

 

3,802,123

 

JPMorgan Chase & Co.

 

241,337

 

9,081,511

 

 

 

 

 

12,883,634

 

PHARMACEUTICALS—3.0%

 

 

 

 

 

Abbott Laboratories

 

111,120

 

5,702,679

 

Allergan Inc.

 

62,000

 

4,489,420

 

Auxilium Pharmaceuticals Inc. *

 

115,900

 

2,868,525

 

Optimer Pharmaceuticals Inc. *

 

337,700

 

3,171,003

 

Pfizer Inc.

 

389,500

 

6,777,300

 

Teva Pharmaceutical Industries Ltd. #

 

36,700

 

1,904,730

 

 

 

 

 

24,913,657

 

PROPERTY & CASUALTY INSURANCE—0.7%

 

 

 

 

 

Travelers Cos., Inc., /The

 

108,400

 

5,983,680

 

 

 

 

 

 

 

RAILROADS—1.2%

 

 

 

 

 

CSX Corp.

 

154,400

 

9,487,880

 

Union Pacific Corp.

 

11,600

 

1,017,088

 

 

 

 

 

10,504,968

 

REAL ESTATE SERVICES—0.4%

 

 

 

 

 

CB Richard Ellis Group, Inc.*

 

181,300

 

3,326,855

 

 

 

 

 

 

 

RESEARCH & CONSULTING SERVICES—0.3%

 

 

 

 

 

Verisk Analytic Inc., Cl. A*

 

98,800

 

2,945,228

 

 

 

 

 

 

 

RESTAURANTS—1.2%

 

 

 

 

 

McDonald’s Corp.

 

125,500

 

9,760,135

 

 

 

 

 

 

 

SEMICONDUCTOR EQUIPMENT—1.2%

 

 

 

 

 

Lam Research Corp.*

 

224,200

 

10,266,118

 

 

 

 

 

 

 

SEMICONDUCTORS—4.1%

 

 

 

 

 

Applied Micro Circuits Corporation *

 

135,900

 

1,368,513

 

 

27



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

SEMICONDUCTORS—(CONT.)

 

 

 

 

 

Broadcom Corp., Cl. A

 

73,000

 

$

2,974,020

 

Marvell Technology Group Ltd. *

 

647,900

 

12,510,949

 

NXP Semiconductor NV *

 

103,500

 

1,365,165

 

ON Semiconductor Corp. *

 

115,100

 

882,817

 

Skyworks Solutions Inc. *

 

350,300

 

8,025,373

 

Texas Instruments Inc.

 

258,300

 

7,637,931

 

 

 

 

 

34,764,768

 

SOFT DRINKS—2.5%

 

 

 

 

 

Coca-Cola Co., /The

 

98,600

 

6,046,152

 

PepsiCo Inc.

 

232,800

 

15,201,840

 

 

 

 

 

21,247,992

 

SPECIALIZED FINANCE—0.8%

 

 

 

 

 

CME Group Inc.

 

24,000

 

6,951,600

 

 

 

 

 

 

 

SYSTEMS SOFTWARE—2.1%

 

 

 

 

 

Oracle Corp.

 

598,600

 

17,598,840

 

 

 

 

 

 

 

TOBACCO—0.8%

 

 

 

 

 

Philip Morris International Inc.

 

115,460

 

6,754,410

 

 

 

 

 

 

 

TRUCKING—1.0%

 

 

 

 

 

Hertz Global Holdings Inc.*

 

731,700

 

8,282,844

 

 

 

 

 

 

 

TOTAL COMMON STOCKS
(Cost $785,921,198)

 

 

 

825,503,912

 

 

 

 

 

 

 

Total Investments
(Cost $785,921,198)(b)

 

98.0

%

825,503,912

 

Other Assets in Excess of Liabilities

 

2.0

 

16,824,935

 

 

 

 

 

 

 

NET ASSETS

 

100.0

%

$

842,328,847

 

 


Securities classified as Level 1 for ASC 820 disclosure purposes based on valuation inputs unless otherwise noted.

 

 

*

Non-income producing security.

#

American Depository Receipts.

(a)

Restricted Security - Investment in security pending registration under the Securities Act of 1933. The investment is deemed to be illiquid and may be sold only to qualified institutional buyers. Security was acquired on October 7, 2010 for a cost of $6,409,497 and represents 1.1% of the net assets of the Fund.

(b)

At October 31, 2010, the net unrealized appreciation on investments, based on cost for federal income tax purposes of $790,380,118 amounted to $35,123,794 which consisted of aggregate gross unrealized appreciation of $66,798,475 and aggregate gross unrealized depreciation of $31,674,681.

(L2)

Security classified as Level 2 for ASC 820 disclosure purposes based on valuation inputs.

 

Industry classifications are unaudited.

See Notes to Financial Statements.

 

28



 

THE ALGER FUNDS  |  ALGER LARGE CAP GROWTH FUND

Schedule of Investments‡ October 31, 2010

 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—95.6%

 

 

 

 

 

AEROSPACE & DEFENSE—3.1%

 

 

 

 

 

Boeing Co., /The

 

27,040

 

$

1,910,105

 

General Dynamics Corp.

 

38,790

 

2,642,375

 

Lockheed Martin Corp.

 

31,500

 

2,245,635

 

United Technologies Corp.

 

38,400

 

2,871,168

 

 

 

 

 

9,669,283

 

AIR FREIGHT & LOGISTICS—2.1%

 

 

 

 

 

FedEx Corp.

 

38,500

 

3,377,220

 

United Parcel Service Inc., Cl. B

 

47,800

 

3,218,852

 

 

 

 

 

6,596,072

 

AIRLINES—0.5%

 

 

 

 

 

Delta Air Lines Inc.*

 

105,000

 

1,458,450

 

 

 

 

 

 

 

APPLICATION SOFTWARE—1.4%

 

 

 

 

 

Adobe Systems Inc. *

 

114,600

 

3,225,990

 

Salesforce.com Inc. *

 

9,800

 

1,137,486

 

 

 

 

 

4,363,476

 

ASSET MANAGEMENT & CUSTODY BANKS—0.7%

 

 

 

 

 

BlackRock Inc.

 

12,000

 

2,051,880

 

 

 

 

 

 

 

BIOTECHNOLOGY—1.5%

 

 

 

 

 

Celgene Corp. *

 

43,600

 

2,706,252

 

Gilead Sciences Inc. *

 

52,100

 

2,066,807

 

 

 

 

 

4,773,059

 

COAL & CONSUMABLE FUELS—1.0%

 

 

 

 

 

Peabody Energy Corp.

 

61,400

 

3,248,060

 

 

 

 

 

 

 

COMMUNICATIONS EQUIPMENT—3.6%

 

 

 

 

 

Cisco Systems Inc. *

 

277,900

 

6,344,457

 

Qualcomm Inc.

 

109,400

 

4,937,222

 

 

 

 

 

11,281,679

 

COMPUTER HARDWARE—7.0%

 

 

 

 

 

Apple Inc. *

 

50,660

 

15,242,074

 

Hewlett-Packard Co.

 

156,665

 

6,589,330

 

 

 

 

 

21,831,404

 

COMPUTER STORAGE & PERIPHERALS—1.4%

 

 

 

 

 

EMC Corp.*

 

216,200

 

4,542,362

 

 

 

 

 

 

 

CONSTRUCTION & FARM MACHINERY & HEAVY TRUCKS—0.5%

 

 

 

 

 

Deere & Co.

 

20,500

 

1,574,400

 

 

 

 

 

 

 

CONSUMER FINANCE—0.5%

 

 

 

 

 

American Express Co.

 

39,800

 

1,650,108

 

 

 

 

 

 

 

DATA PROCESSING & OUTSOURCED SERVICES—2.0%

 

 

 

 

 

Mastercard Inc.

 

15,300

 

3,672,918

 

Visa Inc., Cl. A

 

32,500

 

2,540,525

 

 

 

 

 

6,213,443

 

DEPARTMENT STORES—1.0%

 

 

 

 

 

Kohl’s Corp.*

 

61,100

 

3,128,320

 

 

29



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

DIVERSIFIED CHEMICALS—0.7%

 

 

 

 

 

EI Du Pont de Nemours & Co.

 

46,700

 

$

2,207,976

 

 

 

 

 

 

 

DIVERSIFIED METALS & MINING—1.2%

 

 

 

 

 

Cliffs Natural Resources Inc.

 

39,800

 

2,594,960

 

Freeport-McMoRan Copper & Gold Inc.

 

13,000

 

1,230,840

 

 

 

 

 

3,825,800

 

DRUG RETAIL—1.6%

 

 

 

 

 

CVS Caremark Corp.

 

83,600

 

2,518,032

 

Walgreen Co.

 

74,425

 

2,521,519

 

 

 

 

 

5,039,551

 

ELECTRIC UTILITIES—0.9%

 

 

 

 

 

Southern Co.

 

72,100

 

2,730,427

 

 

 

 

 

 

 

ENVIRONMENTAL & FACILITIES SERVICES—0.9%

 

 

 

 

 

Republic Services Inc.

 

95,800

 

2,855,798

 

 

 

 

 

 

 

FERTILIZERS & AGRICULTURAL CHEMICALS—1.1%

 

 

 

 

 

Monsanto Co.

 

33,080

 

1,965,613

 

Potash Corporation of Saskatchewan Inc.

 

9,900

 

1,436,391

 

 

 

 

 

3,402,004

 

FOOTWEAR—0.5%

 

 

 

 

 

NIKE Inc., Cl. B

 

18,500

 

1,506,640

 

 

 

 

 

 

 

GENERAL MERCHANDISE STORES—0.7%

 

 

 

 

 

Target Corp.

 

45,400

 

2,358,076

 

 

 

 

 

 

 

GOLD—0.9%

 

 

 

 

 

Goldcorp Inc.

 

65,100

 

2,902,809

 

 

 

 

 

 

 

HEALTH CARE EQUIPMENT—1.7%

 

 

 

 

 

Covidien PLC

 

72,000

 

2,870,640

 

Stryker Corp.

 

27,600

 

1,365,924

 

Zimmer Holdings Inc. *

 

25,300

 

1,200,232

 

 

 

 

 

5,436,796

 

HEALTH CARE SERVICES—1.2%

 

 

 

 

 

Medco Health Solutions Inc.*

 

69,500

 

3,650,835

 

 

 

 

 

 

 

HOME ENTERTAINMENT SOFTWARE—1.6%

 

 

 

 

 

Activision Blizzard Inc.

 

274,800

 

3,151,956

 

Electronic Arts Inc. *

 

126,800

 

2,009,780

 

 

 

 

 

5,161,736

 

HOME IMPROVEMENT RETAIL—1.0%

 

 

 

 

 

Lowe’s Companies, Inc.

 

147,800

 

3,152,574

 

 

 

 

 

 

 

HOTELS RESORTS & CRUISE LINES—1.0%

 

 

 

 

 

Carnival Corp.

 

71,700

 

3,095,289

 

 

 

 

 

 

 

HOUSEHOLD APPLIANCES—0.6%

 

 

 

 

 

Stanley Black & Decker Inc.

 

28,000

 

1,735,160

 

 

 

 

 

 

 

HOUSEHOLD PRODUCTS—1.3%

 

 

 

 

 

Procter & Gamble Co., /The

 

62,760

 

3,989,653

 

 

 

 

 

 

 

HYPERMARKETS & SUPER CENTERS—1.6%

 

 

 

 

 

Wal-Mart Stores Inc.

 

92,600

 

5,016,142

 

 

30



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

INDUSTRIAL CONGLOMERATES—2.1%

 

 

 

 

 

3M Co.

 

40,200

 

$

3,385,644

 

Tyco International Ltd.

 

82,500

 

3,158,100

 

 

 

 

 

6,543,744

 

INDUSTRIAL GASES—0.6%

 

 

 

 

 

Praxair Inc.

 

20,200

 

1,845,068

 

 

 

 

 

 

 

INDUSTRIAL MACHINERY—1.6%

 

 

 

 

 

Danaher Corp.

 

57,700

 

2,501,872

 

Illinois Tool Works Inc.

 

58,500

 

2,673,450

 

 

 

 

 

5,175,322

 

INTEGRATED OIL & GAS—3.4%

 

 

 

 

 

Chevron Corp.

 

70,300

 

5,807,483

 

Exxon Mobil Corp.

 

71,300

 

4,739,311

 

 

 

 

 

10,546,794

 

INTEGRATED TELECOMMUNICATION SERVICES—0.5%

 

 

 

 

 

Verizon Communications Inc.

 

52,200

 

1,694,934

 

 

 

 

 

 

 

INTERNET RETAIL—1.7%

 

 

 

 

 

Amazon.com Inc. *

 

26,700

 

4,409,238

 

Expedia Inc.

 

27,400

 

793,230

 

 

 

 

 

5,202,468

 

INTERNET SOFTWARE & SERVICES—5.3%

 

 

 

 

 

eBay Inc. *

 

118,055

 

3,519,220

 

Google Inc., Cl. A *

 

16,195

 

9,927,373

 

Yahoo! Inc. *

 

193,900

 

3,201,289

 

 

 

 

 

16,647,882

 

INVESTMENT BANKING & BROKERAGE—1.1%

 

 

 

 

 

Charles Schwab Corp., /The

 

106,400

 

1,638,560

 

Goldman Sachs Group Inc., /The

 

10,400

 

1,673,880

 

 

 

 

 

3,312,440

 

IT CONSULTING & OTHER SERVICES—2.4%

 

 

 

 

 

Cognizant Technology Solutions Corp., Cl. A *

 

30,400

 

1,981,776

 

International Business Machines Corp.

 

38,600

 

5,542,960

 

 

 

 

 

7,524,736

 

LEISURE PRODUCTS—0.5%

 

 

 

 

 

Coach Inc.

 

31,600

 

1,580,000

 

 

 

 

 

 

 

LIFE & HEALTH INSURANCE—1.0%

 

 

 

 

 

Aflac Inc.

 

28,500

 

1,592,865

 

MetLife Inc.

 

39,900

 

1,609,167

 

 

 

 

 

3,202,032

 

LIFE SCIENCES TOOLS & SERVICES—0.8%

 

 

 

 

 

Thermo Fisher Scientific Inc.*

 

50,800

 

2,612,136

 

 

 

 

 

 

 

MANAGED HEALTH CARE—0.7%

 

 

 

 

 

UnitedHealth Group Inc.

 

57,900

 

2,087,295

 

 

 

 

 

 

 

MOVIES & ENTERTAINMENT—1.8%

 

 

 

 

 

Viacom Inc., Cl. B

 

66,500

 

2,566,235

 

 

31



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

MOVIES & ENTERTAINMENT—(CONT.)

 

 

 

 

 

Walt Disney Co., /The

 

83,100

 

$

3,000,741

 

 

 

 

 

5,566,976

 

OIL & GAS EQUIPMENT & SERVICES—1.7%

 

 

 

 

 

Schlumberger Ltd.

 

64,800

 

4,528,872

 

Weatherford International Ltd. *

 

42,100

 

707,701

 

 

 

 

 

5,236,573

 

OIL & GAS EXPLORATION & PRODUCTION—2.4%

 

 

 

 

 

Devon Energy Corp.

 

67,800

 

4,408,356

 

Nexen Inc.

 

148,400

 

3,159,436

 

 

 

 

 

7,567,792

 

OTHER DIVERSIFIED FINANCIAL SERVICES—1.3%

 

 

 

 

 

Bank of America Corp.

 

87,100

 

996,424

 

JPMorgan Chase & Co.

 

84,100

 

3,164,683

 

 

 

 

 

4,161,107

 

PACKAGED FOODS & MEATS—0.8%

 

 

 

 

 

Kraft Foods Inc., Cl. A

 

78,100

 

2,520,287

 

 

 

 

 

 

 

PERSONAL PRODUCTS—0.3%

 

 

 

 

 

Avon Products Inc.

 

25,300

 

770,385

 

 

 

 

 

 

 

PHARMACEUTICALS—5.1%

 

 

 

 

 

Abbott Laboratories

 

58,100

 

2,981,692

 

Allergan Inc.

 

32,400

 

2,346,084

 

Johnson & Johnson

 

52,000

 

3,310,840

 

Pfizer Inc.

 

171,400

 

2,982,360

 

Roche Holding AG #

 

45,000

 

1,653,750

 

Teva Pharmaceutical Industries Ltd. #

 

49,500

 

2,569,050

 

 

 

 

 

15,843,776

 

PROPERTY & CASUALTY INSURANCE—0.6%

 

 

 

 

 

Travelers Cos., Inc., /The

 

32,000

 

1,766,400

 

 

 

 

 

 

 

RAILROADS—1.1%

 

 

 

 

 

CSX Corp.

 

56,300

 

3,459,635

 

 

 

 

 

 

 

RESTAURANTS—1.1%

 

 

 

 

 

McDonald’s Corp.

 

45,000

 

3,499,650

 

 

 

 

 

 

 

SEMICONDUCTORS—3.3%

 

 

 

 

 

Broadcom Corp., Cl. A

 

60,300

 

2,456,622

 

Intel Corp.

 

163,330

 

3,278,033

 

Marvell Technology Group Ltd. *

 

184,700

 

3,566,557

 

Texas Instruments Inc.

 

33,100

 

978,767

 

 

 

 

 

10,279,979

 

SOFT DRINKS—2.9%

 

 

 

 

 

Coca-Cola Co., /The

 

61,600

 

3,777,312

 

PepsiCo Inc.

 

82,100

 

5,361,130

 

 

 

 

 

9,138,442

 

SPECIALIZED FINANCE—1.0%

 

 

 

 

 

CME Group Inc.

 

10,860

 

3,145,599

 

 

32



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

SPECIALIZED REITS—0.4%

 

 

 

 

 

Weyerhaeuser Company

 

84,053

 

$

1,363,340

 

 

 

 

 

 

 

SPECIALTY STORES—0.6%

 

 

 

 

 

Staples Inc.

 

94,300

 

1,930,321

 

 

 

 

 

 

 

SYSTEMS SOFTWARE—3.6%

 

 

 

 

 

Microsoft Corp.

 

218,895

 

5,831,363

 

Oracle Corp.

 

184,500

 

5,424,300

 

 

 

 

 

11,255,663

 

TOBACCO—1.1%

 

 

 

 

 

Philip Morris International Inc.

 

58,685

 

3,433,073

 

 

 

 

 

 

 

TOTAL COMMON STOCKS
(Cost $277,885,026)

 

 

 

299,363,111

 

 

 

 

 

 

 

Total Investments
(Cost $277,885,026)(a)

 

95.6

%

299,363,111

 

Other Assets in Excess of Liabilities

 

4.4

 

13,753,254

 

 

 

 

 

 

 

NET ASSETS

 

100.0

%

$

313,116,365

 

 


Securities classified as Level 1 for ASC 820 disclosure purposes based on valuation inputs unless otherwise noted.

 

 

*

Non-income producing security.

#

American Depository Receipts.

(a)

At October 31, 2010, the net unrealized appreciation on investments, based on cost for federal income tax purposes of $278,024,369 amounted to $21,338,742 which consisted of aggregate gross unrealized appreciation of $35,041,409 and aggregate gross unrealized depreciation of $13,702,667.

 

Industry classifications are unaudited.

See Notes to Financial Statements.

 

33



 

THE ALGER FUNDS  |  ALGER MID CAP GROWTH FUND

Schedule of Investments‡ October 31, 2010

 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—97.6%

 

 

 

 

 

ADVERTISING—0.8%

 

 

 

 

 

Focus Media Holding Ltd.#*

 

103,100

 

$

2,551,725

 

 

 

 

 

 

 

AEROSPACE & DEFENSE—2.0%

 

 

 

 

 

Goodrich Corp.

 

74,200

 

6,089,594

 

 

 

 

 

 

 

AIRLINES—0.8%

 

 

 

 

 

United Continental Holdings Inc.*

 

84,300

 

2,448,072

 

 

 

 

 

 

 

APPAREL RETAIL—2.8%

 

 

 

 

 

Chico’s FAS Inc.

 

190,300

 

1,849,716

 

J Crew Group Inc. *

 

73,700

 

2,357,663

 

TJX Cos., Inc.

 

65,600

 

3,010,384

 

Urban Outfitters Inc. *

 

49,900

 

1,535,423

 

 

 

 

 

8,753,186

 

APPLICATION SOFTWARE—5.6%

 

 

 

 

 

Adobe Systems Inc. *

 

220,500

 

6,207,075

 

Informatica Corp. *

 

61,900

 

2,518,711

 

Intuit Inc. *

 

47,600

 

2,284,800

 

Nice Systems Ltd. #*

 

99,300

 

3,325,557

 

Salesforce.com Inc. *

 

23,800

 

2,762,466

 

 

 

 

 

17,098,609

 

ASSET MANAGEMENT & CUSTODY BANKS—2.3%

 

 

 

 

 

BlackRock Inc.

 

17,500

 

2,992,325

 

T. Rowe Price Group Inc.

 

72,300

 

3,996,021

 

 

 

 

 

6,988,346

 

BIOTECHNOLOGY—4.4%

 

 

 

 

 

Alexion Pharmaceuticals Inc. *

 

20,500

 

1,400,150

 

Cephalon Inc. *

 

23,800

 

1,581,272

 

China Nuokang Bio-Pharmaceutical Inc. #*

 

284,000

 

1,320,600

 

Human Genome Sciences Inc. *

 

142,400

 

3,827,712

 

Metabolix Inc. *

 

375,100

 

5,236,396

 

 

 

 

 

13,366,130

 

BROADCASTING & CABLE TV—1.0%

 

 

 

 

 

Discovery Communications Inc., Series C*

 

81,200

 

3,155,432

 

 

 

 

 

 

 

COAL & CONSUMABLE FUELS—1.0%

 

 

 

 

 

Patriot Coal Corp.*

 

227,000

 

3,062,230

 

 

 

 

 

 

 

COMMUNICATIONS EQUIPMENT—0.7%

 

 

 

 

 

Finisar Corp.*

 

129,000

 

2,194,290

 

 

 

 

 

 

 

COMPUTER & ELECTRONICS RETAIL—0.5%

 

 

 

 

 

GameStop Corp., Cl. A*

 

85,500

 

1,680,930

 

 

 

 

 

 

 

COMPUTER HARDWARE—0.6%

 

 

 

 

 

Teradata Corp.*

 

44,500

 

1,751,520

 

 

 

 

 

 

 

COMPUTER STORAGE & PERIPHERALS—1.6%

 

 

 

 

 

NetApp Inc. *

 

64,700

 

3,445,275

 

Seagate Technology PLC *

 

111,000

 

1,626,150

 

 

 

 

 

5,071,425

 

CONSTRUCTION & ENGINEERING—1.7%

 

 

 

 

 

Aecom Technology Corp. *

 

115,200

 

3,051,648

 

 

34



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

CONSTRUCTION & ENGINEERING—(CONT.)

 

 

 

 

 

Chicago Bridge & Iron Co., NV #*

 

82,100

 

$

2,069,741

 

 

 

 

 

5,121,389

 

CONSTRUCTION & FARM MACHINERY & HEAVY TRUCKS—1.1%

 

 

 

 

 

Bucyrus International Inc.

 

20,600

 

1,404,096

 

Westport Innovations Inc. *

 

108,100

 

1,958,772

 

 

 

 

 

3,362,868

 

DATA PROCESSING & OUTSOURCED SERVICES—1.5%

 

 

 

 

 

Echo Global Logistics Inc. *

 

114,300

 

1,623,060

 

Fiserv Inc. *

 

55,200

 

3,009,504

 

 

 

 

 

4,632,564

 

DIVERSIFIED METALS & MINING—2.9%

 

 

 

 

 

Cliffs Natural Resources Inc. ^

 

88,500

 

5,770,200

 

Ivanhoe Mines Ltd. *

 

32,500

 

782,275

 

Walter Energy, Inc.

 

27,100

 

2,383,716

 

 

 

 

 

8,936,191

 

ELECTRICAL COMPONENTS & EQUIPMENT—2.6%

 

 

 

 

 

AMETEK Inc.

 

62,800

 

3,394,340

 

General Cable Corp. *

 

163,600

 

4,570,984

 

 

 

 

 

7,965,324

 

ENVIRONMENTAL & FACILITIES SERVICES—0.9%

 

 

 

 

 

Stericycle Inc.*

 

38,600

 

2,769,164

 

 

 

 

 

 

 

GOLD—1.7%

 

 

 

 

 

Yamana Gold Inc.

 

473,800

 

5,207,062

 

 

 

 

 

 

 

HEALTH CARE EQUIPMENT—2.4%

 

 

 

 

 

Insulet Corp. *

 

67,600

 

1,078,220

 

Intuitive Surgical Inc. *

 

4,300

 

1,130,685

 

Mindray Medical International Ltd. #

 

80,000

 

2,318,400

 

NuVasive Inc. *

 

111,600

 

2,923,920

 

 

 

 

 

7,451,225

 

HEALTH CARE FACILITIES—2.3%

 

 

 

 

 

Community Health Systems Inc. *

 

50,000

 

1,504,000

 

Select Medical Holdings Corp. *

 

179,600

 

1,343,408

 

Universal Health Services Inc., Cl. B

 

84,400

 

3,483,188

 

VCA Antech Inc. *

 

35,100

 

725,517

 

 

 

 

 

7,056,113

 

HOME ENTERTAINMENT SOFTWARE—1.4%

 

 

 

 

 

Activision Blizzard Inc.

 

384,900

 

4,414,803

 

 

 

 

 

 

 

HOME FURNISHING RETAIL—0.8%

 

 

 

 

 

Bed Bath & Beyond Inc.*

 

53,100

 

2,331,090

 

 

 

 

 

 

 

HOMEBUILDING—0.9%

 

 

 

 

 

Lennar Corp., Cl. A

 

192,900

 

2,798,979

 

 

 

 

 

 

 

HOTELS RESORTS & CRUISE LINES—6.3%

 

 

 

 

 

Ctrip.com International Ltd. #*

 

91,100

 

4,743,577

 

Home Inns & Hotels Management Inc. #*

 

60,200

 

3,079,832

 

Interval Leisure Group *

 

156,600

 

2,247,210

 

Morgans Hotel Group Co. *

 

99,900

 

806,193

 

 

35



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

HOTELS RESORTS & CRUISE LINES—(CONT.)

 

 

 

 

 

Orient-Express Hotels Ltd., Cl. A *

 

160,500

 

$

2,031,930

 

Royal Caribbean Cruises Ltd. *

 

89,300

 

3,530,922

 

Wyndham Worldwide Corporation

 

98,600

 

2,834,750

 

 

 

 

 

19,274,414

 

HOUSEHOLD APPLIANCES—0.5%

 

 

 

 

 

Stanley Black & Decker Inc.

 

24,400

 

1,512,068

 

 

 

 

 

 

 

INDUSTRIAL CONGLOMERATES—0.5%

 

 

 

 

 

McDermott International Inc.*

 

103,500

 

1,597,005

 

 

 

 

 

 

 

INDUSTRIAL MACHINERY—4.1%

 

 

 

 

 

Duoyuan Global Water Inc. #*

 

30,000

 

375,300

 

Flowserve Corp.

 

40,600

 

4,060,000

 

SmartHeat Inc. *

 

328,100

 

2,129,369

 

SPX Corp.

 

91,100

 

6,109,166

 

 

 

 

 

12,673,835

 

INTERNET RETAIL—3.2%

 

 

 

 

 

Expedia Inc.

 

99,000

 

2,866,050

 

NetFlix Inc. *,^

 

40,100

 

6,957,350

 

 

 

 

 

9,823,400

 

INTERNET SOFTWARE & SERVICES—3.3%

 

 

 

 

 

GSI Commerce Inc. *

 

90,600

 

2,212,452

 

OpenTable Inc. *

 

93,655

 

5,745,734

 

Yahoo! Inc. *

 

140,600

 

2,321,306

 

 

 

 

 

10,279,492

 

INVESTMENT BANKING & BROKERAGE—0.9%

 

 

 

 

 

Greenhill & Co., Inc.

 

36,200

 

2,811,654

 

 

 

 

 

 

 

IT CONSULTING & OTHER SERVICES—1.5%

 

 

 

 

 

Cognizant Technology Solutions Corp., Cl. A*

 

70,900

 

4,621,971

 

 

 

 

 

 

 

LEISURE PRODUCTS—2.0%

 

 

 

 

 

Coach Inc.

 

69,000

 

3,450,000

 

Polo Ralph Lauren Corp., Cl. A

 

27,900

 

2,702,952

 

 

 

 

 

6,152,952

 

LIFE SCIENCES TOOLS & SERVICES—0.9%

 

 

 

 

 

ICON PLC#*

 

148,400

 

2,871,540

 

 

 

 

 

 

 

MANAGED HEALTH CARE—0.5%

 

 

 

 

 

Aetna Inc.

 

48,800

 

1,457,168

 

 

 

 

 

 

 

OIL & GAS DRILLING—1.3%

 

 

 

 

 

Helmerich & Payne Inc.

 

36,300

 

1,552,914

 

Nabors Industries Ltd. *

 

113,300

 

2,367,970

 

 

 

 

 

3,920,884

 

OIL & GAS EQUIPMENT & SERVICES—1.5%

 

 

 

 

 

Cameron International Corp. *

 

61,400

 

2,686,250

 

National Oilwell Varco Inc. ^

 

34,875

 

1,874,880

 

 

 

 

 

4,561,130

 

OIL & GAS EXPLORATION & PRODUCTION—4.2%

 

 

 

 

 

Concho Resources Inc., /Restricted *,(L2),(a)

 

74,900

 

4,829,637

 

 

36



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

OIL & GAS EXPLORATION & PRODUCTION—(CONT.)

 

 

 

 

 

Nexen Inc.

 

239,400

 

$

5,096,826

 

Plains Exploration & Production Co. *

 

114,900

 

3,202,263

 

 

 

 

 

13,128,726

 

OTHER DIVERSIFIED FINANCIAL SERVICES—1.6%

 

 

 

 

 

BM&F Bovespa SA

 

594,027

 

4,977,002

 

 

 

 

 

 

 

PACKAGED FOODS & MEATS—0.4%

 

 

 

 

 

McCormick & Co., Inc.

 

32,600

 

1,441,572

 

 

 

 

 

 

 

PHARMACEUTICALS—4.2%

 

 

 

 

 

Auxilium Pharmaceuticals Inc. *

 

87,400

 

2,163,150

 

Medicis Pharmaceutical Corp., Cl. A

 

66,900

 

1,990,275

 

Mylan Inc. *

 

255,700

 

5,195,824

 

Optimer Pharmaceuticals Inc. *

 

237,100

 

2,226,369

 

Shire PLC #

 

20,100

 

1,409,010

 

 

 

 

 

12,984,628

 

RAILROADS—0.9%

 

 

 

 

 

CSX Corp.

 

45,700

 

2,808,265

 

 

 

 

 

 

 

REAL ESTATE MANAGEMENT & DEVELOPMENT—0.7%

 

 

 

 

 

BR Malls Participacoes SA

 

222,800

 

2,128,704

 

 

 

 

 

 

 

REAL ESTATE SERVICES—1.2%

 

 

 

 

 

CB Richard Ellis Group, Inc. *

 

170,800

 

3,134,180

 

E-House China Holdings Ltd. #

 

39,000

 

651,690

 

 

 

 

 

3,785,870

 

RESEARCH & CONSULTING SERVICES—1.3%

 

 

 

 

 

Verisk Analytic Inc., Cl. A*

 

134,800

 

4,018,388

 

 

 

 

 

 

 

RESTAURANTS—1.4%

 

 

 

 

 

Darden Restaurants Inc.

 

51,100

 

2,335,781

 

McCormick & Schmick’s Seafood Restaurants Inc. *

 

228,100

 

2,036,933

 

 

 

 

 

4,372,714

 

SEMICONDUCTOR EQUIPMENT—1.7%

 

 

 

 

 

Lam Research Corp.*

 

113,400

 

5,192,586

 

 

 

 

 

 

 

SEMICONDUCTORS—5.9%

 

 

 

 

 

Altera Corp.

 

133,300

 

4,160,293

 

Applied Micro Circuits Corporation *

 

278,800

 

2,807,516

 

Atheros Communications Inc. *

 

57,265

 

1,777,506

 

Marvell Technology Group Ltd. *

 

217,600

 

4,201,856

 

Netlogic Microsystems Inc. *

 

84,800

 

2,549,088

 

Skyworks Solutions Inc. *

 

114,400

 

2,620,904

 

 

 

 

 

18,117,163

 

SPECIALIZED FINANCE—1.8%

 

 

 

 

 

CME Group Inc.

 

13,400

 

3,881,310

 

IntercontinentalExchange Inc. *

 

13,000

 

1,493,310

 

 

 

 

 

5,374,620

 

SYSTEMS SOFTWARE—0.5%

 

 

 

 

 

Red Hat Inc.*

 

36,800

 

1,555,168

 

 

37



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

THRIFTS & MORTGAGE FINANCE—0.0%

 

 

 

 

 

Ocwen Financial Corp.*

 

5,700

 

$

49,191

 

TOBACCO—1.0%

 

 

 

 

 

ITC Ltd.*

 

777,700

 

2,982,718

 

TOTAL COMMON STOCKS
(Cost $287,432,733)

 

 

 

300,733,089

 

 

 

 

 

 

 

CONVERTIBLE PREFERRED STOCK—0.7%

 

 

 

 

 

BIOTECHNOLOGY—0.7%

 

 

 

 

 

Merrimack Pharmaceuticals Inc., Cl. B, /Restricted *,(L3),(b)

 

222,725

 

1,289,132

 

Merrimack Pharmaceuticals Inc., Cl. C, /Restricted *,(L3),(c)

 

232,232

 

870,870

 

 

 

 

 

2,160,002

 

TOTAL CONVERTIBLE PREFERRED STOCK
(Cost $2,160,002)

 

 

 

2,160,002

 

 

 

 

PRINCIPAL
AMOUNT

 

 

 

CONVERTIBLE CORPORATE BONDS—1.2%

 

 

 

 

 

WIRELESS TELECOMMUNICATION SERVICES—1.2%

 

 

 

 

 

SBA Communications Corp., 4.00%, 10/1/14(L2)
(Cost $3,175,826)

 

2,587,000

 

3,770,553

 

 

 

 

CONTRACTS

 

 

 

PURCHASED OPTIONS—0.3%

 

 

 

 

 

PUT OPTIONS—0.3%

 

 

 

 

 

Cliffs Natural Resources Inc./ January/ 65

 

694

 

405,990

 

NetFlix Inc./ January/ 160

 

401

 

457,140

 

(Cost $947,625)

 

 

 

863,130

 

CALL OPTIONS—0.0%

 

 

 

 

 

Adobe Systems Inc./ December/ 30
(Cost $103,195)

 

1,100

 

107,800

 

 

 

 

 

 

 

TOTAL PURCHASED OPTIONS
(Cost $1,050,820)

 

 

 

970,930

 

 

 

 

 

 

 

Total Investments
(Cost $293,819,381)(d)

 

99.8

%

307,634,574

 

Other Assets in Excess of Liabilities

 

0.2

 

576,879

 

 

 

 

 

 

 

NET ASSETS

 

100.0

%

$

308,211,453

 

 


Securities classified as Level 1 for ASC 820 disclosure purposes based on valuation inputs unless otherwise noted.

 

 

^

All or a portion of this security has been pledged as collateral for written call options.

*

Non-income producing security.

#

American Depository Receipts.

(a)

Restricted Security - Investment in security pending registration under the Securities Act of 1933. The investment is deemed to be illiquid and may be sold only to qualified institutional buyers. Security was acquired on October 7, 2010 for a cost of $3,392,970 and represents 1.6% of the net assets of the Fund.

 

38



 

(b)

Restricted Security - Investment in security not registered under the Securities Act of 1933. The investment is deemed to be illiquid and may be sold only to qualified institutional buyers.  Security was acquired on August 25, 2010 for a cost of $1,289,132 and represents 0.4% of the net assets of the Fund.

(c)

Restricted Security - Investment in security not registered under the Securities Act of 1933. The investment is deemed to be illiquid and may be sold only to qualified institutional buyers.  Security was acquired on August 25, 2010 for a cost of $870,870 and represents 0.3% of the net assets of the Fund.

(d)

At October 31, 2010, the net unrealized appreciation on investments, based on cost for federal income tax purposes of $295,216,102 amounted to $12,418,472 which consisted of aggregate gross unrealized appreciation of $29,873,762 and aggregate gross unrealized depreciation of $17,455,290.

(L2)

Security classified as Level 2 for ASC 820 disclosure purposes based on valuation inputs.

(L3)

Security classified as Level 3 for ASC 820 disclosure purposes based on valuation inputs.

 

Industry classifications are unaudited.

See Notes to Financial Statements.

 

39



 

THE ALGER FUNDS  | ALGER MID CAP GROWTH FUND

Schedule of Options Written October 31, 2010

 

 

 

CONTRACTS

 

SHARES
SUBJECT
TO PUT/
CALL

 

VALUE

 

PUT OPTIONS WRITTEN

 

 

 

 

 

 

 

Cliffs Natural Resources Inc./ January/ 57.50

 

694

 

69,400

 

188,768

 

TOTAL PUT OPTIONS WRITTEN
(Premiums Received $320,613)

 

 

 

 

 

188,768

 

CALL OPTIONS WRITTEN

 

 

 

 

 

 

 

Cliffs Natural Resources Inc./ January/ 70

 

694

 

69,400

 

$

246,370

 

National Oilwell Varco Inc./ November/ 48

 

144

 

14,400

 

91,440

 

NetFlix Inc./ January/ 170

 

401

 

40,100

 

757,890

 

TOTAL CALL OPTIONS WRITTEN
(Premiums Received $558,347)

 

 

 

 

 

1,095,700

 

TOTAL OPTIONS WRITTEN
(Premiums Received $878,960)

 

 

 

 

 

$

1,284,468

 

 


Securities classified as Level 1 for ASC 820 disclosure purposes based on valuation inputs unless otherwise noted.

 

Industry classifications are unaudited.

See Notes to Financial Statements

 

40



 

(This page has been intentionally left blank.)

 


 


 

THE ALGER FUNDS  |  ALGER SMID CAP GROWTH FUND

Schedule of Investments‡ October 31, 2010

 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—95.9%

 

 

 

 

 

ADVERTISING—1.2%

 

 

 

 

 

Focus Media Holding Ltd. #*

 

294,650

 

$

7,292,588

 

Interpublic Group of Cos., Inc., /The *

 

321,450

 

3,327,007

 

 

 

 

 

10,619,595

 

AEROSPACE & DEFENSE—1.9%

 

 

 

 

 

AAR Corp. *

 

391,750

 

8,634,170

 

BE Aerospace Inc. *

 

197,950

 

7,276,642

 

 

 

 

 

15,910,812

 

AIRLINES—0.8%

 

 

 

 

 

United Continental Holdings Inc.*

 

241,500

 

7,013,160

 

 

 

 

 

 

 

APPAREL RETAIL—2.4%

 

 

 

 

 

AnnTaylor Stores Corp. *

 

455,000

 

10,601,500

 

Childrens Place Retail Stores Inc., /The *

 

46,750

 

2,059,805

 

Coldwater Creek Inc. *

 

814,200

 

2,743,854

 

Urban Outfitters Inc. *

 

171,500

 

5,277,055

 

 

 

 

 

20,682,214

 

APPLICATION SOFTWARE—6.9%

 

 

 

 

 

Ansys Inc. *

 

156,125

 

7,064,656

 

Concur Technologies Inc. *

 

144,450

 

7,456,509

 

Informatica Corp. *

 

258,750

 

10,528,537

 

Nice Systems Ltd. #*

 

271,850

 

9,104,257

 

Pegasystems Inc.

 

128,450

 

3,474,572

 

Solera Holdings Inc.

 

167,606

 

8,053,468

 

Synopsys Inc. *

 

268,420

 

6,866,184

 

Taleo Corp., Cl. A *

 

234,350

 

6,723,502

 

 

 

 

 

59,271,685

 

ASSET MANAGEMENT & CUSTODY BANKS—1.0%

 

 

 

 

 

Affiliated Managers Group Inc.*

 

100,512

 

8,604,832

 

 

 

 

 

 

 

AUTO PARTS & EQUIPMENT—1.1%

 

 

 

 

 

Dana Holding Corp.*

 

674,695

 

9,546,934

 

 

 

 

 

 

 

AUTOMOTIVE RETAIL—0.3%

 

 

 

 

 

Carmax Inc.*

 

86,800

 

2,689,932

 

 

 

 

 

 

 

BIOTECHNOLOGY—3.2%

 

 

 

 

 

Alexion Pharmaceuticals Inc. *

 

145,400

 

9,930,820

 

Human Genome Sciences Inc. *

 

291,900

 

7,846,272

 

Savient Pharmaceuticals Inc. *

 

267,320

 

3,317,441

 

United Therapeutics Corp. *

 

109,950

 

6,597,000

 

 

 

 

 

27,691,533

 

CABLE & SATELLITE—0.9%

 

 

 

 

 

Sirius XM Radio Inc.*

 

5,256,920

 

7,859,095

 

 

 

 

 

 

 

COMMODITY CHEMICALS—0.6%

 

 

 

 

 

STR Holdings Inc.*

 

202,700

 

5,037,095

 

 

 

 

 

 

 

COMMUNICATIONS EQUIPMENT—2.4%

 

 

 

 

 

Acme Packet Inc. *

 

109,750

 

4,340,613

 

Finisar Corp. *

 

369,300

 

6,281,793

 

JDS Uniphase Corp. *

 

570,550

 

5,996,480

 

 

42



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

COMMUNICATIONS EQUIPMENT—(CONT.)

 

 

 

 

 

Riverbed Technology Inc. *

 

60,350

 

$

3,472,539

 

 

 

 

 

20,091,425

 

COMPUTER STORAGE & PERIPHERALS—0.8%

 

 

 

 

 

QLogic Corp. *

 

294,650

 

5,177,000

 

Smart Technologies Inc., Cl. A *

 

155,450

 

2,019,296

 

 

 

 

 

7,196,296

 

CONSTRUCTION & ENGINEERING—0.7%

 

 

 

 

 

Aecom Technology Corp.*

 

237,840

 

6,300,382

 

 

 

 

 

 

 

CONSTRUCTION & FARM MACHINERY & HEAVY TRUCKS—0.6%

 

 

 

 

 

Bucyrus International Inc.

 

79,400

 

5,411,904

 

 

 

 

 

 

 

DATA PROCESSING & OUTSOURCED SERVICES—1.0%

 

 

 

 

 

Wright Express Corp.*

 

234,450

 

8,841,110

 

 

 

 

 

 

 

DISTRIBUTORS—1.0%

 

 

 

 

 

LKQ Corp.*

 

392,950

 

8,542,733

 

 

 

 

 

 

 

DIVERSIFIED METALS & MINING—0.7%

 

 

 

 

 

Walter Energy, Inc.

 

63,750

 

5,607,450

 

 

 

 

 

 

 

EDUCATION SERVICES—0.5%

 

 

 

 

 

ITT Educational Services Inc.*

 

69,450

 

4,481,608

 

 

 

 

 

 

 

ELECTRIC UTILITIES—1.2%

 

 

 

 

 

ITC Holdings Corp.

 

156,550

 

9,801,596

 

 

 

 

 

 

 

ELECTRICAL COMPONENTS & EQUIPMENT—3.9%

 

 

 

 

 

AMETEK Inc.

 

184,500

 

9,972,225

 

GrafTech International Ltd. *

 

435,150

 

7,166,921

 

Roper Industries Inc.

 

104,550

 

7,258,906

 

Woodward Governor Co.

 

300,700

 

9,423,938

 

 

 

 

 

33,821,990

 

ELECTRONIC MANUFACTURING SERVICES—1.1%

 

 

 

 

 

Trimble Navigation Ltd.*

 

256,895

 

9,207,117

 

 

 

 

 

 

 

ENVIRONMENTAL & FACILITIES SERVICES—2.5%

 

 

 

 

 

Clean Harbors, Inc. *

 

93,450

 

6,588,225

 

Tetra Tech Inc. *

 

253,450

 

5,337,657

 

Waste Connections Inc.

 

234,350

 

9,547,419

 

 

 

 

 

21,473,301

 

FOREST PRODUCTS—0.5%

 

 

 

 

 

Louisiana-Pacific Corp.*

 

593,100

 

4,590,594

 

 

 

 

 

 

 

GENERAL MERCHANDISE STORES—1.2%

 

 

 

 

 

Dollar Tree Inc.*

 

206,830

 

10,612,447

 

 

 

 

 

 

 

GOLD—0.4%

 

 

 

 

 

Gammon Gold Inc.*

 

522,250

 

3,566,968

 

 

 

 

 

 

 

HEALTH CARE EQUIPMENT—1.9%

 

 

 

 

 

NuVasive Inc. *

 

125,200

 

3,280,240

 

Sirona Dental Systems Inc. *

 

153,900

 

5,794,335

 

Thoratec Corp. *

 

214,300

 

6,994,752

 

 

 

 

 

16,069,327

 

 

43



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

HEALTH CARE FACILITIES—2.3%

 

 

 

 

 

Community Health Systems Inc. *

 

191,850

 

$

5,770,848

 

Select Medical Holdings Corp. *

 

595,750

 

4,456,210

 

Universal Health Services Inc., Cl. B

 

108,500

 

4,477,795

 

VCA Antech Inc. *

 

249,100

 

5,148,897

 

 

 

 

 

19,853,750

 

HEALTH CARE SERVICES—0.9%

 

 

 

 

 

Emergency Medical Services Corp.*

 

136,650

 

7,431,027

 

 

 

 

 

 

 

HOME FURNISHING RETAIL—1.0%

 

 

 

 

 

Williams-Sonoma Inc.

 

269,600

 

8,726,952

 

 

 

 

 

 

 

HOTELS RESORTS & CRUISE LINES—1.8%

 

 

 

 

 

Gaylord Entertainment Co. *

 

246,100

 

8,204,974

 

Wyndham Worldwide Corporation

 

248,400

 

7,141,500

 

 

 

 

 

15,346,474

 

HOUSEHOLD PRODUCTS—0.7%

 

 

 

 

 

Church & Dwight Co., Inc.

 

92,500

 

6,091,125

 

 

 

 

 

 

 

HOUSEWARES & SPECIALTIES—1.1%

 

 

 

 

 

Tupperware Brands Corp.

 

201,650

 

9,035,937

 

 

 

 

 

 

 

HUMAN RESOURCE & EMPLOYMENT SERVICES—0.8%

 

 

 

 

 

Towers Watson & Co.

 

128,050

 

6,584,331

 

 

 

 

 

 

 

INDUSTRIAL CONGLOMERATES—0.6%

 

 

 

 

 

McDermott International Inc.*

 

352,350

 

5,436,761

 

 

 

 

 

 

 

INDUSTRIAL MACHINERY—3.4%

 

 

 

 

 

Actuant Corp., Cl. A

 

240,550

 

5,405,158

 

Barnes Group Inc.

 

185,100

 

3,366,969

 

Clarcor Inc.

 

129,950

 

5,153,817

 

Pall Corp.

 

192,500

 

8,213,975

 

SPX Corp.

 

101,200

 

6,786,472

 

 

 

 

 

28,926,391

 

INDUSTRIAL REITS—0.6%

 

 

 

 

 

Dupont Fabros Technology Inc.

 

221,700

 

5,564,670

 

 

 

 

 

 

 

INTERNET SOFTWARE & SERVICES—3.6%

 

 

 

 

 

GSI Commerce Inc. *

 

334,250

 

8,162,385

 

IAC/InterActiveCorp. *

 

288,500

 

8,049,150

 

OpenTable Inc. *

 

151,250

 

9,279,187

 

VistaPrint Ltd. *

 

136,900

 

5,759,383

 

 

 

 

 

31,250,105

 

INVESTMENT BANKING & BROKERAGE—1.0%

 

 

 

 

 

Greenhill & Co., Inc.

 

107,250

 

8,330,107

 

 

 

 

 

 

 

IT CONSULTING & OTHER SERVICES—0.4%

 

 

 

 

 

SRA International, Inc. Cl. A*

 

173,250

 

3,466,733

 

 

 

 

 

 

 

LEISURE FACILITIES—0.8%

 

 

 

 

 

Life Time Fitness Inc.*

 

179,600

 

6,488,948

 

 

 

 

 

 

 

LEISURE PRODUCTS—1.7%

 

 

 

 

 

Carter’s Inc. *

 

165,650

 

4,124,685

 

 

44



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

LEISURE PRODUCTS—(CONT.)

 

 

 

 

 

Phillips-Van Heusen Corp.

 

167,600

 

$

10,280,584

 

 

 

 

 

14,405,269

 

LIFE SCIENCES TOOLS & SERVICES—2.1%

 

 

 

 

 

Bruker Corp. *

 

392,600

 

5,885,074

 

ICON PLC #*

 

237,950

 

4,604,332

 

Parexel International Corp. *

 

376,250

 

8,089,375

 

 

 

 

 

18,578,781

 

MANAGED HEALTH CARE—1.0%

 

 

 

 

 

Amerigroup Corp.*

 

207,650

 

8,665,235

 

 

 

 

 

 

 

METAL & GLASS CONTAINERS—0.9%

 

 

 

 

 

Crown Holdings Inc.*

 

246,550

 

7,936,444

 

 

 

 

 

 

 

OIL & GAS EQUIPMENT & SERVICES—1.1%

 

 

 

 

 

Acergy SA #

 

342,200

 

6,902,174

 

Cal Dive International Inc. *

 

523,550

 

2,649,163

 

 

 

 

 

9,551,337

 

OIL & GAS EXPLORATION & PRODUCTION—2.3%

 

 

 

 

 

Concho Resources Inc. *

 

48,250

 

3,313,328

 

Mariner Energy Inc. *

 

133,550

 

3,328,066

 

Plains Exploration & Production Co. *

 

342,400

 

9,542,688

 

Quicksilver Resources Inc. *

 

232,050

 

3,473,788

 

 

 

 

 

19,657,870

 

PACKAGED FOODS & MEATS—1.4%

 

 

 

 

 

Hain Celestial Group Inc. *

 

269,050

 

6,653,606

 

Ralcorp Holdings Inc. *

 

90,600

 

5,622,636

 

 

 

 

 

12,276,242

 

PHARMACEUTICALS—4.1%

 

 

 

 

 

Auxilium Pharmaceuticals Inc. *

 

235,504

 

5,828,724

 

Medicis Pharmaceutical Corp., Cl. A

 

276,850

 

8,236,288

 

Mylan Inc. *

 

356,090

 

7,235,749

 

Optimer Pharmaceuticals Inc. *

 

504,750

 

4,739,602

 

Perrigo Co.

 

97,850

 

6,446,358

 

Valeant Pharmaceuticals International Inc.

 

92,140

 

2,543,985

 

 

 

 

 

35,030,706

 

RAILROADS—1.0%

 

 

 

 

 

Genesee & Wyoming Inc., Cl. A*

 

188,150

 

8,698,174

 

 

 

 

 

 

 

REAL ESTATE SERVICES—0.9%

 

 

 

 

 

CB Richard Ellis Group, Inc.*

 

444,350

 

8,153,822

 

 

 

 

 

 

 

REGIONAL BANKS—0.7%

 

 

 

 

 

Signature Bank*

 

146,900

 

6,205,056

 

 

 

 

 

 

 

REINSURANCE—0.6%

 

 

 

 

 

Platinum Underwriters Holdings Ltd.

 

117,350

 

5,051,918

 

 

 

 

 

 

 

RESEARCH & CONSULTING SERVICES—2.4%

 

 

 

 

 

FTI Consulting Inc. *

 

117,750

 

4,175,415

 

ICF International Inc. *

 

281,700

 

7,217,154

 

IHS Inc., Cl. A *

 

123,100

 

8,892,744

 

 

 

 

 

20,285,313

 

 

45



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

RESTAURANTS—1.0%

 

 

 

 

 

Darden Restaurants Inc.

 

189,650

 

$

8,668,902

 

 

 

 

 

 

 

RETAIL REITS—0.7%

 

 

 

 

 

Macerich Co., /The

 

125,000

 

5,576,250

 

 

 

 

 

 

 

SECURITY & ALARM SERVICES—1.0%

 

 

 

 

 

Geo Group Inc., /The*

 

335,800

 

8,613,270

 

 

 

 

 

 

 

SEMICONDUCTOR EQUIPMENT—1.1%

 

 

 

 

 

Novellus Systems Inc.*

 

329,350

 

9,620,313

 

 

 

 

 

 

 

SEMICONDUCTORS—4.9%

 

 

 

 

 

Applied Micro Circuits Corporation *

 

487,400

 

4,908,118

 

Atheros Communications Inc. *

 

201,250

 

6,246,800

 

Mellanox Technologies Ltd. *

 

291,755

 

6,716,200

 

Monolithic Power Systems Inc. *

 

268,750

 

4,318,813

 

Netlogic Microsystems Inc. *

 

205,450

 

6,175,827

 

ON Semiconductor Corp. *

 

545,100

 

4,180,917

 

Skyworks Solutions Inc. *

 

423,900

 

9,711,549

 

 

 

 

 

42,258,224

 

SPECIALIZED CONSUMER SERVICES—1.1%

 

 

 

 

 

Sotheby’s

 

215,450

 

9,445,328

 

 

 

 

 

 

 

SPECIALTY CHEMICALS—0.9%

 

 

 

 

 

Rockwood Holdings Inc.*

 

235,050

 

7,972,896

 

 

 

 

 

 

 

SPECIALTY STORES—1.1%

 

 

 

 

 

PetSmart Inc.

 

254,650

 

9,531,550

 

 

 

 

 

 

 

SYSTEMS SOFTWARE—1.1%

 

 

 

 

 

Red Hat Inc.*

 

216,700

 

9,157,742

 

 

 

 

 

 

 

THRIFTS & MORTGAGE FINANCE—0.8%

 

 

 

 

 

Brookline Bancorp Inc.

 

353,850

 

3,446,499

 

Ocwen Financial Corp. *

 

364,850

 

3,148,656

 

 

 

 

 

6,595,155

 

WIRELESS TELECOMMUNICATION SERVICES—2.3%

 

 

 

 

 

SBA Communications Corp. *

 

250,350

 

9,828,741

 

Syniverse Holdings Inc. *

 

312,200

 

9,518,978

 

 

 

 

 

19,347,719

 

TOTAL COMMON STOCKS
(Cost $710,561,897)

 

 

 

824,359,962

 

 

 

 

 

 

 

Total Investments
(Cost $710,561,897)(a)

 

95.9

%

824,359,962

 

Other Assets in Excess of Liabilities

 

4.1

 

34,856,365

 

 

 

 

 

 

 

NET ASSETS

 

100.0

%

$

859,216,327

 

 


Securities classified as Level 1 for ASC 820 disclosure purposes based on valuation inputs unless otherwise noted.

 

 

*

Non-income producing security.

 

46



 

#

American Depository Receipts.

(a)

At October 31, 2010, the net unrealized appreciation on investments, based on cost for federal income tax purposes of $711,441,213 amounted to $112,918,749 which consisted of aggregate gross unrealized appreciation of $146,412,528 and aggregate gross unrealized depreciation of $33,493,779.

 

Industry classifications are unaudited.

See Notes to Financial Statements.

 

47


 


 

THE ALGER FUNDS  |  ALGER SMALL CAP GROWTH FUND

Schedule of Investments‡ October 31, 2010

 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—97.5%

 

 

 

 

 

AEROSPACE & DEFENSE—2.4%

 

 

 

 

 

AAR Corp. *

 

44,900

 

$

989,596

 

BE Aerospace Inc. *

 

84,545

 

3,107,874

 

Esterline Technologies Corp. *

 

68,420

 

4,135,305

 

 

 

 

 

8,232,775

 

AIRLINES—0.9%

 

 

 

 

 

Airtran Holdings Inc.*

 

428,945

 

3,174,193

 

 

 

 

 

 

 

APPAREL RETAIL—2.9%

 

 

 

 

 

Aeropostale Inc. *

 

65,300

 

1,592,014

 

AnnTaylor Stores Corp. *

 

176,700

 

4,117,110

 

Childrens Place Retail Stores Inc., /The *

 

75,900

 

3,344,154

 

Coldwater Creek Inc. *

 

319,100

 

1,075,367

 

 

 

 

 

10,128,645

 

APPLICATION SOFTWARE—9.1%

 

 

 

 

 

Cadence Design Systems, Inc. *

 

324,500

 

2,748,515

 

Concur Technologies Inc. *

 

63,995

 

3,303,422

 

Informatica Corp. *

 

88,300

 

3,592,927

 

Nice Systems Ltd. #*

 

124,225

 

4,160,295

 

Pegasystems Inc.

 

52,600

 

1,422,830

 

QLIK Technologies Inc. *

 

98,186

 

2,451,705

 

Solera Holdings Inc.

 

84,145

 

4,043,167

 

Taleo Corp., Cl. A *

 

98,900

 

2,837,441

 

Ultimate Software Group Inc. *

 

79,400

 

3,285,572

 

VanceInfo Technologies Inc. #*

 

91,400

 

3,324,218

 

 

 

 

 

31,170,092

 

AUTO PARTS & EQUIPMENT—1.2%

 

 

 

 

 

Dana Holding Corp.*

 

280,300

 

3,966,245

 

 

 

 

 

 

 

BIOTECHNOLOGY—2.2%

 

 

 

 

 

Acorda Therapeutics Inc. *

 

37,700

 

1,019,408

 

Cubist Pharmaceuticals Inc. *

 

58,900

 

1,371,192

 

Incyte Corp., Ltd. *

 

61,600

 

1,026,256

 

Savient Pharmaceuticals Inc. *

 

121,900

 

1,512,779

 

United Therapeutics Corp. *

 

42,520

 

2,551,200

 

 

 

 

 

7,480,835

 

CASINOS & GAMING—0.7%

 

 

 

 

 

WMS Industries Inc.*

 

57,800

 

2,521,814

 

 

 

 

 

 

 

COAL & CONSUMABLE FUELS—0.8%

 

 

 

 

 

Patriot Coal Corp.*

 

190,600

 

2,571,194

 

 

 

 

 

 

 

COMMERCIAL PRINTING—0.3%

 

 

 

 

 

Warnaco Group Inc., /The*

 

18,500

 

982,535

 

 

 

 

 

 

 

COMMODITY CHEMICALS—0.5%

 

 

 

 

 

STR Holdings Inc.*

 

70,400

 

1,749,440

 

 

 

 

 

 

 

COMMUNICATIONS EQUIPMENT—3.4%

 

 

 

 

 

Acme Packet Inc. *

 

37,900

 

1,498,945

 

Aruba Networks Inc. *

 

162,500

 

3,560,375

 

Finisar Corp. *

 

208,200

 

3,541,482

 

 

48



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

COMMUNICATIONS EQUIPMENT—(CONT.)

 

 

 

 

 

Riverbed Technology Inc. *

 

52,400

 

$

3,015,096

 

 

 

 

 

11,615,898

 

COMPUTER STORAGE & PERIPHERALS—0.8%

 

 

 

 

 

QLogic Corp. *

 

100,200

 

1,760,514

 

Smart Technologies Inc., Cl. A *

 

79,900

 

1,037,901

 

 

 

 

 

2,798,415

 

CONSTRUCTION & ENGINEERING—0.7%

 

 

 

 

 

Aecom Technology Corp.*

 

94,695

 

2,508,471

 

 

 

 

 

 

 

DATA PROCESSING & OUTSOURCED SERVICES—1.0%

 

 

 

 

 

Wright Express Corp.*

 

92,975

 

3,506,087

 

 

 

 

 

 

 

DISTRIBUTORS—1.1%

 

 

 

 

 

LKQ Corp.*

 

178,670

 

3,884,286

 

 

 

 

 

 

 

DIVERSIFIED CHEMICALS—0.3%

 

 

 

 

 

Solutia Inc.*

 

64,000

 

1,159,040

 

 

 

 

 

 

 

EDUCATION SERVICES—1.2%

 

 

 

 

 

American Public Education Inc. *

 

71,700

 

2,004,732

 

Grand Canyon Education, Inc. *

 

106,100

 

1,995,741

 

 

 

 

 

4,000,473

 

ELECTRIC UTILITIES—1.2%

 

 

 

 

 

ITC Holdings Corp.

 

63,200

 

3,956,952

 

 

 

 

 

 

 

ELECTRICAL COMPONENTS & EQUIPMENT—2.2%

 

 

 

 

 

GrafTech International Ltd. *

 

207,600

 

3,419,172

 

Woodward Governor Co.

 

133,460

 

4,182,636

 

 

 

 

 

7,601,808

 

ENVIRONMENTAL & FACILITIES SERVICES—2.7%

 

 

 

 

 

Clean Harbors, Inc. *

 

44,000

 

3,102,000

 

Tetra Tech Inc. *

 

95,200

 

2,004,912

 

Waste Connections Inc.

 

102,100

 

4,159,554

 

 

 

 

 

9,266,466

 

FOOD DISTRIBUTORS—0.6%

 

 

 

 

 

United Natural Foods Inc.*

 

62,500

 

2,235,000

 

 

 

 

 

 

 

FOREST PRODUCTS—0.6%

 

 

 

 

 

Louisiana-Pacific Corp.*

 

275,400

 

2,131,596

 

 

 

 

 

 

 

GOLD—0.4%

 

 

 

 

 

Gammon Gold Inc.*

 

200,900

 

1,372,147

 

 

 

 

 

 

 

HEALTH CARE EQUIPMENT—4.3%

 

 

 

 

 

Arthrocare Corp. *

 

57,600

 

1,571,328

 

Insulet Corp. *

 

194,900

 

3,108,655

 

MAKO Surgical Corp. *

 

137,200

 

1,479,016

 

NuVasive Inc. *

 

63,300

 

1,658,460

 

Sirona Dental Systems Inc. *

 

63,800

 

2,402,070

 

Thoratec Corp. *

 

92,828

 

3,029,906

 

Wright Medical Group Inc. *

 

106,300

 

1,418,042

 

 

 

 

 

14,667,477

 

 

49



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

HEALTH CARE FACILITIES—1.5%

 

 

 

 

 

LifePoint Hospitals Inc. *

 

98,600

 

$

3,344,512

 

Select Medical Holdings Corp. *

 

260,700

 

1,950,036

 

 

 

 

 

5,294,548

 

HEALTH CARE SERVICES—1.8%

 

 

 

 

 

Catalyst Health Solutions, Inc. *

 

92,100

 

3,485,985

 

Gentiva Health Services Inc. *

 

109,600

 

2,551,488

 

 

 

 

 

6,037,473

 

HEALTH CARE SUPPLIES—0.6%

 

 

 

 

 

AGA Medical Holdings Inc.*

 

103,500

 

2,147,625

 

 

 

 

 

 

 

HEALTH CARE TECHNOLOGY—1.7%

 

 

 

 

 

MedAssets Inc. *

 

131,200

 

2,432,448

 

Medidata Solutions Inc. *

 

184,000

 

3,427,920

 

 

 

 

 

5,860,368

 

HOME FURNISHING RETAIL—1.1%

 

 

 

 

 

Williams-Sonoma Inc.

 

118,200

 

3,826,134

 

 

 

 

 

 

 

HOME FURNISHINGS—0.3%

 

 

 

 

 

Ethan Allen Interiors Inc.

 

63,579

 

964,493

 

 

 

 

 

 

 

HOTELS RESORTS & CRUISE LINES—2.0%

 

 

 

 

 

Gaylord Entertainment Co. *

 

111,200

 

3,707,408

 

Interval Leisure Group *

 

209,200

 

3,002,020

 

 

 

 

 

6,709,428

 

HOUSEWARES & SPECIALTIES—1.0%

 

 

 

 

 

Tupperware Brands Corp.

 

80,400

 

3,602,724

 

 

 

 

 

 

 

HUMAN RESOURCE & EMPLOYMENT SERVICES—1.1%

 

 

 

 

 

Towers Watson & Co.

 

71,700

 

3,686,814

 

 

 

 

 

 

 

INDUSTRIAL MACHINERY—3.3%

 

 

 

 

 

Actuant Corp., Cl. A

 

188,940

 

4,245,482

 

Clarcor Inc.

 

78,100

 

3,097,446

 

RBC Bearings Inc. *

 

122,100

 

4,068,372

 

 

 

 

 

11,411,300

 

INTERNET RETAIL—1.3%

 

 

 

 

 

Shutterfly Inc.*

 

145,500

 

4,379,550

 

 

 

 

 

 

 

INTERNET SOFTWARE & SERVICES—4.0%

 

 

 

 

 

GSI Commerce Inc. *

 

143,349

 

3,500,583

 

LogMeIn, Inc. *

 

93,700

 

3,722,701

 

OpenTable Inc. *

 

64,700

 

3,969,345

 

VistaPrint Ltd. *

 

64,900

 

2,730,343

 

 

 

 

 

13,922,972

 

INVESTMENT BANKING & BROKERAGE—1.1%

 

 

 

 

 

Greenhill & Co., Inc.

 

46,200

 

3,588,354

 

 

 

 

 

 

 

IT CONSULTING & OTHER SERVICES—0.4%

 

 

 

 

 

SRA International, Inc. Cl. A*

 

63,600

 

1,272,636

 

 

 

 

 

 

 

LEISURE FACILITIES—0.8%

 

 

 

 

 

Life Time Fitness Inc.*

 

73,375

 

2,651,039

 

 

50



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

LEISURE PRODUCTS—0.6%

 

 

 

 

 

Carter’s Inc. *

 

54,400

 

$

1,354,560

 

Vera Bradley Inc. *

 

27,400

 

749,390

 

 

 

 

 

2,103,950

 

LIFE SCIENCES TOOLS & SERVICES—1.9%

 

 

 

 

 

Bruker Corp. *

 

215,400

 

3,228,846

 

Parexel International Corp. *

 

153,808

 

3,306,872

 

 

 

 

 

6,535,718

 

MANAGED HEALTH CARE—1.0%

 

 

 

 

 

Amerigroup Corp.*

 

83,300

 

3,476,109

 

 

 

 

 

 

 

METAL & GLASS CONTAINERS—0.8%

 

 

 

 

 

Silgan Holdings Inc.

 

82,470

 

2,783,362

 

 

 

 

 

 

 

OFFICE SERVICES & SUPPLIES—0.3%

 

 

 

 

 

American Reprographics Co.*

 

128,300

 

913,496

 

 

 

 

 

 

 

OIL & GAS EQUIPMENT & SERVICES—1.2%

 

 

 

 

 

Cal Dive International Inc. *

 

235,100

 

1,189,606

 

Dril-Quip Inc. *

 

25,220

 

1,742,702

 

Lufkin Industries Inc.

 

23,100

 

1,128,435

 

 

 

 

 

4,060,743

 

OIL & GAS EXPLORATION & PRODUCTION—2.1%

 

 

 

 

 

Kodiak Oil & Gas Corp. *

 

486,000

 

2,002,320

 

Mariner Energy Inc. *

 

61,859

 

1,541,526

 

Quicksilver Resources Inc. *

 

94,800

 

1,419,156

 

Rosetta Resources Inc. *

 

63,800

 

1,525,458

 

SM Energy Co.

 

21,200

 

883,616

 

 

 

 

 

7,372,076

 

PACKAGED FOODS & MEATS—2.1%

 

 

 

 

 

Diamond Foods, Inc.

 

53,300

 

2,355,860

 

Flowers Foods Inc.

 

89,400

 

2,277,912

 

Hain Celestial Group Inc. *

 

98,420

 

2,433,927

 

 

 

 

 

7,067,699

 

PHARMACEUTICALS—2.4%

 

 

 

 

 

Auxilium Pharmaceuticals Inc. *

 

105,300

 

2,606,175

 

Eurand NV *

 

37,600

 

412,096

 

Medicis Pharmaceutical Corp., Cl. A

 

95,800

 

2,850,050

 

Optimer Pharmaceuticals Inc. *

 

260,600

 

2,447,034

 

 

 

 

 

8,315,355

 

PUBLISHING—0.8%

 

 

 

 

 

Valassis Communications Inc.*

 

87,500

 

2,887,500

 

 

 

 

 

 

 

RAILROADS—1.2%

 

 

 

 

 

Genesee & Wyoming Inc., Cl. A*

 

88,000

 

4,068,240

 

 

 

 

 

 

 

REGIONAL BANKS—1.4%

 

 

 

 

 

Investors Bancorp, Inc. *

 

173,800

 

2,085,600

 

Signature Bank *

 

64,900

 

2,741,376

 

 

 

 

 

4,826,976

 

REINSURANCE—0.5%

 

 

 

 

 

Platinum Underwriters Holdings Ltd.

 

40,400

 

1,739,220

 

 

51



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

RESEARCH & CONSULTING SERVICES—1.9%

 

 

 

 

 

FTI Consulting Inc. *

 

49,500

 

$

1,755,270

 

ICF International Inc. *

 

94,300

 

2,415,966

 

Resources Connection Inc.

 

148,000

 

2,396,120

 

 

 

 

 

6,567,356

 

RESTAURANTS—1.7%

 

 

 

 

 

Cheesecake Factory Inc., /The *

 

100,700

 

2,932,384

 

McCormick & Schmick’s Seafood Restaurants Inc. *

 

189,935

 

1,696,120

 

Sonic Corp. *

 

149,400

 

1,326,672

 

 

 

 

 

5,955,176

 

SECURITY & ALARM SERVICES—1.3%

 

 

 

 

 

Geo Group Inc., /The*

 

168,970

 

4,334,080

 

 

 

 

 

 

 

SEMICONDUCTOR EQUIPMENT—1.3%

 

 

 

 

 

Novellus Systems Inc.*

 

150,600

 

4,399,026

 

 

 

 

 

 

 

SEMICONDUCTORS—4.7%

 

 

 

 

 

Applied Micro Circuits Corporation *

 

276,700

 

2,786,369

 

Atheros Communications Inc. *

 

93,825

 

2,912,328

 

Mellanox Technologies Ltd. *

 

108,861

 

2,505,980

 

Monolithic Power Systems Inc. *

 

137,900

 

2,216,053

 

Netlogic Microsystems Inc. *

 

85,200

 

2,561,112

 

Skyworks Solutions Inc. *

 

145,600

 

3,335,696

 

 

 

 

 

16,317,538

 

SPECIALIZED CONSUMER SERVICES—1.2%

 

 

 

 

 

Sotheby’s

 

94,900

 

4,160,416

 

 

 

 

 

 

 

SPECIALTY CHEMICALS—1.9%

 

 

 

 

 

Kraton Performance Polymers Inc. *

 

79,300

 

2,574,078

 

Rockwood Holdings Inc. *

 

112,600

 

3,819,392

 

 

 

 

 

6,393,470

 

SPECIALTY STORES—1.1%

 

 

 

 

 

Ulta Salon, Cosmetics & Fragrance, Inc.*

 

120,100

 

3,685,869

 

 

 

 

 

 

 

THRIFTS & MORTGAGE FINANCE—0.5%

 

 

 

 

 

Ocwen Financial Corp.*

 

204,700

 

1,766,561

 

 

 

 

 

 

 

TRUCKING—0.7%

 

 

 

 

 

Dollar Thrifty Automotive Group Inc.*

 

55,400

 

2,570,560

 

 

 

 

 

 

 

WIRELESS TELECOMMUNICATION SERVICES—1.4%

 

 

 

 

 

Syniverse Holdings Inc.*

 

162,100

 

4,942,429

 

 

 

 

 

 

 

TOTAL COMMON STOCKS
(Cost $289,224,180)

 

 

 

335,280,267

 

 

 

 

 

 

 

Total Investments
(Cost $289,224,180)(a)

 

97.5

%

335,280,267

 

Other Assets in Excess of Liabilities

 

2.5

 

8,557,033

 

 

 

 

 

 

 

NET ASSETS

 

100.0

%

$

343,837,300

 

 

52



 


Securities classified as Level 1 for ASC 820 disclosure purposes based on valuation inputs unless otherwise noted.

 

 

*

Non-income producing security.

#

American Depository Receipts.

(a)

At October 31, 2010, the net unrealized appreciation on investments, based on cost for federal income tax purposes of $289,588,321 amounted to $45,691,946 which consisted of aggregate gross unrealized appreciation of $65,060,793 and aggregate gross unrealized depreciation of $19,368,847.

 

Industry classifications are unaudited.

See Notes to Financial Statements.

 

53


 


 

THE ALGER FUNDS  |  ALGER GROWTH OPPORTUNITIES FUND

Schedule of Investments‡ October 31, 2010

 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—96.4%

 

 

 

 

 

ADVERTISING—0.5%

 

 

 

 

 

Focus Media Holding Ltd.#*

 

2,670

 

$

66,082

 

 

 

 

 

 

 

AEROSPACE & DEFENSE—2.6%

 

 

 

 

 

AAR Corp. *

 

3,010

 

66,340

 

BE Aerospace Inc. *

 

3,865

 

142,078

 

Esterline Technologies Corp. *

 

2,345

 

141,732

 

 

 

 

 

350,150

 

APPAREL RETAIL—2.4%

 

 

 

 

 

AnnTaylor Stores Corp. *

 

6,410

 

149,353

 

Childrens Place Retail Stores Inc., /The *

 

2,615

 

115,217

 

Coldwater Creek Inc. *

 

15,380

 

51,830

 

 

 

 

 

316,400

 

APPLICATION SOFTWARE—8.3%

 

 

 

 

 

Ansys Inc. *

 

2,040

 

92,310

 

Concur Technologies Inc. *

 

1,700

 

87,754

 

Informatica Corp. *

 

4,210

 

171,305

 

Mentor Graphics Corp. *

 

5,750

 

62,100

 

Nice Systems Ltd. #*

 

2,045

 

68,487

 

Pegasystems Inc.

 

3,720

 

100,626

 

QLIK Technologies Inc. *

 

5,325

 

132,965

 

Taleo Corp., Cl. A *

 

5,120

 

146,893

 

VanceInfo Technologies Inc. #*

 

4,360

 

158,573

 

Verint Systems Inc. *

 

2,410

 

79,313

 

 

 

 

 

1,100,326

 

ASSET MANAGEMENT & CUSTODY BANKS—1.0%

 

 

 

 

 

Affiliated Managers Group Inc.*

 

1,570

 

134,408

 

 

 

 

 

 

 

AUTO PARTS & EQUIPMENT—1.0%

 

 

 

 

 

Dana Holding Corp.*

 

9,100

 

128,765

 

 

 

 

 

 

 

BIOTECHNOLOGY—3.9%

 

 

 

 

 

Alexion Pharmaceuticals Inc. *

 

2,005

 

136,941

 

AVEO Pharmaceuticals Inc. *

 

7,725

 

117,420

 

Human Genome Sciences Inc. *

 

4,360

 

117,197

 

Savient Pharmaceuticals Inc. *

 

5,510

 

68,379

 

United Therapeutics Corp. *

 

1,275

 

76,500

 

 

 

 

 

516,437

 

CABLE & SATELLITE—0.9%

 

 

 

 

 

Sirius XM Radio Inc.*

 

84,585

 

126,455

 

 

 

 

 

 

 

CASINOS & GAMING—0.9%

 

 

 

 

 

WMS Industries Inc.*

 

2,650

 

115,620

 

 

 

 

 

 

 

COMMUNICATIONS EQUIPMENT—2.7%

 

 

 

 

 

Aruba Networks Inc. *

 

5,590

 

122,477

 

Finisar Corp. *

 

5,535

 

94,150

 

JDS Uniphase Corp. *

 

6,690

 

70,312

 

Riverbed Technology Inc. *

 

1,280

 

73,651

 

 

 

 

 

360,590

 

COMPUTER STORAGE & PERIPHERALS—0.3%

 

 

 

 

 

Smart Technologies Inc., Cl. A*

 

3,385

 

43,971

 

 

54



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

CONSTRUCTION & ENGINEERING—0.8%

 

 

 

 

 

Aecom Technology Corp.*

 

3,840

 

$

101,722

 

 

 

 

 

 

 

CONSTRUCTION & FARM MACHINERY & HEAVY TRUCKS—0.7%

 

 

 

 

 

Bucyrus International Inc.

 

1,310

 

89,289

 

 

 

 

 

 

 

DATA PROCESSING & OUTSOURCED SERVICES—0.5%

 

 

 

 

 

Echo Global Logistics Inc.*

 

4,945

 

70,219

 

 

 

 

 

 

 

DISTRIBUTORS—0.8%

 

 

 

 

 

LKQ Corp.*

 

5,125

 

111,417

 

 

 

 

 

 

 

DIVERSIFIED METALS & MINING—0.5%

 

 

 

 

 

Walter Energy, Inc.

 

765

 

67,289

 

 

 

 

 

 

 

EDUCATION SERVICES—1.2%

 

 

 

 

 

American Public Education Inc. *

 

2,350

 

65,706

 

Grand Canyon Education, Inc. *

 

4,785

 

90,006

 

 

 

 

 

155,712

 

ELECTRIC UTILITIES—0.9%

 

 

 

 

 

ITC Holdings Corp.

 

1,975

 

123,655

 

 

 

 

 

 

 

ELECTRICAL COMPONENTS & EQUIPMENT—2.8%

 

 

 

 

 

AMETEK Inc.

 

2,685

 

145,124

 

GrafTech International Ltd. *

 

6,165

 

101,537

 

Woodward Governor Co.

 

3,870

 

121,286

 

 

 

 

 

367,947

 

ELECTRONIC COMPONENTS—0.9%

 

 

 

 

 

Fabrinet*

 

8,590

 

120,947

 

 

 

 

 

 

 

ELECTRONIC MANUFACTURING SERVICES—0.9%

 

 

 

 

 

Trimble Navigation Ltd.*

 

3,425

 

122,752

 

 

 

 

 

 

 

ENVIRONMENTAL & FACILITIES SERVICES—1.7%

 

 

 

 

 

Clean Harbors, Inc. *

 

1,595

 

112,448

 

Waste Connections Inc.

 

2,930

 

119,368

 

 

 

 

 

231,816

 

FOOD DISTRIBUTORS—0.5%

 

 

 

 

 

United Natural Foods Inc.*

 

1,810

 

64,726

 

 

 

 

 

 

 

FOREST PRODUCTS—0.6%

 

 

 

 

 

Louisiana-Pacific Corp.*

 

9,690

 

75,001

 

 

 

 

 

 

 

GENERAL MERCHANDISE STORES—1.2%

 

 

 

 

 

Dollar Tree Inc.*

 

3,222

 

165,321

 

 

 

 

 

 

 

GOLD—0.4%

 

 

 

 

 

Gammon Gold Inc.*

 

8,810

 

60,172

 

 

 

 

 

 

 

HEALTH CARE EQUIPMENT—3.3%

 

 

 

 

 

HeartWare International Inc. *

 

1,465

 

100,118

 

Insulet Corp. *

 

6,920

 

110,374

 

MAKO Surgical Corp. *

 

5,170

 

55,733

 

Sirona Dental Systems Inc. *

 

2,625

 

98,831

 

Thoratec Corp. *

 

2,145

 

70,013

 

 

 

 

 

435,069

 

 

55



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

HEALTH CARE FACILITIES—0.7%

 

 

 

 

 

Community Health Systems Inc.*

 

2,875

 

$

86,480

 

 

 

 

 

 

 

HEALTH CARE SERVICES—1.6%

 

 

 

 

 

Catalyst Health Solutions, Inc. *

 

3,210

 

121,498

 

Gentiva Health Services Inc. *

 

3,900

 

90,792

 

 

 

 

 

212,290

 

HEALTH CARE SUPPLIES—0.4%

 

 

 

 

 

AGA Medical Holdings Inc.*

 

2,790

 

57,893

 

 

 

 

 

 

 

HEALTH CARE TECHNOLOGY—1.4%

 

 

 

 

 

MedAssets Inc. *

 

3,945

 

73,140

 

Medidata Solutions Inc. *

 

6,180

 

115,134

 

 

 

 

 

188,274

 

HOME FURNISHINGS—0.4%

 

 

 

 

 

Ethan Allen Interiors Inc.

 

3,630

 

55,067

 

 

 

 

 

 

 

HOTELS RESORTS & CRUISE LINES—2.5%

 

 

 

 

 

eLong Inc. #*

 

6,310

 

112,633

 

Interval Leisure Group *

 

8,015

 

115,015

 

Morgans Hotel Group Co. *

 

13,265

 

107,049

 

 

 

 

 

334,697

 

HOUSEHOLD PRODUCTS—0.7%

 

 

 

 

 

Church & Dwight Co., Inc.

 

1,345

 

88,568

 

 

 

 

 

 

 

INDUSTRIAL MACHINERY—3.8%

 

 

 

 

 

Actuant Corp., Cl. A

 

4,730

 

106,283

 

Barnes Group Inc.

 

3,555

 

64,665

 

Clarcor Inc.

 

2,745

 

108,867

 

RBC Bearings Inc. *

 

3,350

 

111,622

 

SPX Corp.

 

1,610

 

107,967

 

 

 

 

 

499,404

 

INTERNET RETAIL—1.2%

 

 

 

 

 

Shutterfly Inc.*

 

5,310

 

159,831

 

 

 

 

 

 

 

INTERNET SOFTWARE & SERVICES—6.0%

 

 

 

 

 

GSI Commerce Inc. *

 

5,240

 

127,961

 

IAC/InterActiveCorp. *

 

3,590

 

100,161

 

LogMeIn, Inc. *

 

3,770

 

149,782

 

OpenTable Inc. *

 

2,565

 

157,363

 

support.com Inc. *

 

30,390

 

172,311

 

VistaPrint Ltd. *

 

2,110

 

88,768

 

 

 

 

 

796,346

 

INVESTMENT BANKING & BROKERAGE—1.0%

 

 

 

 

 

Greenhill & Co., Inc.

 

1,655

 

128,544

 

 

 

 

 

 

 

LEISURE FACILITIES—0.8%

 

 

 

 

 

Life Time Fitness Inc.*

 

3,035

 

109,655

 

 

 

 

 

 

 

LEISURE PRODUCTS—1.5%

 

 

 

 

 

Phillips-Van Heusen Corp.

 

2,090

 

128,201

 

Vera Bradley Inc. *

 

2,430

 

66,460

 

 

 

 

 

194,661

 

 

56



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

LIFE SCIENCES TOOLS & SERVICES—0.9%

 

 

 

 

 

Parexel International Corp.*

 

5,460

 

$

117,390

 

 

 

 

 

 

 

MANAGED HEALTH CARE—0.8%

 

 

 

 

 

Amerigroup Corp.*

 

2,525

 

105,368

 

 

 

 

 

 

 

METAL & GLASS CONTAINERS—0.8%

 

 

 

 

 

Silgan Holdings Inc.

 

3,120

 

105,300

 

 

 

 

 

 

 

OFFICE REITS—0.5%

 

 

 

 

 

Mack-Cali Realty Corp.

 

1,820

 

61,115

 

 

 

 

 

 

 

OFFICE SERVICES & SUPPLIES—0.4%

 

 

 

 

 

American Reprographics Co.*

 

8,320

 

59,238

 

 

 

 

 

 

 

OIL & GAS EQUIPMENT & SERVICES—1.3%

 

 

 

 

 

Acergy SA #

 

3,945

 

79,571

 

Dril-Quip Inc. *

 

1,265

 

87,411

 

 

 

 

 

166,982

 

OIL & GAS EXPLORATION & PRODUCTION—2.6%

 

 

 

 

 

Concho Resources Inc. *

 

730

 

50,129

 

Kodiak Oil & Gas Corp. *

 

13,140

 

54,137

 

Plains Exploration & Production Co. *

 

3,215

 

89,602

 

Quicksilver Resources Inc. *

 

3,725

 

55,763

 

Resolute Entergy Corp. *

 

8,350

 

100,284

 

 

 

 

 

349,915

 

PACKAGED FOODS & MEATS—2.1%

 

 

 

 

 

Diamond Foods, Inc.

 

2,405

 

106,301

 

Flowers Foods Inc.

 

3,570

 

90,964

 

Hain Celestial Group Inc. *

 

3,650

 

90,264

 

 

 

 

 

287,529

 

PHARMACEUTICALS—3.0%

 

 

 

 

 

Auxilium Pharmaceuticals Inc. *

 

4,480

 

110,880

 

Cadence Pharmaceuticals Inc. *

 

8,645

 

76,768

 

Mylan Inc. *

 

5,880

 

119,482

 

Optimer Pharmaceuticals Inc. *

 

10,050

 

94,369

 

 

 

 

 

401,499

 

PUBLISHING—0.4%

 

 

 

 

 

Valassis Communications Inc.*

 

1,835

 

60,555

 

 

 

 

 

 

 

RAILROADS—1.0%

 

 

 

 

 

Genesee & Wyoming Inc., Cl. A*

 

2,825

 

130,600

 

 

 

 

 

 

 

REAL ESTATE SERVICES—1.0%

 

 

 

 

 

CB Richard Ellis Group, Inc.*

 

7,060

 

129,551

 

 

 

 

 

 

 

REGIONAL BANKS—1.8%

 

 

 

 

 

Investors Bancorp, Inc. *

 

7,045

 

84,540

 

Park Sterling Bank *

 

10,345

 

60,208

 

Signature Bank *

 

2,135

 

90,182

 

 

 

 

 

234,930

 

REINSURANCE—0.7%

 

 

 

 

 

Platinum Underwriters Holdings Ltd.

 

2,300

 

99,015

 

 

57



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

RESEARCH & CONSULTING SERVICES—1.8%

 

 

 

 

 

ICF International Inc. *

 

4,440

 

$

113,753

 

IHS Inc., Cl. A *

 

1,795

 

129,671

 

 

 

 

 

243,424

 

RESTAURANTS—0.5%

 

 

 

 

 

Country Style Cooking Restaurant#*

 

2,065

 

61,041

 

 

 

 

 

 

 

RETAIL REITS—0.5%

 

 

 

 

 

Macerich Co., /The

 

1,565

 

69,815

 

 

 

 

 

 

 

SECURITY & ALARM SERVICES—0.9%

 

 

 

 

 

Geo Group Inc., /The*

 

4,660

 

119,529

 

 

 

 

 

 

 

SEMICONDUCTOR EQUIPMENT—1.0%

 

 

 

 

 

Novellus Systems Inc.*

 

4,400

 

128,524

 

 

 

 

 

 

 

SEMICONDUCTORS—4.7%

 

 

 

 

 

Applied Micro Circuits Corporation *

 

7,455

 

75,072

 

Atheros Communications Inc. *

 

3,050

 

94,672

 

Mellanox Technologies Ltd. *

 

5,090

 

117,172

 

Netlogic Microsystems Inc. *

 

4,195

 

126,102

 

ON Semiconductor Corp. *

 

7,785

 

59,711

 

Skyworks Solutions Inc. *

 

6,360

 

145,707

 

 

 

 

 

618,436

 

SPECIALIZED CONSUMER SERVICES—1.6%

 

 

 

 

 

Sotheby’s

 

2,645

 

115,957

 

Steiner Leisure Ltd. *

 

2,435

 

94,405

 

 

 

 

 

210,362

 

SPECIALTY CHEMICALS—1.9%

 

 

 

 

 

Kraton Performance Polymers Inc. *

 

4,000

 

129,840

 

Rockwood Holdings Inc. *

 

3,570

 

121,095

 

 

 

 

 

250,935

 

THRIFTS & MORTGAGE FINANCE—0.3%

 

 

 

 

 

Ocwen Financial Corp.*

 

5,400

 

46,602

 

 

 

 

 

 

 

TRUCKING—0.6%

 

 

 

 

 

Dollar Thrifty Automotive Group Inc.*

 

1,660

 

77,024

 

 

 

 

 

 

 

WIRELESS TELECOMMUNICATION SERVICES—1.1%

 

 

 

 

 

SBA Communications Corp.*

 

3,615

 

141,925

 

 

 

 

 

 

 

TOTAL COMMON STOCKS
(Cost $9,885,600)

 

 

 

12,810,572

 

 

 

 

 

 

 

Total Investments
(Cost $9,885,600)(a)

 

96.4

%

12,810,572

 

Other Assets in Excess of Liabilities

 

3.6

 

478,389

 

 

 

 

 

 

 

NET ASSETS

 

100.0

%

$

13,288,961

 

 

58



 


Securities classified as Level 1 for ASC 820 disclosure purposes based on valuation inputs unless otherwise noted.

 

 

*

Non-income producing security.

#

American Depository Receipts.

(a)

At October 31, 2010, the net unrealized appreciation on investments, based on cost for federal income tax purposes of $9,947,749 amounted to $2,862,823 which consisted of aggregate gross unrealized appreciation of $3,117,920 and aggregate gross unrealized depreciation of $255,097.

 

Industry classifications are unaudited.

See Notes to Financial Statements.

 

59


 


 

THE ALGER FUNDS  |  ALGER HEALTH SCIENCES FUND

Schedule of Investments‡ October 31, 2010

 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—92.8%

 

 

 

 

 

BIOTECHNOLOGY—18.4%

 

 

 

 

 

Acorda Therapeutics Inc. *

 

69,950

 

$

1,891,448

 

Actelion Ltd. *

 

93,600

 

4,670,727

 

Alexion Pharmaceuticals Inc. *

 

53,050

 

3,623,315

 

Arqule Inc. *

 

446,200

 

2,463,024

 

AVEO Pharmaceuticals Inc. *

 

170,150

 

2,586,280

 

Celgene Corp. *

 

113,059

 

7,017,572

 

Cephalon Inc. *

 

94,050

 

6,248,682

 

China Nuokang Bio-Pharmaceutical Inc. #*

 

170,739

 

793,937

 

Cubist Pharmaceuticals Inc. *

 

50,050

 

1,165,164

 

Human Genome Sciences Inc. *

 

284,600

 

7,650,048

 

Savient Pharmaceuticals Inc. *

 

132,100

 

1,639,361

 

United Therapeutics Corp. *

 

67,900

 

4,074,000

 

 

 

 

 

43,823,558

 

DRUG RETAIL—2.5%

 

 

 

 

 

CVS Caremark Corp.

 

197,400

 

5,945,688

 

 

 

 

 

 

 

HEALTH CARE EQUIPMENT—13.9%

 

 

 

 

 

Arthrocare Corp. *

 

58,850

 

1,605,428

 

Covidien PLC

 

31,900

 

1,271,853

 

Edwards Lifesciences Corp. *

 

42,500

 

2,716,175

 

Hospira Inc. *

 

50,200

 

2,985,896

 

Insulet Corp. *

 

107,960

 

1,721,962

 

Intuitive Surgical Inc. *

 

18,100

 

4,759,395

 

Kinetic Concepts Inc. *

 

60,050

 

2,283,702

 

MAKO Surgical Corp. *

 

146,750

 

1,581,965

 

Medtronic Inc.

 

67,150

 

2,364,351

 

NuVasive Inc. *

 

62,669

 

1,641,928

 

Stryker Corp.

 

47,950

 

2,373,045

 

Thoratec Corp. *

 

59,950

 

1,956,768

 

Wright Medical Group Inc. *

 

108,300

 

1,444,722

 

Zimmer Holdings Inc. *

 

91,200

 

4,326,528

 

 

 

 

 

33,033,718

 

HEALTH CARE FACILITIES—4.5%

 

 

 

 

 

Community Health Systems Inc. *

 

101,650

 

3,057,632

 

LifePoint Hospitals Inc. *

 

62,350

 

2,114,912

 

Select Medical Holdings Corp. *

 

404,600

 

3,026,408

 

Universal Health Services Inc., Cl. B

 

59,350

 

2,449,374

 

 

 

 

 

10,648,326

 

HEALTH CARE SERVICES—2.1%

 

 

 

 

 

Medco Health Solutions Inc.*

 

93,900

 

4,932,567

 

 

 

 

 

 

 

HEALTH CARE SUPPLIES—2.0%

 

 

 

 

 

AGA Medical Holdings Inc. *

 

164,800

 

3,419,600

 

Align Technology Inc. *

 

73,800

 

1,256,814

 

 

 

 

 

4,676,414

 

HEALTH CARE TECHNOLOGY—1.5%

 

 

 

 

 

Medidata Solutions Inc.*

 

186,700

 

3,478,221

 

 

 

 

 

 

 

INDUSTRIAL MACHINERY—0.6%

 

 

 

 

 

Pall Corp.

 

34,450

 

1,469,982

 

 

60



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

LIFE SCIENCES TOOLS & SERVICES—7.0%

 

 

 

 

 

Affymetrix Inc. *

 

203,365

 

$

911,075

 

Bruker Corp. *

 

164,650

 

2,468,104

 

Charles River Laboratories International Inc. *

 

98,450

 

3,226,207

 

Illumina Inc. *

 

54,630

 

2,966,955

 

Parexel International Corp. *

 

104,083

 

2,237,784

 

Thermo Fisher Scientific Inc. *

 

96,600

 

4,967,172

 

 

 

 

 

16,777,297

 

MANAGED HEALTH CARE—7.9%

 

 

 

 

 

CIGNA Corp.

 

74,350

 

2,616,377

 

Humana Inc. *

 

73,800

 

4,301,802

 

UnitedHealth Group Inc.

 

234,350

 

8,448,317

 

WellPoint Inc. *

 

62,950

 

3,420,703

 

 

 

 

 

18,787,199

 

PHARMACEUTICALS—32.4%

 

 

 

 

 

Abbott Laboratories

 

158,500

 

8,134,220

 

Allergan Inc.

 

84,500

 

6,118,645

 

Auxilium Pharmaceuticals Inc. *

 

334,078

 

8,268,430

 

Cadence Pharmaceuticals Inc. *

 

136,900

 

1,215,672

 

Eurand NV *

 

42,820

 

469,307

 

Forest Laboratories Inc. *

 

102,450

 

3,385,973

 

Johnson & Johnson

 

42,150

 

2,683,691

 

Medicis Pharmaceutical Corp., Cl. A

 

116,390

 

3,462,602

 

Merck & Co., Inc.

 

108,300

 

3,929,124

 

Mylan Inc. *

 

262,850

 

5,341,112

 

Optimer Pharmaceuticals Inc. *

 

917,460

 

8,614,949

 

Pfizer Inc.

 

286,000

 

4,976,400

 

Roche Holding AG

 

50,200

 

7,370,726

 

Sanofi-Aventis SA #

 

64,450

 

2,262,840

 

Shire PLC #

 

104,650

 

7,335,965

 

SuperGen Inc. *

 

492,250

 

1,368,455

 

Valeant Pharmaceuticals International Inc.

 

81,654

 

2,254,467

 

 

 

 

 

77,192,578

 

TOTAL COMMON STOCKS
(Cost $210,126,669)

 

 

 

220,765,548

 

 

 

 

 

 

 

CONVERTIBLE PREFERRED STOCK—0.7%

 

 

 

 

 

BIOTECHNOLOGY—0.7%

 

 

 

 

 

Merrimack Pharmaceuticals Inc., Cl. B, /Restricted *,(L3),(a)

 

174,261

 

1,008,623

 

Merrimack Pharmaceuticals Inc., Cl. C, /Restricted *,(L3),(b)

 

181,700

 

681,375

 

 

 

 

 

1,689,998

 

TOTAL CONVERTIBLE PREFERRED STOCK
(Cost $1,689,998)

 

 

 

1,689,998

 

 

 

 

 

 

 

Total Investments
(Cost $211,816,667)(c)

 

93.5

%

222,455,546

 

Other Assets in Excess of Liabilities

 

6.5

 

15,482,461

 

 

 

 

 

 

 

NET ASSETS

 

100.0

%

$

237,938,007

 

 

61



 


Securities classified as Level 1 for ASC 820 disclosure purposes based on valuation inputs unless otherwise noted.

 

 

*

Non-income producing security.

#

American Depository Receipts.

(a)

Restricted Security - Investment in security not registered under the Securities Act of 1933. The investment is deemed to be illiquid and may be sold only to qualified institutional buyers.  Security was acquired on August 25, 2010 for a cost of $1,008,623 and represents 0.4% of the net assets of the Fund.

(b)

Restricted Security - Investment in security not registered under the Securities Act of 1933. The investment is deemed to be illiquid and may be sold only to qualified institutional buyers.  Security was acquired on August 25, 2010 for a cost of $681,375 and represents 0.3% of the net assets of the Fund.

(c)

At October 31, 2010, the net unrealized appreciation on investments, based on cost for federal income tax purposes of $212,738,620 amounted to $9,716,926 which consisted of aggregate gross unrealized appreciation of $21,400,247 and aggregate gross unrealized depreciation of $11,683,321.

(L3)

Security classified as Level 3 for ASC 820 disclosure purposes based on valuation inputs.

 

Industry classifications are unaudited.

See Notes to Financial Statements.

 

62


 


 

THE ALGER FUNDS  |  ALGER BALANCED FUND

Schedule of Investments‡ October 31, 2010

 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—46.4%

 

 

 

 

 

ADVERTISING—0.2%

 

 

 

 

 

Focus Media Holding Ltd.#*

 

6,200

 

$

153,450

 

 

 

 

 

 

 

AEROSPACE & DEFENSE—1.5%

 

 

 

 

 

BE Aerospace Inc. *

 

4,500

 

165,420

 

Boeing Co., /The

 

2,120

 

149,757

 

General Dynamics Corp.

 

4,200

 

286,104

 

ITT Corp.

 

3,010

 

142,042

 

Lockheed Martin Corp.

 

3,000

 

213,870

 

 

 

 

 

957,193

 

AIR FREIGHT & LOGISTICS—0.9%

 

 

 

 

 

FedEx Corp.

 

2,900

 

254,388

 

United Parcel Service Inc., Cl. B

 

4,500

 

303,030

 

 

 

 

 

557,418

 

APPLICATION SOFTWARE—0.4%

 

 

 

 

 

Adobe Systems Inc. *

 

4,400

 

123,860

 

Intuit Inc. *

 

3,000

 

144,000

 

 

 

 

 

267,860

 

ASSET MANAGEMENT & CUSTODY BANKS—0.4%

 

 

 

 

 

Invesco Ltd.

 

5,000

 

115,000

 

Legg Mason Inc.

 

3,800

 

117,914

 

 

 

 

 

232,914

 

BIOTECHNOLOGY—0.8%

 

 

 

 

 

Celgene Corp. *

 

3,100

 

192,417

 

Cephalon Inc. *

 

2,800

 

186,032

 

Gilead Sciences Inc. *

 

2,100

 

83,307

 

Human Genome Sciences Inc. *

 

1,100

 

29,568

 

 

 

 

 

491,324

 

BROADCASTING & CABLE TV—0.4%

 

 

 

 

 

Scripps Networks Interactive Inc.

 

5,000

 

254,450

 

 

 

 

 

 

 

CABLE & SATELLITE—0.2%

 

 

 

 

 

Comcast Corp., Cl. A

 

7,500

 

144,975

 

 

 

 

 

 

 

CASINOS & GAMING—0.2%

 

 

 

 

 

International Game Technology

 

7,600

 

118,484

 

 

 

 

 

 

 

COAL & CONSUMABLE FUELS—0.3%

 

 

 

 

 

Peabody Energy Corp.

 

3,800

 

201,020

 

 

 

 

 

 

 

COMMUNICATIONS EQUIPMENT—1.7%

 

 

 

 

 

Brocade Communications Systems Inc. *

 

22,200

 

140,304

 

Cisco Systems Inc. *

 

25,555

 

583,421

 

Qualcomm Inc.

 

7,400

 

333,962

 

 

 

 

 

1,057,687

 

COMPUTER HARDWARE—3.1%

 

 

 

 

 

Apple Inc. *

 

4,665

 

1,403,558

 

Hewlett-Packard Co.

 

12,800

 

538,368

 

 

 

 

 

1,941,926

 

COMPUTER STORAGE & PERIPHERALS—0.8%

 

 

 

 

 

EMC Corp. *

 

17,300

 

363,473

 

 

63



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

COMPUTER STORAGE & PERIPHERALS—(CONT.)

 

 

 

 

 

NetApp Inc. *

 

2,300

 

$

122,475

 

 

 

 

 

485,948

 

CONSTRUCTION & ENGINEERING—0.4%

 

 

 

 

 

Fluor Corp.

 

3,500

 

168,665

 

Foster Wheeler AG *

 

3,700

 

86,654

 

 

 

 

 

255,319

 

CONSTRUCTION & FARM MACHINERY & HEAVY TRUCKS—0.8%

 

 

 

 

 

Caterpillar Inc.

 

2,600

 

204,360

 

Deere & Co.

 

2,400

 

184,320

 

Joy Global Inc.

 

1,700

 

120,615

 

 

 

 

 

509,295

 

DATA PROCESSING & OUTSOURCED SERVICES—0.5%

 

 

 

 

 

Mastercard Inc.

 

1,300

 

312,078

 

 

 

 

 

 

 

DIVERSIFIED BANKS—0.3%

 

 

 

 

 

Wells Fargo & Co.

 

7,700

 

200,816

 

 

 

 

 

 

 

DIVERSIFIED CHEMICALS—0.3%

 

 

 

 

 

EI Du Pont de Nemours & Co.

 

3,900

 

184,392

 

 

 

 

 

 

 

DIVERSIFIED METALS & MINING—0.2%

 

 

 

 

 

Cliffs Natural Resources Inc.

 

2,200

 

143,440

 

 

 

 

 

 

 

DRUG RETAIL—0.7%

 

 

 

 

 

CVS Caremark Corp.

 

8,000

 

240,960

 

Walgreen Co.

 

7,000

 

237,160

 

 

 

 

 

478,120

 

ENVIRONMENTAL & FACILITIES SERVICES—0.2%

 

 

 

 

 

Republic Services Inc.

 

3,500

 

104,335

 

 

 

 

 

 

 

EXCHANGE TRADED FUNDS—1.0%

 

 

 

 

 

iPATH S&P 500 VIX Short-Term Futures ETN *

 

2,100

 

27,552

 

iShares FTSE/Xinhua China 25 Index Fund

 

10,123

 

455,332

 

ProShares UltraShort 20+ Year Treasury *

 

3,803

 

129,264

 

 

 

 

 

612,148

 

FERTILIZERS & AGRICULTURAL CHEMICALS—0.8%

 

 

 

 

 

CF Industries Holdings Inc.

 

1,200

 

147,036

 

Monsanto Co.

 

2,300

 

136,666

 

Mosaic Co., /The

 

900

 

65,844

 

Potash Corporation of Saskatchewan Inc.

 

900

 

130,581

 

 

 

 

 

480,127

 

FOOTWEAR—0.4%

 

 

 

 

 

NIKE Inc., Cl. B

 

3,100

 

252,464

 

 

 

 

 

 

 

GENERAL MERCHANDISE STORES—0.3%

 

 

 

 

 

Target Corp.

 

4,100

 

212,954

 

 

 

 

 

 

 

GOLD—0.5%

 

 

 

 

 

Goldcorp Inc.

 

4,400

 

196,196

 

Yamana Gold Inc.

 

11,600

 

127,484

 

 

 

 

 

323,680

 

 

64



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

HEALTH CARE EQUIPMENT—0.5%

 

 

 

 

 

Covidien PLC

 

2,100

 

$

83,727

 

Medtronic Inc.

 

3,800

 

133,798

 

Zimmer Holdings Inc. *

 

2,700

 

128,088

 

 

 

 

 

345,613

 

HEALTH CARE SUPPLIES—0.1%

 

 

 

 

 

Alere Inc.*

 

2,100

 

62,055

 

 

 

 

 

 

 

HOME ENTERTAINMENT SOFTWARE—0.4%

 

 

 

 

 

Electronic Arts Inc. *

 

6,500

 

103,025

 

Take-Two Interactive Software Inc. *

 

15,700

 

167,362

 

 

 

 

 

270,387

 

HOME IMPROVEMENT RETAIL—0.1%

 

 

 

 

 

Lowe’s Companies, Inc.

 

3,300

 

70,389

 

 

 

 

 

 

 

HOMEBUILDING—0.5%

 

 

 

 

 

Toll Brothers Inc.*

 

16,400

 

294,216

 

 

 

 

 

 

 

HOTELS RESORTS & CRUISE LINES—0.2%

 

 

 

 

 

Carnival Corp.

 

2,200

 

94,974

 

 

 

 

 

 

 

HOUSEHOLD PRODUCTS—0.7%

 

 

 

 

 

Procter & Gamble Co., /The

 

6,625

 

421,151

 

 

 

 

 

 

 

HYPERMARKETS & SUPER CENTERS—1.0%

 

 

 

 

 

Costco Wholesale Corp.

 

2,500

 

156,925

 

Wal-Mart Stores Inc.

 

8,300

 

449,611

 

 

 

 

 

606,536

 

INDUSTRIAL CONGLOMERATES—1.2%

 

 

 

 

 

3M Co.

 

3,700

 

311,614

 

General Electric Co.

 

10,400

 

166,608

 

McDermott International Inc. *

 

6,000

 

92,580

 

Tyco International Ltd.

 

4,400

 

168,432

 

 

 

 

 

739,234

 

INDUSTRIAL GASES—0.2%

 

 

 

 

 

Praxair Inc.

 

1,400

 

127,876

 

 

 

 

 

 

 

INTEGRATED OIL & GAS—2.0%

 

 

 

 

 

Chevron Corp.

 

5,100

 

421,311

 

Exxon Mobil Corp.

 

9,700

 

644,759

 

Petroleo Brasileiro SA #

 

5,000

 

170,600

 

 

 

 

 

1,236,670

 

INTEGRATED TELECOMMUNICATION SERVICES—0.3%

 

 

 

 

 

Verizon Communications Inc.

 

6,100

 

198,067

 

 

 

 

 

 

 

INTERNET RETAIL—0.8%

 

 

 

 

 

Amazon.com Inc. *

 

1,500

 

247,710

 

Expedia Inc.

 

9,700

 

280,815

 

 

 

 

 

528,525

 

INTERNET SOFTWARE & SERVICES—2.4%

 

 

 

 

 

ChinaCache International Holdings Ltd. #*

 

1,400

 

33,810

 

eBay Inc. *

 

11,290

 

336,555

 

Google Inc., Cl. A *

 

905

 

554,756

 

 

65



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

INTERNET SOFTWARE & SERVICES—(CONT.)

 

 

 

 

 

IAC/InterActiveCorp. *

 

10,600

 

$

295,740

 

Yahoo! Inc. *

 

17,300

 

285,623

 

 

 

 

 

1,506,484

 

INVESTMENT BANKING & BROKERAGE—1.2%

 

 

 

 

 

Charles Schwab Corp., /The

 

10,400

 

160,160

 

Goldman Sachs Group Inc., /The

 

1,100

 

177,045

 

Lazard Ltd., Cl. A

 

5,730

 

211,437

 

Morgan Stanley

 

8,500

 

211,395

 

 

 

 

 

760,037

 

IT CONSULTING & OTHER SERVICES—1.1%

 

 

 

 

 

Cognizant Technology Solutions Corp., Cl. A *

 

2,200

 

143,418

 

International Business Machines Corp.

 

3,800

 

545,680

 

 

 

 

 

689,098

 

LEISURE PRODUCTS—0.3%

 

 

 

 

 

Coach Inc.

 

3,100

 

155,000

 

 

 

 

 

 

 

LIFE & HEALTH INSURANCE—0.5%

 

 

 

 

 

MetLife Inc.

 

3,100

 

125,023

 

Prudential Financial Inc.

 

3,200

 

168,256

 

 

 

 

 

293,279

 

LIFE SCIENCES TOOLS & SERVICES—0.5%

 

 

 

 

 

Charles River Laboratories International Inc. *

 

1,700

 

55,709

 

Thermo Fisher Scientific Inc. *

 

5,000

 

257,100

 

 

 

 

 

312,809

 

MANAGED HEALTH CARE—0.7%

 

 

 

 

 

Aetna Inc.

 

3,400

 

101,524

 

UnitedHealth Group Inc.

 

6,600

 

237,930

 

WellPoint Inc. *

 

1,300

 

70,642

 

 

 

 

 

410,096

 

METAL & GLASS CONTAINERS—0.2%

 

 

 

 

 

Owens-Illinois Inc.*

 

4,300

 

120,529

 

 

 

 

 

 

 

MOVIES & ENTERTAINMENT—0.5%

 

 

 

 

 

Regal Entertainment Group, Cl. A

 

4,600

 

62,100

 

Viacom Inc., Cl. B

 

6,900

 

266,271

 

 

 

 

 

328,371

 

OFFICE REITS—0.2%

 

 

 

 

 

Digital Realty Trust Inc.

 

2,500

 

149,325

 

 

 

 

 

 

 

OIL & GAS DRILLING—0.3%

 

 

 

 

 

Transocean Ltd.*

 

2,516

 

159,414

 

 

 

 

 

 

 

OIL & GAS EQUIPMENT & SERVICES—1.1%

 

 

 

 

 

Cameron International Corp. *

 

6,100

 

266,875

 

Schlumberger Ltd.

 

5,400

 

377,406

 

Weatherford International Ltd. *

 

4,100

 

68,921

 

 

 

 

 

713,202

 

OIL & GAS EXPLORATION & PRODUCTION—1.0%

 

 

 

 

 

Anadarko Petroleum Corp.

 

2,400

 

147,768

 

Chesapeake Energy Corp.

 

8,600

 

186,620

 

 

66


 

 


 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

OIL & GAS EXPLORATION & PRODUCTION—(CONT.)

 

 

 

 

 

Devon Energy Corp.

 

1,500

 

$

97,530

 

Nexen Inc.

 

2,900

 

61,741

 

Plains Exploration & Production Co. *

 

4,800

 

133,776

 

 

 

 

 

627,435

 

OIL & GAS STORAGE & TRANSPORTATION—0.2%

 

 

 

 

 

Enterprise Products Partners LP

 

3,500

 

149,975

 

 

 

 

 

 

 

OTHER DIVERSIFIED FINANCIAL SERVICES—1.0%

 

 

 

 

 

Bank of America Corp.

 

24,700

 

282,568

 

JPMorgan Chase & Co.

 

9,200

 

346,196

 

 

 

 

 

628,764

 

PACKAGED FOODS & MEATS—0.4%

 

 

 

 

 

Kraft Foods Inc., Cl. A

 

8,300

 

267,841

 

 

 

 

 

 

 

PERSONAL PRODUCTS—0.1%

 

 

 

 

 

Avon Products Inc.

 

1,900

 

57,855

 

 

 

 

 

 

 

PHARMACEUTICALS—2.4%

 

 

 

 

 

Abbott Laboratories

 

5,600

 

287,392

 

Johnson & Johnson

 

6,200

 

394,754

 

Merck & Co., Inc.

 

4,200

 

152,376

 

Mylan Inc. *

 

11,400

 

231,648

 

Pfizer Inc.

 

18,859

 

328,147

 

Shire PLC #

 

2,000

 

140,200

 

 

 

 

 

1,534,517

 

PROPERTY & CASUALTY INSURANCE—0.3%

 

 

 

 

 

Travelers Cos., Inc., /The

 

3,400

 

187,680

 

 

 

 

 

 

 

RAILROADS—0.2%

 

 

 

 

 

CSX Corp.

 

1,800

 

110,610

 

 

 

 

 

 

 

RESEARCH & CONSULTING SERVICES—0.2%

 

 

 

 

 

FTI Consulting Inc.*

 

3,600

 

127,656

 

 

 

 

 

 

 

RESTAURANTS—0.6%

 

 

 

 

 

Cheesecake Factory Inc., /The *

 

4,300

 

125,216

 

McDonald’s Corp.

 

3,400

 

264,418

 

 

 

 

 

389,634

 

RETAIL REITS—0.2%

 

 

 

 

 

Macerich Co., /The

 

2,100

 

93,681

 

 

 

 

 

 

 

SEMICONDUCTOR EQUIPMENT—0.4%

 

 

 

 

 

Lam Research Corp. *

 

4,200

 

192,318

 

Novellus Systems Inc. *

 

1,700

 

49,657

 

 

 

 

 

241,975

 

SEMICONDUCTORS—0.6%

 

 

 

 

 

Intel Corp.

 

17,800

 

357,246

 

 

 

 

 

 

 

SOFT DRINKS—1.4%

 

 

 

 

 

Coca-Cola Co., /The

 

5,800

 

355,656

 

Hansen Natural Corp. *

 

3,000

 

153,630

 

PepsiCo Inc.

 

5,500

 

359,150

 

 

 

 

 

868,436

 

 

67



 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—(CONT.)

 

 

 

 

 

SPECIALIZED FINANCE—0.8%

 

 

 

 

 

CME Group Inc.

 

690

 

$

199,859

 

Hong Kong Exchanges and Clearing Ltd.

 

9,100

 

200,285

 

IntercontinentalExchange Inc. *

 

1,000

 

114,870

 

 

 

 

 

515,014

 

SPECIALIZED REITS—0.2%

 

 

 

 

 

Weyerhaeuser Company

 

8,551

 

138,697

 

 

 

 

 

 

 

SPECIALTY STORES—0.2%

 

 

 

 

 

Staples Inc.

 

5,700

 

116,679

 

 

 

 

 

 

 

SYSTEMS SOFTWARE—0.9%

 

 

 

 

 

Microsoft Corp.

 

21,600

 

575,424

 

 

 

 

 

 

 

TOBACCO—0.8%

 

 

 

 

 

Altria Group Inc.

 

5,915

 

150,359

 

Philip Morris International Inc.

 

5,815

 

340,178

 

 

 

 

 

490,537

 

TRUCKING—0.2%

 

 

 

 

 

Hertz Global Holdings Inc.*

 

13,100

 

148,292

 

 

 

 

 

 

 

TOTAL COMMON STOCKS
(Cost $28,308,256)

 

 

 

29,155,102

 

 

 

 

 

 

 

CONVERTIBLE PREFERRED STOCK—0.8%

 

 

 

 

 

ELECTRIC UTILITIES—0.3%

 

 

 

 

 

PPL Corp., 9.50%, 07/1/13*

 

4,000

 

225,720

 

 

 

 

 

 

 

MULTI-LINE INSURANCE—0.5%

 

 

 

 

 

Hartford Financial Services Group Inc., 7.25%, 04/1/13*

 

12,000

 

294,600

 

 

 

 

 

 

 

TOTAL CONVERTIBLE PREFERRED STOCK
(Cost $511,100)

 

 

 

520,320

 

 

 

 

 

 

 

MANDATORY CONVERTIBLE PREFERRED STOCK—0.6%

 

 

 

 

 

OTHER DIVERSIFIED FINANCIAL SERVICES—0.6%

 

 

 

 

 

Citigroup Inc., 7.50%, 12/15/12*(a)
(Cost $297,280)

 

2,900

 

358,266

 

 

 

 

 

 

 

PREFERRED STOCKS—1.1%

 

 

 

 

 

DIVERSIFIED BANKS—0.9%

 

 

 

 

 

HSBC Holdings PLC, 8.00%, 12/15/15*

 

20,000

 

553,000

 

 

 

 

 

 

 

OTHER DIVERSIFIED FINANCIAL SERVICES—0.2%

 

 

 

 

 

Citigroup Capital XIII, 7.88%, 10/30/40*

 

4,300

 

113,950

 

 

 

 

 

 

 

TOTAL PREFERRED STOCKS
(Cost $607,500)

 

 

 

666,950

 

 

 

 

 

 

 

 

 

PRINCIPAL
AMOUNT

 

 

 

CONVERTIBLE CORPORATE BONDS—3.2%

 

 

 

 

 

COMPUTER STORAGE & PERIPHERALS—0.6%

 

 

 

 

 

SanDisk Corp., 1.50%, 8/15/17(L2)

 

400,000

 

391,000

 

 

68



 

 

 

PRINCIPAL
AMOUNT

 

VALUE

 

CONVERTIBLE CORPORATE BONDS—(CONT.)

 

 

 

 

 

GOLD—0.7%

 

 

 

 

 

AngloGold Ashanti Holdings Finance PLC, 3.50%, 5/22/14(L2)(b)

 

$

350,000

 

$

420,875

 

 

 

 

 

 

 

MULTI-UTILITIES—0.5%

 

 

 

 

 

CMS Energy Corp., 5.50%, 6/15/29(L2)

 

250,000

 

345,937

 

 

 

 

 

 

 

OFFICE REITS—0.4%

 

 

 

 

 

SL Green Operating Partnership LP, 3.00%, 10/15/17(L2)(b)

 

250,000

 

252,813

 

 

 

 

 

 

 

OIL & GAS EXPLORATION & PRODUCTION—0.3%

 

 

 

 

 

Quicksilver Resources Inc., 1.88%, 11/1/24(L2)

 

150,000

 

167,062

 

 

 

 

 

 

 

SEMICONDUCTORS—0.4%

 

 

 

 

 

Intel Corp., 3.25%, 8/1/39(L2)(b)

 

200,000

 

238,250

 

 

 

 

 

 

 

WIRELESS TELECOMMUNICATION SERVICES—0.3%

 

 

 

 

 

SBA Communications Corp., 4.00%, 10/1/14(L2)

 

150,000

 

218,625

 

 

 

 

 

 

 

TOTAL CONVERTIBLE CORPORATE BONDS
(Cost $1,763,170)

 

 

 

2,034,562

 

 

 

 

 

 

 

CORPORATE BONDS—27.2%

 

 

 

 

 

AEROSPACE & DEFENSE—0.9%

 

 

 

 

 

Bombardier Inc., 7.75%, 3/15/20(L2)(b)

 

350,000

 

390,250

 

L-3 Communications Corp., 4.75%, 7/15/20(L2)

 

150,000

 

156,886

 

 

 

 

 

547,136

 

APPLICATION SOFTWARE—0.6%

 

 

 

 

 

Adobe Systems Inc., 4.75%, 2/1/20(L2)

 

350,000

 

378,960

 

 

 

 

 

 

 

AUTOMOBILE MANUFACTURERS—0.5%

 

 

 

 

 

Toyota Motor Credit Corp., 1.38%, 8/12/13(L2)

 

300,000

 

304,631

 

 

 

 

 

 

 

CABLE & SATELLITE—0.8%

 

 

 

 

 

Cablevision Systems Corp., 7.75%, 4/15/18(L2)

 

100,000

 

109,625

 

Comcast Corp., 5.70%, 7/1/19(L2)

 

325,000

 

372,283

 

 

 

 

 

481,908

 

COMMUNICATIONS EQUIPMENT—0.2%

 

 

 

 

 

Cisco Systems Inc., 4.95%, 2/15/19(L2)

 

125,000

 

142,411

 

 

 

 

 

 

 

COMPUTER HARDWARE—0.7%

 

 

 

 

 

Hewlett-Packard Co., 6.13%, 3/1/14(L2)

 

350,000

 

405,603

 

 

 

 

 

 

 

CONSUMER FINANCE—2.0%

 

 

 

 

 

American Express Credit Corp., 7.30%, 8/20/13(L2)

 

400,000

 

457,710

 

Capital One Capital V, 10.25%, 8/15/39(L2)

 

700,000

 

763,875

 

 

 

 

 

1,221,585

 

DIVERSIFIED BANKS—0.6%

 

 

 

 

 

Barclays Bank PLC, 5.14%, 10/14/20(L2)

 

350,000

 

346,795

 

 

 

 

 

 

 

DIVERSIFIED METALS & MINING—0.3%

 

 

 

 

 

Anglo American Capital PLC, 9.38%, 4/8/14(L2)(b)

 

150,000

 

184,381

 

 

 

 

 

 

 

ELECTRIC UTILITIES—0.6%

 

 

 

 

 

Florida Power Corp., 5.80%, 9/15/17(L2)

 

300,000

 

356,083

 

 

69



 

 

 

PRINCIPAL
AMOUNT

 

VALUE

 

CORPORATE BONDS—(CONT.)

 

 

 

 

 

ELECTRONIC EQUIP., INSTRUMENTS—0.7%

 

 

 

 

 

Jabil Circuit Inc., 5.63%, 12/15/20(L2)

 

$

425,000

 

$

429,250

 

 

 

 

 

 

 

HEALTH CARE DISTRIBUTORS—0.6%

 

 

 

 

 

AmerisourceBergen Corp., 4.88%, 11/15/19(L2)

 

350,000

 

376,181

 

 

 

 

 

 

 

HEALTH CARE FACILITIES—0.7%

 

 

 

 

 

Omega Healthcare Investors Inc., 7.00%, 4/1/14(L2)

 

400,000

 

410,000

 

 

 

 

 

 

 

HEALTH CARE SERVICES—0.6%

 

 

 

 

 

HCA Inc., 7.25%, 9/15/20(L2)

 

350,000

 

384,563

 

 

 

 

 

 

 

HOMEBUILDING—1.2%

 

 

 

 

 

Lennar Corp., 12.25%, 6/1/17(L2)

 

350,000

 

418,250

 

Meritage Homes Corp., 7.15%, 4/15/20(L2)

 

350,000

 

341,250

 

 

 

 

 

759,500

 

HOTELS RESORTS & CRUISE LINES—0.1%

 

 

 

 

 

Wyndham Worldwide Corp., 7.38%, 3/1/20(L2)

 

75,000

 

83,324

 

 

 

 

 

 

 

INDUSTRIAL CONGLOMERATES—1.4%

 

 

 

 

 

General Electric Capital Corp., 2.50%, 8/11/15(L2)

 

700,000

 

695,587

 

Tyco International Finance SA, 8.50%, 1/15/19(L2)

 

150,000

 

198,523

 

 

 

 

 

894,110

 

INTEGRATED TELECOMMUNICATION SERVICES—0.6%

 

 

 

 

 

Cellco Partnership / Verizon Wireless Capital LLC, 7.38%, 11/15/13(L2)

 

325,000

 

384,838

 

 

 

 

 

 

 

INTERNET SOFTWARE & SERVICES—0.6%

 

 

 

 

 

eBay Inc., 1.63%, 10/15/15(L2)

 

350,000

 

348,677

 

 

 

 

 

 

 

LIFE & HEALTH INSURANCE—0.6%

 

 

 

 

 

Lincoln National Corp., 8.75%, 7/1/19(L2)

 

150,000

 

193,730

 

Prudential Financial Inc., 8.88%, 6/15/38(L2)

 

150,000

 

174,000

 

 

 

 

 

367,730

 

LIFE SCIENCES TOOLS & SERVICES—0.3%

 

 

 

 

 

Life Technologies Corp., 4.40%, 3/1/15(L2)

 

150,000

 

160,694

 

 

 

 

 

 

 

MANAGED HEALTH CARE—0.2%

 

 

 

 

 

UnitedHealth Group Inc., 3.88%, 10/15/20(L2)

 

150,000

 

149,877

 

 

 

 

 

 

 

MOVIES & ENTERTAINMENT—0.3%

 

 

 

 

 

Time Warner Cable Inc., 8.25%, 2/14/14(L2)

 

100,000

 

119,474

 

Time Warner Inc., 3.15%, 7/15/15(L2)

 

100,000

 

104,779

 

 

 

 

 

224,253

 

MULTI-LINE INSURANCE—0.1%

 

 

 

 

 

International Lease Finance Corp., 6.50%, 9/1/14(L2)(b)

 

75,000

 

81,375

 

 

 

 

 

 

 

MULTI-UTILITIES—0.9%

 

 

 

 

 

Consolidated Edison Co., of New York Inc., 5.30%, 12/1/16(L2)

 

475,000

 

556,064

 

 

 

 

 

 

 

OIL & GAS DRILLING—0.7%

 

 

 

 

 

Transocean Inc., 6.50%, 11/15/20(L2)

 

350,000

 

390,755

 

 

 

 

 

 

 

OIL & GAS EXPLORATION & PRODUCTION—1.5%

 

 

 

 

 

Anadarko Petroleum Corp., 6.38%, 9/15/17(L2)

 

350,000

 

389,365

 

Devon Energy Corp., 6.30%, 1/15/19(L2)

 

150,000

 

183,478

 

 

70


 


 

 

 

PRINCIPAL
AMOUNT

 

VALUE

 

CORPORATE BONDS—(CONT.)

 

 

 

 

 

OIL & GAS EXPLORATION & PRODUCTION—(CONT.)

 

 

 

 

 

Plains Exploration & Production Co., 7.63%, 4/1/20(L2)

 

$

350,000

 

$

378,875

 

 

 

 

 

951,718

 

OIL & GAS STORAGE & TRANSPORTATION—0.4%

 

 

 

 

 

Inergy LP/Inergy Finance Corp., 7.00%, 10/1/18(L2)(b)

 

75,000

 

78,750

 

Williams Cos Inc., /The, 8.75%, 1/15/20(L2)

 

150,000

 

186,174

 

 

 

 

 

264,924

 

OTHER DIVERSIFIED FINANCIAL SERVICES—2.1%

 

 

 

 

 

Citigroup Inc., 8.50%, 5/22/19(L2)

 

350,000

 

440,188

 

JPMorgan Chase & Co., 4.25%, 10/15/20(L2)

 

350,000

 

353,264

 

JPMorgan Chase & Co., 7.90%, 4/30/49(L2)

 

500,000

 

534,806

 

 

 

 

 

1,328,258

 

PACKAGED FOODS & MEATS—0.1%

 

 

 

 

 

Kraft Foods Inc., 6.75%, 2/19/14(L2)

 

75,000

 

87,700

 

 

 

 

 

 

 

PHARMACEUTICALS—1.1%

 

 

 

 

 

AstraZeneca PLC, 5.40%, 6/1/14(L2)

 

300,000

 

342,554

 

Roche Holdings Inc., 5.00%, 3/1/14(L2)(b)

 

325,000

 

364,791

 

 

 

 

 

707,345

 

PROPERTY & CASUALTY INSURANCE—1.2%

 

 

 

 

 

Liberty Mutual Group Inc., 7.80%, 3/15/37(L2)(b)

 

300,000

 

303,000

 

XL Group PLC, 6.50%, 12/29/49(L2)

 

500,000

 

452,500

 

 

 

 

 

755,500

 

PUBLISHING—0.6%

 

 

 

 

 

Valassis Communications Inc., 8.25%, 3/1/15(L2)

 

350,000

 

369,687

 

 

 

 

 

 

 

REINSURANCE—1.1%

 

 

 

 

 

White Mountains Re Group Ltd., 6.38%, 3/20/17(L2)(b)

 

700,000

 

704,886

 

 

 

 

 

 

 

SEMICONDUCTORS—0.5%

 

 

 

 

 

Analog Devices Inc., 5.00%, 7/1/14(L2)

 

150,000

 

165,789

 

Broadcom Corp., 1.50%, 11/1/13(L2)(b)

 

150,000

 

150,800

 

 

 

 

 

316,589

 

SOFT DRINKS—0.6%

 

 

 

 

 

Coco-Cola Co., /The, 4.88%, 3/15/19(L2)

 

300,000

 

342,172

 

 

 

 

 

 

 

SPECIALIZED REITS—0.4%

 

 

 

 

 

Host Hotels & Resorts LP, 7.13%, 11/1/13(L2)

 

241,000

 

245,218

 

 

 

 

 

 

 

SPECIALTY CHEMICALS—0.5%

 

 

 

 

 

Sigma-Aldrich Corp., 3.38%, 11/1/20(L2)

 

350,000

 

349,409

 

 

 

 

 

 

 

SYSTEMS SOFTWARE—0.2%

 

 

 

 

 

Microsoft Corp., 3.00%, 10/1/20(L2)

 

150,000

 

149,296

 

 

 

 

 

 

 

WIRELESS TELECOMMUNICATION SERVICES—0.1%

 

 

 

 

 

MetroPCS Wireless Inc., 7.88%, 9/1/18(L2)

 

75,000

 

80,813

 

 

 

 

 

 

 

TOTAL CORPORATE BONDS
(Cost $15,617,218)

 

 

 

17,024,199

 

 

71



 

 

 

PRINCIPAL
AMOUNT

 

VALUE

 

COLLATERALIZED MORTGAGE OBLIGATIONS—0.8%

 

 

 

 

 

WIRELESS TELECOMMUNICATION SERVICES—0.8%

 

 

 

 

 

American Tower Trust, 2007-1A, 5.96%, 4/15/37(L2)(b)
(Cost $500,000)

 

$

500,000

 

$

535,510

 

 

 

 

 

 

 

ASSET BACKED SECURITIES—0.8%

 

 

 

 

 

MULTI-UTILITIES—0.3%

 

 

 

 

 

CenterPoint Energy Transition Bond Co., LLC, 2005A, 4.97%, 8/1/14(L2)

 

194,113

 

201,064

 

 

 

 

 

 

 

OTHER DIVERSIFIED FINANCIAL SERVICES—0.5%

 

 

 

 

 

Nissan Auto Receivables Owner Trust, 2005A, 3.20%, 2/15/13(L2)

 

327,598

 

332,894

 

 

 

 

 

 

 

TOTAL ASSET BACKED SECURITIES
(Cost $521,913)

 

 

 

533,958

 

 

 

 

 

 

 

U.S. GOVERNMENT & AGENCY MORTGAGE BACKED OBLIGATIONS—3.5% (c)

 

 

 

 

 

COLLATERALIZED MORTGAGE BACKED OBLIGATIONS—2.9%

 

 

 

 

 

Federal National Mortgage Association, REMICS, 6.00%, 4/25/35 +,(L2)

 

950,000

 

1,072,455

 

 

 

 

 

 

 

Federal Home Loan Mortgage Corp., REMICS, 6.00%, 8/15/29 +,(L2)

 

631,418

 

635,791

 

 

 

 

 

 

 

Government National Mortgage Association, REMICS, 5.00%, 5/16/29 +,(L2)

 

94,625

 

95,260

 

 

 

 

 

1,803,506

 

FEDERAL NATIONAL MORTGAGE ASSOCIATION—0.6%

 

 

 

 

 

Federal National Mortgage Association, 5.00%, 4/01/18 (L2)

 

350,244

 

375,944

 

 

 

 

 

 

 

TOTAL U.S. GOVERNMENT & AGENCY MORTGAGE BACKED OBLIGATIONS
(Cost $2,032,819)

 

 

 

2,179,450

 

 

 

 

 

 

 

U.S. GOVERNMENT & AGENCY OBLIGATIONS (EXCLUDING MORTGAGE-BACKED)—11.6% (c)

 

 

 

 

 

FEDERAL FARM CREDIT BANK—0.9%

 

 

 

 

 

Federal Farm Credit Bank, 4.95%, 10/18/18 (L2)

 

455,000

 

534,426

 

 

 

 

 

 

 

FEDERAL HOME LOAN BANK—0.5%

 

 

 

 

 

Federal Home Loan Banks, 5.38%, 6/08/12 (L2)

 

275,000

 

297,121

 

 

 

 

 

 

 

FEDERAL NATIONAL MORTGAGE ASSOCIATION—2.1%

 

 

 

 

 

Federal National Mortgage Association,

 

 

 

 

 

4.63%, 5/01/13 (L2)

 

600,000

 

650,943

 

5.00%, 2/13/17 (L2)

 

600,000

 

709,619

 

 

 

 

 

1,360,562

 

 

72



 

 

 

PRINCIPAL
AMOUNT

 

VALUE

 

U.S. GOVERNMENT & AGENCY OBLIGATIONS (EXCLUDING MORTGAGE-BACKED)—(CONT.)

 

 

 

 

 

U.S. GOVERNMENT NOTE/BOND—8.1%

 

 

 

 

 

U.S. Treasury Notes

 

 

 

 

 

4.38%, 5/15/40 (L2)

 

$

350,000

 

$

372,861

 

5.00%, 8/15/11 (L2)

 

700,000

 

726,414

 

1.13%, 1/15/12 (L2)

 

300,000

 

303,129

 

1.50%, 12/31/13 (L2)

 

600,000

 

617,719

 

4.75%, 5/15/14 (L2)

 

552,000

 

631,091

 

4.25%, 11/15/14 (L2)

 

400,000

 

454,438

 

4.50%, 2/15/16 (L2)

 

300,000

 

349,641

 

4.75%, 8/15/17 (L2)

 

300,000

 

355,852

 

3.38%, 11/15/19 (L2)

 

850,000

 

912,488

 

3.50%, 5/15/20 (L2)

 

350,000

 

377,537

 

 

 

 

 

5,101,170

 

TOTAL U.S. GOVERNMENT & AGENCY OBLIGATIONS (EXCLUDING MORTGAGE-BACKED)
(Cost $6,752,765)

 

 

 

7,293,279

 

 

 

 

 

 

 

Total Investments
(Cost $56,912,021)(d)

 

96.0

%

60,301,596

 

Other Assets in Excess of Liabilities

 

4.0

 

2,497,269

 

 

 

 

 

 

 

NET ASSETS

 

100.0

%

$

 62,798,865

 

 


Securities classified as Level 1 for ASC 820 disclosure purposes based on valuation inputs unless otherwise noted.

 

 

+

Real Estate Mortgage Investment Conduit

*

Non-income producing security.

#

American Depository Receipts.

(a)

These securities are required to be converted on the date listed; they generally may be converted prior to this date at the option of the holder.

(b)

Pursuant to Securities and Exchange Commission Rule 144A, these securities may be sold prior to their maturity only to qualified institutional buyers.  These securities are deemed to be liquid and represent 5.9% of the net assets of the Fund.

(c)

Securities issued by these agencies, except for United States Treasury Notes and Bonds, are neither guaranteed nor issued by the United States Government.

(d)

At October 31, 2010, the net unrealized appreciation on investments, based on cost for federal income tax purposes of $56,955,045 amounted to $3,346,551 which consisted of aggregate gross unrealized appreciation of $6,771,192 and aggregate gross unrealized depreciation of $3,424,641.

(L2)

Security classified as Level 2 for ASC 820 disclosure purposes based on valuation inputs.

 

Industry classifications are unaudited.

See Notes to Financial Statements.

 

73


 


 

THE ALGER FUNDS  |  ALGER CONVERTIBLE FUND

Schedule of Investments‡ October 31, 2010

 

 

 

SHARES

 

VALUE

 

COMMON STOCKS—3.7%

 

 

 

 

 

INDUSTRIAL CONGLOMERATES—0.6%

 

 

 

 

 

General Electric Co.

 

10,000

 

$

160,200

 

 

 

 

 

 

 

OIL & GAS EXPLORATION & PRODUCTION—1.0%

 

 

 

 

 

Whitinig Petroleum Corp.*

 

2,803

 

281,533

 

 

 

 

 

 

 

OIL & GAS STORAGE & TRANSPORTATION—2.1%

 

 

 

 

 

Inergy LP

 

15,000

 

588,900

 

 

 

 

 

 

 

TOTAL COMMON STOCKS
(Cost $742,112)

 

 

 

1,030,633

 

 

 

 

 

 

 

CONVERTIBLE PREFERRED STOCK—9.3%

 

 

 

 

 

CONSUMER FINANCE—1.3%

 

 

 

 

 

SLM Corp., 7.25%, 12/15/10*,(L2)

 

600

 

372,150

 

 

 

 

 

 

 

DIVERSIFIED METALS & MINING—1.2%

 

 

 

 

 

Vale Capital II, 6.75%, 06/15/12*,(L2)

 

3,400

 

317,900

 

 

 

 

 

 

 

ELECTRIC UTILITIES—1.0%

 

 

 

 

 

PPL Corp., 9.50%, 07/1/13*

 

5,000

 

282,150

 

 

 

 

 

 

 

GOLD—1.9%

 

 

 

 

 

AngloGold Ashanti Ltd., 6.00%, 09/15/13*

 

10,000

 

542,500

 

 

 

 

 

 

 

MULTI-LINE INSURANCE—0.9%

 

 

 

 

 

Hartford Financial Services Group Inc., 7.25%, 04/1/13*

 

10,000

 

245,500

 

 

 

 

 

 

 

OTHER DIVERSIFIED FINANCIAL SERVICES—0.9%

 

 

 

 

 

Bank of America Corp., 7.25%, 12/31/49*

 

250

 

236,750

 

 

 

 

 

 

 

PHARMACEUTICALS—1.0%

 

 

 

 

 

Mylan Inc., 6.50%, 11/15/10*(a)

 

221

 

262,904

 

 

 

 

 

 

 

PROPERTY & CASUALTY INSURANCE—1.1%

 

 

 

 

 

XL Capital Ltd., 10.75%, 08/15/11*(a)

 

10,000

 

298,600

 

 

 

 

 

 

 

TOTAL CONVERTIBLE PREFERRED STOCK
(Cost $2,012,518)

 

 

 

2,558,454

 

 

 

 

 

 

 

MANDATORY CONVERTIBLE PREFERRED STOCK—5.9%

 

 

 

 

 

ELECTRIC UTILITIES—1.9%

 

 

 

 

 

Nextera Energy Inc., 8.38%, 06/1/12*

 

10,000

 

522,500

 

 

 

 

 

 

 

OIL & GAS EXPLORATION & PRODUCTION—2.7%

 

 

 

 

 

Apache Corp., 6.00%, 08/1/13*

 

12,748

 

741,934

 

 

 

 

 

 

 

OTHER DIVERSIFIED FINANCIAL SERVICES—1.3%

 

 

 

 

 

Citigroup Inc., 7.50%, 12/15/12*(a)

 

3,000

 

370,620

 

 

 

 

 

 

 

TOTAL MANDATORY CONVERTIBLE PREFERRED STOCK
(Cost $1,452,350)

 

 

 

1,635,054

 

 

 

 

 

 

 

PREFERRED STOCKS—12.0%

 

 

 

 

 

ASSET MANAGEMENT & CUSTODY BANKS—0.9%

 

 

 

 

 

Ares Capital Corp., 7.75%, 10/15/40*,(L2)

 

10,000

 

253,000

 

 

 

 

 

 

 

DIVERSIFIED BANKS—3.6%

 

 

 

 

 

HSBC Holdings PLC, 8.00%, 12/15/15 *

 

20,000

 

553,000

 

 

74



 

 

 

SHARES

 

VALUE

 

PREFERRED STOCKS—(CONT.)

 

 

 

 

 

DIVERSIFIED BANKS—(CONT.)

 

 

 

 

 

Wells Fargo Capital XIV, 8.63%, 09/14/68 *

 

15,000

 

$

415,800

 

 

 

 

 

968,800

 

INDUSTRIAL REITS—1.8%

 

 

 

 

 

DuPont Fabros Technology Inc., 7.88%, 10/15/15*

 

20,000

 

499,000

 

 

 

 

 

 

 

OTHER DIVERSIFIED FINANCIAL SERVICES—2.3%

 

 

 

 

 

Citigroup Capital XIII, 7.88%, 10/30/40 *

 

3,550

 

94,075

 

JPMorgan Chase & Co., 8.63%, 09/1/13 *

 

20,000

 

552,000

 

 

 

 

 

646,075

 

REGIONAL BANKS—3.0%

 

 

 

 

 

BB&T Capital Trust V, 8.95%, 09/15/13 *

 

10,000

 

275,900

 

Zions Bancorporation, 11.00%, 06/15/12 *

 

20,000

 

541,600

 

 

 

 

 

817,500

 

SPECIALIZED REITS—0.4%

 

 

 

 

 

Public Storage, 6.88%, 04/15/15*

 

4,419

 

115,999

 

 

 

 

 

 

 

TOTAL PREFERRED STOCKS
(Cost $3,074,225)

 

 

 

3,300,374

 

 

 

 

 

 

 

 

 

PRINCIPAL
AMOUNT

 

 

 

CONVERTIBLE CORPORATE BONDS—63.2%

 

 

 

 

 

ADVERTISING—1.0%

 

 

 

 

 

Interpublic Group of Cos., Inc., /The, 4.25%, 3/15/23(L2)

 

250,000

 

276,875

 

 

 

 

 

 

 

AEROSPACE & DEFENSE—0.9%

 

 

 

 

 

AAR Corp., 1.75%, 2/1/26(L2)

 

250,000

 

254,063

 

 

 

 

 

 

 

AIRLINES—2.0%

 

 

 

 

 

UAL Corp., 6.00%, 10/15/29(L2)

 

150,000

 

527,625

 

 

 

 

 

 

 

APPLICATION SOFTWARE—2.2%

 

 

 

 

 

Lawson Software Inc., 2.50%, 4/15/12(L2)

 

300,000

 

309,374

 

Salesforce.com Inc., 0.75%, 1/15/15(L2)(b)

 

200,000

 

299,500

 

 

 

 

 

608,874

 

AUTO PARTS & EQUIPMENT—1.9%

 

 

 

 

 

TRW Automotive Inc., 3.50%, 12/1/15(L2)(b)

 

300,000

 

514,500

 

 

 

 

 

 

 

AUTOMOBILE MANUFACTURERS—0.9%

 

 

 

 

 

Ford Motor Co., 4.25%, 11/15/16(L2)

 

150,000

 

261,375

 

 

 

 

 

 

 

BIOTECHNOLOGY—1.7%

 

 

 

 

 

Celphalon Inc., 2.00%, 6/1/15(L2)

 

250,000

 

377,500

 

Cubist Pharmaceuticals, 2.50%, 11/1/17(L2)

 

100,000

 

101,375

 

 

 

 

 

478,875

 

BREWERS—1.2%

 

 

 

 

 

Molson Coors Brewing Co., 2.50%, 7/30/13(L2)

 

300,000

 

338,250

 

 

 

 

 

 

 

CABLE & SATELLITE—2.6%

 

 

 

 

 

Virgin Media Inc., 6.50%, 11/15/16(L2)

 

250,000

 

399,999

 

XM Satellite Radio Inc., 7.00%, 12/1/14(L2)(b)

 

250,000

 

296,875

 

 

 

 

 

696,874

 

CASINOS & GAMING—1.0%

 

 

 

 

 

MGM Resorts International, 4.25%, 4/15/15(L2)(b)

 

300,000

 

288,375

 

 

75



 

 

 

PRINCIPAL
AMOUNT

 

VALUE

 

CONVERTIBLE CORPORATE BONDS—(CONT.)

 

 

 

 

 

COAL & CONSUMABLE FUELS—1.3%

 

 

 

 

 

Alpha Natural Resources Inc., 2.38%, 4/15/15(L2)

 

$

300,000

 

$

352,875

 

 

 

 

 

 

 

COMMUNICATIONS EQUIPMENT—2.6%

 

 

 

 

 

Ciena Corp., 4.00%, 3/15/15(L2)(b)

 

250,000

 

255,938

 

Finisar Corp., 5.00%, 10/15/29(L2)(b)

 

250,000

 

450,624

 

 

 

 

 

706,562

 

COMPUTER STORAGE & PERIPHERALS—4.6%

 

 

 

 

 

EMC Corp., 1.75%, 12/1/13(L2)

 

500,000

 

715,624

 

Sandisk Corp., 1.00%, 5/15/13(L2)

 

250,000

 

235,938

 

SanDisk Corp., 1.50%, 8/15/17(L2)

 

300,000

 

293,250

 

 

 

 

 

1,244,812

 

CONSTRUCTION MATERIALS—0.9%

 

 

 

 

 

Cemex SAB de CV, 4.88%, 3/15/15(L2)(b)

 

250,000

 

251,875

 

 

 

 

 

 

 

DEPARTMENT STORES—1.3%

 

 

 

 

 

Saks Inc., 2.00%, 3/15/24(L2)

 

350,000

 

367,063

 

 

 

 

 

 

 

DIVERSIFIED METALS & MINING—1.1%

 

 

 

 

 

Sterlite Industries India Ltd., 4.00%, 10/30/14(L2)

 

300,000

 

298,125

 

 

 

 

 

 

 

ELECTRICAL COMPONENTS & EQUIPMENT—1.0%

 

 

 

 

 

General Cable Corp., 4.50%, 11/15/29(L2)

 

262,000

 

271,825

 

 

 

 

 

 

 

GOLD—2.2%

 

 

 

 

 

AngloGold Ashanti Holdings Finance PLC, 3.50%, 5/22/14(L2)(b)

 

200,000

 

240,500

 

Goldcorp Inc., 2.00%, 8/1/14(L2)

 

300,000

 

371,625

 

 

 

 

 

612,125

 

HEALTH CARE EQUIPMENT—2.2%

 

 

 

 

 

Insulet Corp., 5.38%, 6/15/13(L2)

 

250,000

 

262,188

 

Volcano Corp., 2.88%, 9/1/15(L2)

 

300,000

 

330,749

 

 

 

 

 

592,937

 

HOMEBUILDING—1.0%

 

 

 

 

 

D.R. Horton Inc., 2.00%, 5/15/14(L2)

 

250,000

 

269,375

 

 

 

 

 

 

 

HOTELS RESORTS & CRUISE LINES—2.0%

 

 

 

 

 

Gaylord Entertainment Co., 3.75%, 10/1/14(L2)(b)

 

225,000

 

314,156

 

Wyndham Worldwide Corp., 3.50%, 5/1/12(L2)

 

100,000

 

232,625

 

 

 

 

 

546,781

 

INDUSTRIAL CONGLOMERATES—0.6%

 

 

 

 

 

Textron Inc., 4.50%, 5/1/13(L2)

 

100,000

 

173,375

 

 

 

 

 

 

 

INTERNET SOFTWARE & SERVICES—2.2%

 

 

 

 

 

Equinix Inc., 4.75%, 6/15/16(L2)

 

250,000

 

316,563

 

VeriSign Inc., 3.25%, 8/15/37(L2)

 

250,000

 

289,375

 

 

 

 

 

605,938

 

MANAGED HEALTH CARE—1.3%

 

 

 

 

 

Amerigroup Corp., 2.00%, 5/15/12(L2)

 

300,000

 

345,750

 

 

 

 

 

 

 

METAL & GLASS CONTAINERS—1.8%

 

 

 

 

 

Owens-Brockway Glass Container Inc., 3.00%, 6/1/15(L2)(b)

 

500,000

 

501,875

 

 

76



 

 

 

PRINCIPAL
AMOUNT

 

VALUE

 

CONVERTIBLE CORPORATE BONDS—(CONT.)

 

 

 

 

 

MULTI-UTILITIES—1.3%

 

 

 

 

 

CMS Energy Corp., 5.50%, 6/15/29(L2)

 

$

250,000

 

$

345,938

 

 

 

 

 

 

 

OFFICE REITS—2.8%

 

 

 

 

 

Boston Properties LP, 2.88%, 2/15/37(L2)

 

500,000

 

509,374

 

SL Green Operating Partnership LP, 3.00%, 10/15/17(L2)(b)

 

250,000

 

252,813

 

 

 

 

 

762,187

 

OIL & GAS EQUIPMENT & SERVICES—2.2%

 

 

 

 

 

Newpark Resources Inc., 4.00%, 10/1/17(L2)

 

400,000

 

371,499

 

Sesi LLC, 1.50%, 12/15/26(L2)

 

250,000

 

247,188

 

 

 

 

 

618,687

 

OIL & GAS EXPLORATION & PRODUCTION—2.1%

 

 

 

 

 

Bill Barrett Corp., 5.00%, 3/15/28(L2)

 

300,000

 

307,500

 

Quicksilver Resources Inc., 1.88%, 11/1/24(L2)

 

250,000

 

278,438

 

 

 

 

 

585,938

 

OIL & GAS REFINING & MARKETING—1.2%

 

 

 

 

 

St. Mary Land & Exploration Co., 3.50%, 4/1/27(L2)

 

300,000

 

321,375

 

 

 

 

 

 

 

PHARMACEUTICALS—3.0%

 

 

 

 

 

Biovail Corp., 5.38%, 8/1/14(L2)(b)

 

250,000

 

491,562

 

Teva Pharmaceutical Finance Co., BV, 1.75%, 2/1/26(L2)

 

300,000

 

337,875

 

 

 

 

 

829,437

 

PROPERTY & CASUALTY INSURANCE—1.0%

 

 

 

 

 

Tower Group Inc., 5.00%, 9/15/14(L2)(b)

 

250,000

 

276,875

 

 

 

 

 

 

 

SEMICONDUCTORS—2.0%

 

 

 

 

 

Intel Corp., 3.25%, 8/1/39(L2)(b)

 

175,000

 

208,469

 

Xilinx Inc., 2.63%, 6/15/17(L2)(b)

 

300,000

 

345,750

 

 

 

 

 

554,219

 

SPECIALIZED FINANCE—1.2%

 

 

 

 

 

KKR Financial Holdings LLC, 7.50%, 1/15/17(L2)

 

250,000

 

331,250

 

 

 

 

 

 

 

SPECIALIZED REITS—1.2%

 

 

 

 

 

Host Hotels & Resorts LP, 2.50%, 10/15/29(L2)(b)

 

250,000

 

329,688

 

 

 

 

 

 

 

SYSTEMS SOFTWARE—1.1%

 

 

 

 

 

Rovi Corp., 2.63%, 2/15/40(L2)(b)

 

250,000

 

314,688

 

 

 

 

 

 

 

THRIFTS & MORTGAGE FINANCE—1.0%

 

 

 

 

 

MGIC Investments Inc., 5.00%, 5/1/17(L2)

 

250,000

 

280,313

 

 

 

 

 

 

 

WIRELESS TELECOMMUNICATION SERVICES—1.6%

 

 

 

 

 

SBA Communications Corp., 1.88%, 5/1/13(L2)

 

400,000

 

444,500

 

 

 

 

 

 

 

TOTAL CONVERTIBLE CORPORATE BONDS
(Cost $14,547,618)

 

 

 

17,382,074

 

 

77



 

 

 

PRINCIPAL
AMOUNT

 

VALUE

 

CORPORATE BONDS—2.3%

 

 

 

 

 

APPLICATION SOFTWARE—2.3%

 

 

 

 

 

Cadence Design System Inc., 2.63%, 6/1/15(L2)(b)
(Cost $500,000)

 

$

500,000

 

$

645,000

 

 

 

 

 

 

 

Total Investments
(Cost $22,328,823)(c)

 

96.4

%

26,551,589

 

Other Assets in Excess of Liabilities

 

3.6

 

999,742

 

 

 

 

 

 

 

NET ASSETS

 

100.0

%

$

27,551,331

 

 


Securities classified as Level 1 for ASC 820 disclosure purposes based on valuation inputs unless otherwise noted.

 

 

*

Non-income producing security.

(a)

These securities are required to be converted on the date listed; they generally may be converted prior to this date at the option of the holder.

(b)

Pursuant to Securities and Exchange Commission Rule 144A, these securities may be sold prior to their maturity only to qualified institutional buyers.  These securities are deemed to be liquid and represent 22.8% of the net assets of the Fund.

(c)

At October 31, 2010, the net unrealized appreciation on investments, based on cost for federal income tax purposes of $22,289,370 amounted to $4,262,219 which consisted of aggregate gross unrealized appreciation of $4,458,553 and aggregate gross unrealized depreciation of $196,334.

(L2)

Security classified as Level 2 for ASC 820 disclosure purposes based on valuation inputs.

 

Industry classifications are unaudited.

See Notes to Financial Statements.

 

78



 

THE ALGER FUNDS  |  ALGER MONEY MARKET FUND

Schedule of Investments October 31, 2010

 

 

 

PRINCIPAL
AMOUNT

 

VALUE

 

U.S. GOVERNMENT & AGENCY OBLIGATIONS (EXCLUDING MORTGAGE-BACKED)—54.0% (a)

 

 

 

 

 

FEDERAL AGRICULTURE MORTGAGE CORPORATION—22.1%

 

 

 

 

 

Federal Agricultural Mortgage Corporation Discount Notes,

 

 

 

 

 

0.16%, 11/12/10 (L2)

 

$

4,000,000

 

$

3,999,804

 

0.16%, 12/23/10 (L2)

 

5,000,000

 

4,998,857

 

 

 

 

 

8,998,661

 

FEDERAL HOME LOAN BANK—31.9%

 

 

 

 

 

Federal Home Loan Bank Discount Notes,

 

 

 

 

 

0.10%, 11/05/10 (L2)

 

5,000,000

 

4,999,945

 

0.12%, 11/22/10 (L2)

 

5,000,000

 

4,999,650

 

0.13%, 12/13/10 (L2)

 

3,000,000

 

2,999,545

 

 

 

 

 

12,999,140

 

TOTAL U.S. GOVERNMENT & AGENCY OBLIGATIONS (EXCLUDING MORTGAGE-BACKED)
(Cost $21,997,801)

 

 

 

21,997,801

 

 

 

 

 

 

 

SHORT-TERM INVESTMENTS—46.0%

 

 

 

 

 

TIME DEPOSITS—46.0%

 

 

 

 

 

Bank of American, NA, 0.03%, 11/1/10(L2)

 

1,600,000

 

1,600,000

 

Brown Bothers Harriman, Cayman, 0.03%, 11/1/10(L2)

 

12,339,557

 

12,339,556

 

Citibank, London, 0.03%, 11/1/10(L2)

 

1,600,000

 

1,600,000

 

HSBC Bank USA, Grand Cayman, 0.03%, 11/1/10(L2)

 

1,600,000

 

1,600,000

 

Wells Fargo, Grand Cayman, 0.03%, 11/1/10(L2)

 

1,600,000

 

1,600,000

 

TOTAL TIME DEPOSITS
(Cost $18,739,556)

 

 

 

18,739,556

 

 

 

 

 

 

 

Total Investments
(Cost $40,737,357)(b)

 

100.0

%

40,737,357

 

Liabilities in Excess of Other Assets

 

 

(17,275

)

 

 

 

 

 

 

NET ASSETS

 

100.0

%

$

40,720,082

 

 


(a)

Securities issued by these agencies, except for United States Treasury Notes and Bonds, are neither guaranteed nor issued by the United States Government.

(b)

At October 31, 2010, the cost of investments for federal income tax purposes was the same as the cost for financial reporting purposes.

(L2)

Security classified as Level 2 for ASC 820 disclosure purposes based on valuation inputs.

 

Industry classifications are unaudited.

See Notes to Financial Statements.

 

79


 


 

THE ALGER FUNDS

Statements of Assets and Liabilities October 31, 2010

(in thousands)

 

 

 

Alger Capital
Appreciation
Fund

 

Alger Large
Cap Growth
Fund

 

Alger Mid Cap
Growth Fund

 

ASSETS:

 

 

 

 

 

 

 

Investments in securities, at value (Identified cost)* see accompanying schedules of investments

 

$

825,504

 

$

299,363

 

$

307,635

 

Cash and cash equivalents

 

25,064

 

14,765

 

10,601

 

Receivable for investment securities sold

 

16,549

 

2,826

 

5,234

 

Receivable for shares of beneficial interest sold

 

1,193

 

616

 

272

 

Dividends and interest receivable

 

465

 

235

 

25

 

Receivable from Investment Manager

 

 

 

 

Prepaid expenses

 

99

 

53

 

52

 

Total Assets

 

868,874

 

317,858

 

323,819

 

LIABILITIES:

 

 

 

 

 

 

 

Payable for investment securities purchased

 

19,901

 

3,242

 

9,204

 

Written options outstanding, at value**

 

 

 

1,285

 

Payable for shares of beneficial interest redeemed

 

5,357

 

927

 

4,495

 

Accrued investment advisory fees

 

577

 

186

 

200

 

Accrued transfer agent fees

 

238

 

128

 

124

 

Accrued distribution fees

 

284

 

149

 

127

 

Accrued administrative fees

 

20

 

7

 

7

 

Accrued shareholder servicing fees

 

12

 

4

 

4

 

Dividends payable

 

 

 

 

Accrued other expenses

 

156

 

99

 

162

 

Total Liabilities

 

26,545

 

4,742

 

15,608

 

NET ASSETS

 

$

842,329

 

$

313,116

 

$

308,211

 

Net Assets Consist of:

 

 

 

 

 

 

 

Paid in capital (par value of $.001 per share)

 

975,296

 

396,665

 

457,880

 

Undistributed net investment income (accumulated loss)

 

278

 

700

 

(599

)

Undistributed net realized gain (accumulated realized loss)

 

(172,828

)

(105,727

)

(162,479

)

Net unrealized appreciation on investments

 

39,583

 

21,478

 

13,409

 

NET ASSETS

 

$

842,329

 

$

313,116

 

$

308,211

 

 


*Identified cost

 

$

785,921

 

$

277,885

 

$

293,819

 

**Written options premiums received

 

$

 

$

 

$

879

 

 

See Notes to Financial Statements.

 

80



 

 

 

Alger SMid
Cap Growth
Fund

 

Alger Small
Cap Growth
Fund

 

Alger Growth
Opportunities
Fund

 

Alger Health
Sciences
Fund

 

Alger
Balanced
Fund

 

Alger
Convertible
Fund

 

Alger Money
Market Fund

 

ASSETS:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments in securities, at value (Identified cost)* see accompanying schedules of investments

 

$

824,360

 

$

335,280

 

$

12,811

 

$

222,456

 

$

60,302

 

$

26,551

 

$

40,737

 

Cash and cash equivalents

 

34,953

 

8,042

 

464

 

13,816

 

2,219

 

224

 

 

Receivable for investment securities sold

 

 

1,794

 

 

2,364

 

1,058

 

947

 

 

Receivable for shares of beneficial interest sold

 

3,350

 

384

 

34

 

134

 

3

 

 

32

 

Dividends and interest receivable

 

184

 

33

 

 

130

 

352

 

177

 

 

Receivable from Investment Manager

 

 

 

8

 

 

 

1

 

29

 

Prepaid expenses

 

93

 

59

 

29

 

43

 

20

 

19

 

17

 

Total Assets

 

862,940

 

345,592

 

13,346

 

238,943

 

63,954

 

27,919

 

40,815

 

LIABILITIES:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Payable for investment securities purchased

 

1,613

 

556

 

 

 

952

 

305

 

 

Written options outstanding, at value**

 

 

 

 

 

 

 

 

Payable for shares of beneficial interest redeemed

 

955

 

617

 

12

 

559

 

60

 

 

32

 

Accrued investment advisory fees

 

577

 

236

 

9

 

166

 

33

 

17

 

16

 

Accrued transfer agent fees

 

168

 

113

 

6

 

81

 

27

 

5

 

13

 

Accrued distribution fees

 

229

 

102

 

4

 

104

 

27

 

6

 

 

Accrued administrative fees

 

19

 

8

 

1

 

6

 

1

 

8

 

1

 

Accrued shareholder servicing fees

 

11

 

5

 

 

3

 

1

 

 

1

 

Dividends payable

 

 

 

 

 

 

 

1

 

Accrued other expenses

 

152

 

118

 

25

 

86

 

54

 

27

 

31

 

Total Liabilities

 

3,724

 

1,755

 

57

 

1,005

 

1,155

 

368

 

95

 

NET ASSETS

 

$

859,216

 

$

343,837

 

$

13,289

 

$

237,938

 

$

62,799

 

$

27,551

 

$

40,720

 

Net Assets Consist of:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Paid in capital (par value of $.001 per share)

 

844,848

 

377,303

 

11,114

 

245,791

 

72,659

 

38,299

 

40,721

 

Undistributed net investment income (accumulated loss)

 

11

 

22

 

 

 

835

 

39

 

 

Undistributed net realized gain (accumulated realized loss)

 

(99,441

)

(79,544

)

(750

)

(18,495

)

(14,085

)

(15,010

)

(1

)

Net unrealized appreciation on investments

 

113,798

 

46,056

 

2,925

 

10,642

 

3,390

 

4,223

 

 

NET ASSETS

 

$

859,216

 

$

343,837

 

$

13,289

 

$

237,938

 

$

62,799

 

$

27,551

 

$

40,720

 

 


*Identified cost

 

$

710,562

 

$

289,224

 

$

9,886

 

$

211,817

 

$

56,912

 

$

22,329

 

$

40,737

 

**Written options premiums received

 

$

 

$

 

$

 

$

 

$

 

$

 

$

 

 

81



 

THE ALGER FUNDS

Statements of Assets and Liabilities October 31, 2010 (Continued)

(in thousands) except for Net Asset Value and Offering Price Per Share

 

 

 

Alger Capital
Appreciation
Fund

 

Alger Large
Cap Growth
Fund

 

Alger Mid Cap
Growth Fund

 

NET ASSETS BY CLASS

 

 

 

 

 

 

 

Class A

 

$

673,841

 

$

180,267

 

$

210,641

 

Class B

 

$

45,294

 

$

107,663

 

$

63,782

 

Class C

 

$

123,194

 

$

25,186

 

$

33,788

 

Class I

 

$

 

$

 

$

 

 

 

 

 

 

 

 

 

SHARES OF BENEFICIAL INTEREST OUTSTANDING— NOTE 6

 

 

 

 

 

 

 

Class A

 

49,982

 

16,026

 

32,961

 

Class B

 

3,762

 

10,690

 

11,825

 

Class C

 

10,206

 

2,506

 

6,289

 

Class I

 

 

 

 

 

 

 

 

 

 

 

 

NET ASSET VALUE AND OFFERING PRICE PER SHARE

 

 

 

 

 

 

 

Class A — Net Asset Value Per Share

 

$

13.48

 

$

11.25

 

$

6.39

 

Class A — Offering Price Per Share (includes 5.25% sales charge)

 

$

14.23

 

$

11.87

 

$

6.74

 

Class B — Net Asset Value Per Share

 

$

12.04

 

$

10.07

 

$

5.39

 

Class C — Net Asset Value Per Share

 

$

12.07

 

$

10.05

 

$

5.37

 

Class I — Net Asset Value Per Share

 

 

 

 

 

See Notes to Financial Statements.

 

82



 

 

 

Alger SMid
Cap Growth
Fund

 

Alger Small
Cap Growth
Fund

 

Alger Growth
Opportunities
Fund

 

Alger Health
Sciences
Fund

 

Alger
Balanced
Fund

 

Alger
Convertible
Fund

 

Alger Money
Market Fund

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET ASSETS BY CLASS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A

 

$

586,359

 

$

298,103

 

$

8,186

 

$

156,438

 

$

41,160

 

$

27,551

 

$

 

Class B

 

$

11,650

 

$

22,348

 

$

 

$

16,675

 

$

10,380

 

$

 

$

40,720

 

Class C

 

$

68,916

 

$

23,386

 

$

2,304

 

$

64,825

 

$

11,259

 

$

 

$

 

Class I

 

$

192,291

 

$

 

$

2,799

 

$

 

$

 

$

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SHARES OF BENEFICIAL INTEREST OUTSTANDING— NOTE 6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A

 

40,498

 

44,484

 

800

 

8,979

 

1,926

 

1,262

 

 

Class B

 

863

 

3,758

 

 

1,028

 

492

 

 

40,721

 

Class C

 

5,095

 

3,932

 

230

 

3,993

 

536

 

 

 

Class I

 

13,195

 

 

272

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET ASSET VALUE AND OFFERING PRICE PER SHARE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A — Net Asset Value Per Share

 

$

14.48

 

$

6.70

 

$

10.23

 

$

17.42

 

$

21.38

 

$

21.83

 

 

Class A — Offering Price Per Share (includes 5.25% sales charge)

 

$

15.28

 

$

7.07

 

$

10.80

 

$

18.39

 

$

22.56

 

$

23.04

 

 

Class B — Net Asset Value Per Share

 

$

13.50

 

$

5.95

 

 

$

16.21

 

$

21.08

 

 

$

1.00

 

Class C — Net Asset Value Per Share

 

$

13.53

 

$

5.95

 

$

10.02

 

$

16.23

 

$

21.02

 

 

 

Class I — Net Asset Value Per Share

 

$

14.57

 

 

$

10.29

 

 

 

 

 

 

83



 

THE ALGER FUNDS

Statements of Operations (in thousands)

For the year ended October 31, 2010

 

 

 

Alger Capital
Appreciation
Fund

 

Alger Large
Cap Growth
Fund

 

Alger Mid Cap
Growth Fund

 

INCOME

 

 

 

 

 

 

 

Dividends (net of foreign withholding taxes*)

 

$

9,044

 

$

5,413

 

$

3,807

 

Interest

 

19

 

2

 

(38

)

Other

 

9

 

108

 

 

Total Income

 

9,072

 

5,523

 

3,769

 

EXPENSES

 

 

 

 

 

 

 

Advisory fees—Note 3(a)

 

6,509

 

2,048

 

2,459

 

Distribution fees—Note3(b):

 

 

 

 

 

 

 

Class A

 

1,597

 

391

 

559

 

Class B

 

494

 

1,060

 

649

 

Class C

 

1,154

 

260

 

353

 

Class I

 

 

 

 

Administrative fees—Note 3(a)

 

221

 

79

 

89

 

Custodian fees

 

95

 

46

 

78

 

Interest expenses

 

 

 

 

Transfer agent fees and expenses—Note 3(e)

 

1,291

 

576

 

624

 

Printing fees

 

216

 

121

 

144

 

Professional fees

 

62

 

87

 

95

 

Registration fees

 

122

 

80

 

92

 

Trustee fees—Note 3(f)

 

21

 

19

 

19

 

Miscellaneous

 

133

 

57

 

69

 

Total Expenses

 

11,915

 

4,824

 

5,230

 

Less, expense reimbursements/waivers Note 3(a)

 

 

 

 

Net Expenses

 

11,915

 

4,824

 

5,230

 

NET INVESTMENT INCOME (LOSS)

 

(2,843

)

699

 

(1,461

)

 

 

 

 

 

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS, OPTIONS AND FOREIGN CURRENCY

 

 

 

 

 

 

 

Net realized gain on investments and purchased options

 

95,309

 

10,438

 

50,644

 

Net realized gain on redemption-in-kind

 

 

 

 

Net realized loss on foreign currency transactions

 

(361

)

 

(81

)

Net realized loss on options written

 

 

 

(436

)

Net change in unrealized appreciation (depreciation) on investments, options and foreign currency

 

29,687

 

29,949

 

14,081

 

Net change in unrealized appreciation (depreciation) on written options

 

 

 

(405

)

Net realized and unrealized gain on investments, options and foreign currency

 

124,635

 

40,387

 

63,803

 

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

 

$

121,792

 

$

41,086

 

$

62,342

 

 


*Foreign withholding taxes

 

$

30

 

$

9

 

$

27

 

 

See Notes to Financial Statements.

 

84



 

 

 

Alger SMid
Cap Growth
Fund

 

Alger Small
Cap Growth
Fund

 

Alger Growth
Opportunities
Fund

 

Alger Health
Sciences
Fund

 

Alger
Balanced
Fund

 

Alger
Convertible
Fund

 

Alger Money
Market Fund

 

INCOME

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividends (net of foreign withholding taxes*)

 

$

3,014

 

$

999

 

$

29

 

$

1,955

 

$

611

 

$

529

 

$

 

Interest

 

9

 

2

 

 

4

 

1,507

 

533

 

42

 

Other

 

 

176

 

 

 

 

15

 

 

Total Income

 

3,023

 

1,177

 

29

 

1,959

 

2,118

 

1,077

 

42

 

EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Advisory fees—Note 3(a)

 

5,855

 

2,806

 

94

 

2,117

 

437

 

188

 

194

 

Distribution fees—Note3(b):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A

 

1,221

 

750

 

18

 

433

 

94

 

66

 

 

Class B

 

111

 

232

 

 

178

 

122

 

 

 

Class C

 

623

 

232

 

17

 

703

 

117

 

 

 

Class I

 

402

 

 

5

 

 

 

 

 

Administrative fees—Note 3(a)

 

199

 

95

 

3

 

72

 

17

 

7

 

12

 

Custodian fees

 

56

 

40

 

19

 

32

 

23

 

 

10

 

Interest expenses

 

 

1

 

 

 

 

 

 

Transfer agent fees and expenses—Note 3(e)

 

908

 

657

 

29

 

400

 

139

 

29

 

78

 

Printing fees

 

251

 

146

 

12

 

69

 

29

 

11

 

17

 

Professional fees

 

54

 

98

 

25

 

36

 

26

 

31

 

25

 

Registration fees

 

126

 

94

 

33

 

74

 

42

 

31

 

23

 

Trustee fees—Note 3(f)

 

20

 

19

 

17

 

19

 

18

 

18

 

18

 

Miscellaneous

 

127

 

65

 

7

 

50

 

13

 

1

 

11

 

Total Expenses

 

9,953

 

5,235

 

279

 

4,183

 

1,077

 

382

 

388

 

Less, expense reimbursements/waivers Note 3(a)

 

 

 

(105

)

 

(55

)

(54

)

(356

)

Net Expenses

 

9,953

 

5,235

 

174

 

4,183

 

1,022

 

328

 

32

 

NET INVESTMENT INCOME (LOSS)

 

(6,930

)

(4,058

)

(145

)

(2,224

)

1,096

 

749

 

10

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS, OPTIONS AND FOREIGN CURRENCY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net realized gain on investments and purchased options

 

47,505

 

27,707

 

630

 

25,296

 

555

 

1,292

 

 

Net realized gain on redemption-in-kind

 

13,570

 

 

 

 

 

 

 

Net realized loss on foreign currency transactions

 

 

(1

)

 

(85

)

 

 

 

Net realized loss on options written

 

 

 

 

 

 

 

 

Net change in unrealized appreciation (depreciation) on investments, options and foreign currency

 

103,066

 

57,521

 

2,042

 

1,490

 

5,042

 

3,339

 

 

Net change in unrealized appreciation (depreciation) on written options

 

 

 

 

 

 

 

 

Net realized and unrealized gain on investments, options and foreign currency

 

164,141

 

85,227

 

2,672

 

26,701

 

5,597

 

4,631

 

 

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

 

$

157,211

 

$

81,169

 

$

2,527

 

$

24,477

 

$

6,693

 

$

5,380

 

$

10

 

 


*Foreign withholding taxes

 

$

 

$

2

 

$

 

$

43

 

$

1

 

$

 

$

 

 

85



 

THE ALGER FUNDS

Statements of Changes in Net Assets (in thousands)

 

 

 

Alger Capital Appreciation Fund

 

 

 

For the
Year Ended
October 31, 2010

 

For the
Year Ended
October 31, 2009

 

Net investment income (loss)

 

$

(2,843

)

$

(251

)

Net realized gain (loss) on investments, options and foreign currency

 

94,948

 

(56,026

)

Net change in unrealized appreciation on investments, options and foreign currency

 

29,687

 

172,864

 

Net increase in net assets resulting from operations

 

121,792

 

116,587

 

Dividends and distributions to shareholders from:

 

 

 

 

 

Net investment income

 

 

 

 

 

Class A

 

 

 

Class B

 

 

 

Class C

 

 

 

Class I

 

 

 

Net realized gains

 

 

 

 

 

Class A

 

 

 

Class B

 

 

 

Class C

 

 

 

Class I

 

 

 

Return of capital

 

 

 

 

 

Class A

 

 

 

Class B

 

 

 

Class C

 

 

 

Class I

 

 

 

Total dividends and distributions to shareholders

 

 

 

Increase (decrease) from shares of beneficial interest transactions:

 

 

 

 

 

Class A

 

32,701

 

51,681

 

Class B

 

(14,421

)

(16,554

)

Class C

 

10,033

 

7,568

 

Class I

 

 

 

Net increase (decrease) from shares of beneficial interest transactions—Note 6

 

28,313

 

42,695

 

Total increase (decrease)

 

150,105

 

159,282

 

Net Assets:

 

 

 

 

 

Beginning of period

 

692,224

 

532,942

 

END OF PERIOD

 

$

842,329

 

$

692,224

 

Undistributed net investment income (accumulated loss)

 

$

278

 

$

122

 

 

See Notes to Financial Statements.

 

86



 

 

 

Alger Large Cap Growth Fund

 

Alger Mid Cap Growth Fund

 

Alger SMid Cap Growth Fund

 

 

 

For the
Year Ended
October 31, 2010

 

For the
Year Ended
October 31, 2009

 

For the
Year Ended
October 31, 2010

 

For the
Year Ended
October 31, 2009

 

For the
Year Ended
October 31, 2010

 

For the
Year Ended
October 31, 2009

 

Net investment income (loss)

 

$

699

 

$

170

 

$

(1,461

)

$

(2,934

)

$

(6,930

)

$

(4,911

)

Net realized gain (loss) on investments, options and foreign currency

 

10,438

 

(66,344

)

50,127

 

(79,873

)

61,075

 

(81,427

)

Net change in unrealized appreciation on investments, options and foreign currency

 

29,949

 

102,476

 

13,676

 

139,295

 

103,066

 

177,832

 

Net increase in net assets resulting from operations

 

41,086

 

36,302

 

62,342

 

56,488

 

157,211

 

91,494

 

Dividends and distributions to shareholders from:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net investment income

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A

 

(147

)

 

 

 

 

 

Class B

 

 

 

 

 

 

 

Class C

 

 

 

 

 

 

 

Class I

 

 

 

 

 

 

 

Net realized gains

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A

 

 

 

 

 

 

 

Class B

 

 

 

 

 

 

 

Class C

 

 

 

 

 

 

 

Class I

 

 

 

 

 

 

 

Return of capital

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A

 

 

 

 

 

 

 

Class B

 

 

 

 

 

 

 

Class C

 

 

 

 

 

 

 

Class I

 

 

 

 

 

 

 

Total dividends and distributions to shareholders

 

(147

)

 

 

 

 

 

Increase (decrease) from shares of beneficial interest transactions:

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A

 

25,099

 

(21,950

)

(47,767

)

(21,747

)

88,865

 

32,290

 

Class B

 

(6,280

)

(9,813

)

(12,755

)

(15,986

)

(515

)

(190

)

Class C

 

(3,579

)

(4,221

)

(8,046

)

(7,549

)

4,925

 

4,022

 

Class I

 

 

 

 

 

6,836

 

53,960

 

Net increase (decrease) from shares of beneficial interest transactions—Note 6

 

15,240

 

(35,984

)

(68,568

)

(45,282

)

100,111

 

90,082

 

Total increase (decrease)

 

56,179

 

318

 

(6,226

)

11,206

 

257,322

 

181,576

 

Net Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

Beginning of period

 

256,937

 

256,619

 

314,437

 

303,231

 

601,894

 

420,318

 

END OF PERIOD

 

$

313,116

 

$

256,937

 

$

308,211

 

$

314,437

 

$

859,216

 

$

601,894

 

Undistributed net investment income (accumulated loss)

 

$

700

 

$

163

 

$

(599

)

$

(24

)

$

11

 

$

15

 

 

87



 

THE ALGER FUNDS

Statements of Changes in Net Assets (in thousands)

 

 

 

Alger Small Cap Growth Fund

 

 

 

For the
Year Ended
October 31, 2010

 

For the
Year Ended
October 31, 2009

 

Net investment income (loss)

 

$

(4,058

)

$

(3,511

)

Net realized gain (loss) on investments, options and foreign currency

 

27,706

 

(53,181

)

Net change in unrealized appreciation on investments, options and foreign currency

 

57,521

 

107,078

 

Net increase in net assets resulting from operations

 

81,169

 

50,386

 

Dividends and distributions to shareholders from:

 

 

 

 

 

Net investment income

 

 

 

 

 

Class A

 

 

 

Class B

 

 

 

Class C

 

 

 

Class I

 

 

 

Net realized gains

 

 

 

 

 

Class A

 

 

 

Class B

 

 

 

Class C

 

 

 

Class I

 

 

 

Return of capital

 

 

 

 

 

Class A

 

 

 

Class B

 

 

 

Class C

 

 

 

Class I

 

 

 

Total dividends and distributions to shareholders

 

 

 

Increase (decrease) from shares of beneficial interest transactions:

 

 

 

 

 

Class A

 

(55,280

)

(20,287

)

Class B

 

(5,233

)

(5,009

)

Class C

 

(2,042

)

(1,231

)

Class I

 

 

 

Net increase (decrease) from shares of beneficial interest transactions—Note 6

 

(62,555

)

(26,527

)

Total increase (decrease)

 

18,614

 

23,859

 

Net Assets:

 

 

 

 

 

Beginning of period

 

325,223

 

301,364

 

END OF PERIOD

 

$

343,837

 

$

325,223

 

Undistributed net investment income

 

$

22

 

$

22

 

 

See Notes to Financial Statements.

 

88



 

 

 

Alger Growth Opportunities Fund

 

Alger Health Sciences Fund

 

Alger Balanced Fund

 

 

 

For the
Year Ended
October 31, 2010

 

For the
Year Ended
October 31, 2009

 

For the
Year Ended
October 31, 2010

 

For the
Year Ended
October 31, 2009

 

For the
Year Ended
October 31, 2010

 

For the
Year Ended
October 31, 2009

 

Net investment income (loss)

 

$

(145

)

$

(75

)

$

(2,224

)

$

(2,148

)

$

1,096

 

$

1,032

 

Net realized gain (loss) on investments, options and foreign currency

 

630

 

(939

)

25,211

 

(8,501

)

555

 

(10,758

)

Net change in unrealized appreciation on investments, options and foreign currency

 

2,042

 

2,593

 

1,490

 

43,796

 

5,042

 

18,894

 

Net increase in net assets resulting from operations

 

2,527

 

1,579

 

24,477

 

33,147

 

6,693

 

9,168

 

Dividends and distributions to shareholders from:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net investment income

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A

 

 

 

 

 

(712

)

(746

)

Class B

 

 

 

 

 

(132

)

(206

)

Class C

 

 

 

 

 

(156

)

(155

)

Class I

 

 

 

 

 

 

 

Net realized gains

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A

 

 

 

 

 

 

 

Class B

 

 

 

 

 

 

 

Class C

 

 

 

 

 

 

 

Class I

 

 

 

 

 

 

 

Return of capital

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A

 

 

 

 

 

 

 

Class B

 

 

 

 

 

 

 

Class C

 

 

 

 

 

 

 

Class I

 

 

 

 

 

 

 

Total dividends and distributions to shareholders

 

 

 

 

 

(1,000

)

(1,107

)

Increase (decrease) from shares of beneficial interest transactions:

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A

 

1,222

 

2,096

 

(26,635

)

(35,957

)

2,212

 

(469

)

Class B

 

 

 

(1,954

)

(1,817

)

(5,170

)

(8,217

)

Class C

 

423

 

302

 

(9,922

)

(10,543

)

(1,125

)

(1,107

)

Class I

 

532

 

188

 

 

 

 

 

Net increase (decrease) from shares of beneficial interest transactions—Note 6

 

2,177

 

2,586

 

(38,511

)

(48,317

)

(4,083

)

(9,793

)

Total increase (decrease)

 

4,704

 

4,165

 

(14,034

)

(15,170

)

1,610

 

(1,732

)

Net Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

Beginning of period

 

8,585

 

4,420

 

251,972

 

267,142

 

61,189

 

62,921

 

END OF PERIOD

 

$

13,289

 

$

8,585

 

$

237,938

 

$

251,972

 

$

62,799

 

$

61,189

 

Undistributed net investment income

 

$

 

$

 

$

 

$

 

$

835

 

$

751

 

 

89



 

THE ALGER FUNDS

Statements of Changes in Net Assets (in thousands)

 

 

 

Alger Convertible Fund*

 

 

 

For the
Year Ended
October 31, 2010

 

For the
Year Ended
October 31, 2009

 

Net investment income

 

$

749

 

$

1,051

 

Net realized gain (loss) on investments, options and foreign currency

 

1,292

 

(9,880

)

Net change in unrealized appreciation on investments, options and foreign currency

 

3,339

 

13,868

 

Net increase in net assets resulting from operations

 

5,380

 

5,039

 

Dividends and distributions to shareholders from:

 

 

 

 

 

Net investment income

 

 

 

 

 

Class A

 

(332

)

(883

)

Class B

 

 

 

Net realized gains

 

 

 

 

 

Class A

 

 

 

Class B

 

 

 

Return of capital

 

 

 

 

 

Class A

 

 

(409

)

Class B

 

 

 

Total dividends and distributions to shareholders

 

(332

)

(1,292

)

Increase (decrease) from shares of beneficial interest transactions:

 

 

 

 

 

Class A

 

(2,171

)

(12,671

)

Class B

 

 

 

Net decrease from shares of beneficial interest transactions—Note 6

 

(2,171

)

(12,671

)

Total increase (decrease)

 

2,877

 

(8,924

)

Net Assets:

 

 

 

 

 

Beginning of period

 

24,674

 

33,598

 

END OF PERIOD

 

$

27,551

 

$

24,674

 

Undistributed net investment income (accumulated loss)

 

$

39

 

$

(182

)

 

See Notes to Financial Statements.

 


* Commenced operations on January 9, 2009.  Change in net assets prior to January 9, 2009 are that of its predecessor fund, Castle Convertible Fund, Inc.  See Note 11.

 

90



 

 

 

Alger Money Market Fund

 

 

 

For the
Year Ended
October 31, 2010

 

For the
Year Ended
October 31, 2009

 

Net investment income

 

$

10

 

$

41

 

Net realized gain (loss) on investments, options and foreign currency

 

 

 

Net change in unrealized appreciation on investments, options and foreign currency

 

 

 

Net increase in net assets resulting from operations

 

10

 

41

 

Dividends and distributions to shareholders from:

 

 

 

 

 

Net investment income

 

 

 

 

 

Class A

 

 

 

Class B

 

(10

)

(41

)

Net realized gains

 

 

 

 

 

Class A

 

 

 

Class B

 

 

 

Return of capital

 

 

 

 

 

Class A

 

 

 

Class B

 

 

 

Total dividends and distributions to shareholders

 

(10

)

(41

)

Increase (decrease) from shares of beneficial interest transactions:

 

 

 

 

 

Class A

 

 

 

Class B

 

(4,584

)

(11,091

)

Net decrease from shares of beneficial interest transactions—Note 6

 

(4,584

)

(11,091

)

Total increase (decrease)

 

(4,584

)

(11,091

)

Net Assets:

 

 

 

 

 

Beginning of period

 

45,304

 

56,395

 

END OF PERIOD

 

$

40,720

 

$

45,304

 

Undistributed net investment income (accumulated loss)

 

$

 

$

 

 

91



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Capital Appreciation Fund

 

 

 

Class A

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

11.48

 

$

9.24

 

$

15.66

 

$

11.05

 

$

9.27

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment income (loss)(i)

 

(0.02

)

0.01

 

(0.05

)

(0.09

)

(0.06

)

Net realized and unrealized gain (loss) on investments

 

2.02

 

2.23

 

(6.37

)

4.70

 

1.84

 

Total from investment operations

 

2.00

 

2.24

 

(6.42

)

4.61

 

1.78

 

Net asset value, end of period

 

$

13.48

 

$

11.48

 

$

9.24

 

$

15.66

 

$

11.05

 

Total return (ii)

 

17.4

%

24.2

%

(41.0

)%

41.7

%

19.2

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

673,841

 

$

543,395

 

$

400,523

 

$

452,152

 

$

152,808

 

Ratio of gross expenses to average net assets

 

1.32

%

1.43

%

1.35

%

1.44

%

1.39

%

Ratio of expense reimbursements to average net assets

 

0.00

%

0.00

%

0.00

%

0.00

%

0.00

%

Ratio of net expenses to average net assets

 

1.32

%

1.43

%

1.35

%

1.44

%

1.39

%

Ratio of net investment income (loss) to average net assets

 

(0.19

)%

0.15

%

(0.40

)%

(0.69

)%

(0.57

)%

Portfolio turnover rate

 

211.96

%

318.87

%

288.74

%

251.53

%

223.23

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

92



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Capital Appreciation Fund

 

 

 

Class B

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

10.34

 

$

8.40

 

$

14.35

 

$

10.20

 

$

8.62

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment loss(i)

 

(0.12

)

(0.07

)

(0.14

)

(0.17

)

(0.12

)

Net realized and unrealized gain (loss) on investments

 

1.82

 

2.01

 

(5.81

)

4.32

 

1.70

 

Total from investment operations

 

1.70

 

1.94

 

(5.95

)

4.15

 

1.58

 

Net asset value, end of period

 

$

12.04

 

$

10.34

 

$

8.40

 

$

14.35

 

$

10.20

 

Total return (ii)

 

16.4

%

23.0

%

(41.5

)%

40.7

%

18.3

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

45,294

 

$

52,055

 

$

59,164

 

$

186,431

 

$

179,706

 

Ratio of gross expenses to average net assets

 

2.20

%

2.40

%

2.09

%

2.21

%

2.14

%

Ratio of expense reimbursements to average net assets

 

0.00

%

0.00

%

0.00

%

0.00

%

0.00

%

Ratio of net expenses to average net assets

 

2.20

%

2.40

%

2.09

%

2.21

%

2.14

%

Ratio of net investment income (loss) to average net assets

 

(1.05

)%

(0.76

)%

(1.15

)%

(1.42

)%

(1.31

)%

Portfolio turnover rate

 

211.96

%

318.87

%

288.74

%

251.53

%

223.23

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

93



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Capital Appreciation Fund

 

 

 

Class C

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

10.36

 

$

8.40

 

$

14.34

 

$

10.19

 

$

8.61

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment loss(i)

 

(0.11

)

(0.06

)

(0.14

)

(0.17

)

(0.12

)

Net realized and unrealized gain (loss) on investments

 

1.82

 

2.02

 

(5.80

)

4.32

 

1.70

 

Total from investment operations

 

1.71

 

1.96

 

(5.94

)

4.15

 

1.58

 

Net asset value, end of period

 

$

12.07

 

$

10.36

 

$

8.40

 

$

14.34

 

$

10.19

 

Total return (ii)

 

16.5

%

23.3

%

(41.4

)%

40.7

%

18.4

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

123,194

 

$

96,774

 

$

73,255

 

$

94,265

 

$

34,933

 

Ratio of gross expenses to average net assets

 

2.09

%

2.21

%

2.10

%

2.19

%

2.14

%

Ratio of expense reimbursements to average net assets

 

0.00

%

0.00

%

0.00

%

0.00

%

0.00

%

Ratio of net expenses to average net assets

 

2.09

%

2.21

%

2.10

%

2.19

%

2.14

%

Ratio of net investment income (loss) to average net assets

 

(0.97

)%

(0.63

)%

(1.15

)%

(1.44

)%

(1.31

)%

Portfolio turnover rate

 

211.96

%

318.87

%

288.74

%

251.53

%

223.23

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

94



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Large Cap Growth Fund

 

 

 

Class A

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

9.72

 

$

8.20

 

$

14.25

 

$

11.13

 

$

10.48

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment income (loss)(i)

 

0.06

 

0.03

 

(0.01

)

(0.01

)

(0.02

)

Net realized and unrealized gain (loss) on investments

 

1.48

 

1.49

 

(6.04

)

3.13

 

0.67

 

Total from investment operations

 

1.54

 

1.52

 

(6.05

)

3.12

 

0.65

 

Dividends from net investment income

 

(0.01

)

 

 

 

 

Net asset value, end of period

 

$

11.25

 

$

9.72

 

$

8.20

 

$

14.25

 

$

11.13

 

Total return (ii)

 

15.9

%

18.5

%

(42.5

)%

28.0

%

6.2

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

180,267

 

$

132,551

 

$

136,464

 

$

224,617

 

$

157,185

 

Ratio of gross expenses to average net assets

 

1.38

%

1.50

%

1.30

%

1.34

%

1.21

%

Ratio of expense reimbursements to average net assets

 

0.00

%

0.00

%

0.00

%

0.00

%

0.00

%

Ratio of net expenses to average net assets

 

1.38

%

1.50

%

1.30

%

1.34

%

1.21

%

Ratio of net investment income (loss) to average net assets

 

0.54

%

0.39

%

(0.10

)%

(0.08

)%

(0.14

)%

Portfolio turnover rate

 

61.58

%

88.21

%

181.48

%

171.78

%

322.94

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

95



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Large Cap Growth Fund

 

 

 

Class B

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

8.75

 

$

7.42

 

$

12.99

 

$

10.22

 

$

9.70

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment loss(i)

 

(0.01

)

(0.02

)

(0.09

)

(0.09

)

(0.09

)

Net realized and unrealized gain (loss) on investments

 

1.33

 

1.35

 

(5.48

)

2.86

 

0.61

 

Total from investment operations

 

1.32

 

1.33

 

(5.57

)

2.77

 

0.52

 

Net asset value, end of period

 

$

10.07

 

$

8.75

 

$

7.42

 

$

12.99

 

$

10.22

 

Total return (ii)

 

15.1

%

17.9

%

(42.9

)%

27.1

%

5.4

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

107,663

 

$

99,170

 

$

94,253

 

$

206,695

 

$

221,298

 

Ratio of gross expenses to average net assets

 

2.00

%

2.13

%

2.05

%

2.10

%

1.96

%

Ratio of expense reimbursements to average net assets

 

0.00

%

0.00

%

0.00

%

0.00

%

0.00

%

Ratio of net expenses to average net assets

 

2.00

%

2.13

%

2.05

%

2.10

%

1.96

%

Ratio of net investment income (loss) to average net assets

 

(0.10

)%

(0.25

)%

(0.87

)%

(0.81

)%

0.91

%

Portfolio turnover rate

 

61.58

%

88.21

%

181.48

%

171.78

%

322.94

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

96



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Large Cap Growth Fund

 

 

 

Class C

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

8.73

 

$

7.42

 

$

12.98

 

$

10.21

 

$

9.69

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment loss(i)

 

(0.02

)

(0.02

)

(0.09

)

(0.09

)

(0.09

)

Net realized and unrealized gain (loss) on investments

 

1.34

 

1.33

 

(5.47

)

2.86

 

0.61

 

Total from investment operations

 

1.32

 

1.31

 

(5.56

)

2.77

 

0.52

 

Net asset value, end of period

 

$

10.05

 

$

8.73

 

$

7.42

 

$

12.98

 

$

10.21

 

Total return (ii)

 

15.1

%

17.7

%

(42.8

)%

27.1

%

5.4

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

25,186

 

$

25,216

 

$

25,902

 

$

44,993

 

$

40,151

 

Ratio of gross expenses to average net assets

 

2.08

%

2.20

%

2.05

%

2.09

%

1.96

%

Ratio of expense reimbursements to average net assets

 

0.00

%

0.00

%

0.00

%

0.00

%

0.00

%

Ratio of net expenses to average net assets

 

2.08

%

2.20

%

2.05

%

2.09

%

1.96

%

Ratio of net investment income (loss) to average net assets

 

(0.16

)%

(0.31

)%

(0.86

)%

(0.82

)%

(0.90

)%

Portfolio turnover rate

 

61.58

%

88.21

%

181.48

%

171.78

%

322.94

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

97



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Mid Cap Growth Fund

 

 

 

Class A

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

5.24

 

$

4.26

 

$

11.36

 

$

8.93

 

$

9.15

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment loss(i)

 

(0.01

)

(0.03

)

(0.05

)

(0.07

)

(0.07

)

Net realized and unrealized gain (loss) on investments

 

1.16

 

1.01

 

(5.23

)

3.46

 

0.85

 

Total from investment operations

 

1.15

 

0.98

 

(5.28

)

3.39

 

0.78

 

Distributions from net realized gains

 

 

 

(1.82

)

(0.96

)

(1.00

)

Net asset value, end of period

 

$

6.39

 

$

5.24

 

$

4.26

 

$

11.36

 

$

8.93

 

Total return (ii)

 

21.7

%

23.0

%

(54.9

)%

41.6

%

8.9

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

210,641

 

$

215,190

 

$

197,507

 

$

445,903

 

$

318,934

 

Ratio of gross expenses to average net assets

 

1.38

%

1.49

%

1.30

%

1.33

%

1.23

%

Ratio of expense reimbursements to average net assets

 

0.00

%

0.00

%

0.00

%

0.00

%

0.00

%

Ratio of net expenses to average net assets

 

1.38

%

1.49

%

1.30

%

1.33

%

1.23

%

Ratio of net investment income (loss) to average net assets

 

(0.21

)%

(0.78

)%

(0.67

)%

(0.69

)%

(0.77

)%

Portfolio turnover rate

 

195.64

%

297.11

%

328.95

%

279.32

%

272.41

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

98



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Mid Cap Growth Fund

 

 

 

Class B

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

4.46

 

$

3.66

 

$

10.09

 

$

8.09

 

$

8.43

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment loss(i)

 

(0.05

)

(0.06

)

(0.09

)

(0.12

)

(0.12

)

Net realized and unrealized gain (loss) on investments

 

0.98

 

0.86

 

(4.52

)

3.08

 

0.78

 

Total from investment operations

 

0.93

 

0.80

 

(4.61

)

2.96

 

0.66

 

Distributions from net realized gains

 

 

 

(1.82

)

(0.96

)

(1.00

)

Net asset value, end of period

 

$

5.39

 

$

4.46

 

$

3.66

 

$

10.09

 

$

8.09

 

Total return (ii)

 

20.9

%

21.9

%

(55.2

)%

40.5

%

8.2

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

63,782

 

$

64,096

 

$

69,142

 

$

218,783

 

$

212,286

 

Ratio of gross expenses to average net assets

 

2.12

%

2.32

%

2.04

%

2.08

%

1.98

%

Ratio of expense reimbursements to average net assets

 

0.00

%

0.00

%

0.00

%

0.00

%

0.00

%

Ratio of net expenses to average net assets

 

2.12

%

2.32

%

2.04

%

2.08

%

1.98

%

Ratio of net investment income (loss) to average net assets

 

(0.97

)%

(1.59

)%

(1.42

)%

(1.43

)%

(1.52

)%

Portfolio turnover rate

 

195.64

%

297.11

%

328.95

%

279.32

%

272.41

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

99



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Mid Cap Growth Fund

 

 

 

Class C

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

4.44

 

$

3.64

 

$

10.07

 

$

8.07

 

$

8.41

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment loss(i)

 

(0.05

)

(0.06

)

(0.10

)

(0.12

)

(0.12

)

Net realized and unrealized gain (loss) on investments

 

0.98

 

0.86

 

(4.51

)

3.08

 

0.78

 

Total from investment operations

 

0.93

 

0.80

 

(4.61

)

2.96

 

0.66

 

Distributions from net realized gains

 

 

 

(1.82

)

(0.96

)

(1.00

)

Net asset value, end of period

 

$

5.37

 

$

4.44

 

$

3.64

 

$

10.07

 

$

8.07

 

Total return (ii)

 

20.7

%

21.9

%

(55.3

)%

40.6

%

8.2

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

33,788

 

$

35,151

 

$

36,582

 

$

84,846

 

$

69,063

 

Ratio of gross expenses to average net assets

 

2.20

%

2.36

%

2.05

%

2.08

%

1.98

%

Ratio of expense reimbursements to average net assets

 

0.00

%

0.00

%

0.00

%

0.00

%

0.00

%

Ratio of net expenses to average net assets

 

2.20

%

2.36

%

2.05

%

2.08

%

1.98

%

Ratio of net investment income (loss) to average net assets

 

(1.04

)%

(1.63

)%

(1.42

)%

(1.43

)%

(1.52

)%

Portfolio turnover rate

 

195.64

%

297.11

%

328.95

%

279.32

%

272.41

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

100



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger SMid Cap Growth Fund

 

 

 

Class A

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

11.57

 

$

9.72

 

$

18.16

 

$

13.92

 

$

12.23

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment loss(i)

 

(0.12

)

(0.10

)

(0.14

)

(0.12

)

(0.14

)

Net realized and unrealized gain (loss) on investments

 

3.03

 

1.95

 

(8.04

)

5.05

 

2.58

 

Total from investment operations

 

2.91

 

1.85

 

(8.18

)

4.93

 

2.44

 

Distributions from net realized gains

 

 

 

(0.26

)

(0.69

)

(0.75

)

Net asset value, end of period

 

$

14.48

 

$

11.57

 

$

9.72

 

$

18.16

 

$

13.92

 

Total return (ii)

 

25.2

%

19.0

%

(45.6

)%

37.0

%

20.8

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

586,359

 

$

391,804

 

$

299,644

 

$

280,672

 

$

33,419

 

Ratio of gross expenses to average net assets

 

1.32

%

1.42

%

1.34

%

1.34

%

1.68

%

Ratio of expense reimbursements to average net assets

 

0.00

%

0.00

%

0.00

%

0.00

%

(0.18

)%

Ratio of net expenses to average net assets

 

1.32

%

1.42

%

1.34

%

1.34

%

1.50

%

Ratio of net investment income (loss) to average net assets

 

(0.90

)%

(1.00

)%

(0.95

)%

(0.80

)%

(1.02

)%

Portfolio turnover rate

 

58.80

%

76.25

%

68.50

%

64.72

%

80.64

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

101



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger SMid Cap Growth Fund

 

 

 

Class B

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

10.88

 

$

9.23

 

$

17.39

 

$

13.44

 

$

11.92

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment loss(i)

 

(0.21

)

(0.18

)

(0.24

)

(0.23

)

(0.23

)

Net realized and unrealized gain (loss) on investments

 

2.83

 

1.83

 

(7.66

)

4.87

 

2.50

 

Total from investment operations

 

2.62

 

1.65

 

(7.90

)

4.64

 

2.27

 

Distributions from net realized gains

 

 

 

(0.26

)

(0.69

)

(0.75

)

Net asset value, end of period

 

$

13.50

 

$

10.88

 

$

9.23

 

$

17.39

 

$

13.44

 

Total return (ii)

 

24.1

%

17.9

%

(46.1

)%

36.1

%

19.8

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

11,650

 

$

9,891

 

$

8,717

 

$

16,285

 

$

7,251

 

Ratio of gross expenses to average net assets

 

2.16

%

2.35

%

2.13

%

2.15

%

2.43

%

Ratio of expense reimbursements to average net assets

 

0.00

%

0.00

%

0.00

%

0.00

%

(0.18

)%

Ratio of net expenses to average net assets

 

2.16

%

2.35

%

2.13

%

2.15

%

2.25

%

Ratio of net investment income (loss) to average net assets

 

(1.74

)%

(1.92

)%

(1.74

)%

(1.58

)%

(1.77

)%

Portfolio turnover rate

 

58.80

%

76.25

%

68.50

%

64.72

%

80.64

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

102



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger SMid Cap Growth Fund

 

 

 

Class C

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

10.90

 

$

9.24

 

$

17.40

 

$

13.45

 

$

11.92

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment loss(i)

 

(0.21

)

(0.17

)

(0.23

)

(0.23

)

(0.23

)

Net realized and unrealized gain (loss) on investments

 

2.84

 

1.83

 

(7.67

)

4.87

 

2.51

 

Total from investment operations

 

2.63

 

1.66

 

(7.90

)

4.64

 

2.28

 

Distributions from net realized gains

 

 

 

(0.26

)

(0.69

)

(0.75

)

Net asset value, end of period

 

$

13.53

 

$

10.90

 

$

9.24

 

$

17.40

 

$

13.45

 

Total return (ii)

 

24.1

%

18.0

%

(46.0

)%

36.0

%

19.9

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

68,916

 

$

51,274

 

$

40,849

 

$

46,775

 

$

11,940

 

Ratio of gross expenses to average net assets

 

2.13

%

2.29

%

2.07

%

2.12

%

2.42

%

Ratio of expense reimbursements to average net assets

 

0.00

%

0.00

%

0.00

%

0.00

%

(0.17

)%

Ratio of net expenses to average net assets

 

2.13

%

2.29

%

2.07

%

2.12

%

2.25

%

Ratio of net investment income (loss) to average net assets

 

(1.71

)%

(1.86

)%

(1.68

)%

(1.55

)%

(1.79

)%

Portfolio turnover rate

 

58.80

%

76.25

%

68.50

%

64.72

%

80.64

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

103


 


 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger SMid Cap Growth Fund

 

 

 

Class I

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

From
8/5/2007
(commencement
of
operations) to
10/31/2007(i)

 

Net asset value, beginning of period

 

$

11.63

 

$

9.75

 

$

18.21

 

$

15.64

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

Net investment loss(ii)

 

(0.10

)

(0.08

)

(0.12

)

(0.02

)

Net realized and unrealized gain (loss) on investments

 

3.04

 

1.96

 

(8.08

)

2.59

 

Total from investment operations

 

2.94

 

1.88

 

(8.20

)

2.57

 

Distributions from net realized gains

 

 

 

(0.26

)

 

Net asset value, end of period

 

$

14.57

 

$

11.63

 

$

9.75

 

$

18.21

 

Total return (iii)

 

25.3

%

19.2

%

(45.6

)%

16.4

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

192,291

 

$

148,925

 

$

71,108

 

$

3,007

 

Ratio of gross expenses to average net assets

 

1.20

%

1.23

%

1.24

%

2.35

%

Ratio of expense reimbursements to average net assets

 

0.00

%

(0.02

)%

0.00

%

(1.10

)%

Ratio of net expenses to average net assets

 

1.20

%

1.21

%

1.24

%

1.25

%

Ratio of net investment income (loss) to average net assets

 

(0.78

)%

(0.79

)%

(0.87

)%

(0.94

)%

Portfolio turnover rate

 

58.80

%

76.25

%

68.50

%

64.72

%

 

See Notes to Financial Statements.

 


(i) Ratios have been annualized; total return and portfolio turnover rate have not been annualized.

(ii) Amount was computed based on average shares outstanding during the period.

(iii) Does not reflect the effect of sales charges, if applicable.

 

104



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Small Cap Growth Fund

 

 

 

Class A

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

5.27

 

$

4.37

 

$

8.02

 

$

6.31

 

$

5.21

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment loss(i)

 

(0.06

)

(0.05

)

(0.07

)

(0.07

)

(0.05

)

Net realized and unrealized gain (loss) on investments

 

1.49

 

0.95

 

(3.58

)

1.78

 

1.15

 

Total from investment operations

 

1.43

 

0.90

 

(3.65

)

1.71

 

1.10

 

Net asset value, end of period

 

$

6.70

 

$

5.27

 

$

4.37

 

$

8.02

 

$

6.31

 

Total return (ii)

 

27.1

%

20.6

%

(45.5

)%

27.1

%

21.1

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

298,103

 

$

282,794

 

$

258,783

 

$

482,318

 

$

221,019

 

Ratio of gross expenses to average net assets

 

1.40

%

1.53

%

1.38

%

1.41

%

1.37

%

Ratio of expense reimbursements to average net assets

 

0.00

%

0.00

%

0.00

%

0.00

%

0.00

%

Ratio of net expenses to average net assets

 

1.40

%

1.53

%

1.38

%

1.41

%

1.37

%

Ratio of net investment income (loss) to average net assets

 

(1.07

)%

(1.14

)%

(1.09

)%

(0.97

)%

(0.91

)%

Portfolio turnover rate

 

48.45

%

86.89

%

62.37

%

73.54

%

83.72

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

105



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Small Cap Growth Fund

 

 

 

Class B

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

4.71

 

$

3.94

 

$

7.28

 

$

5.77

 

$

4.80

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment loss(i)

 

(0.10

)

(0.08

)

(0.11

)

(0.11

)

(0.09

)

Net realized and unrealized gain (loss) on investments

 

1.34

 

0.85

 

(3.23

)

1.62

 

1.06

 

Total from investment operations

 

1.24

 

0.77

 

(3.34

)

1.51

 

0.97

 

Net asset value, end of period

 

$

5.95

 

$

4.71

 

$

3.94

 

$

7.28

 

$

5.77

 

Total return (ii)

 

26.3

%

19.5

%

(45.9

)%

26.2

%

20.2

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

22,348

 

$

22,174

 

$

23,783

 

$

57,488

 

$

57,928

 

Ratio of gross expenses to average net assets

 

2.15

%

2.44

%

2.13

%

2.16

%

2.14

%

Ratio of expense reimbursements to average net assets

 

0.00

%

0.00

%

0.00

%

0.00

%

0.00

%

Ratio of net expenses to average net assets

 

2.15

%

2.44

%

2.13

%

2.16

%

2.14

%

Ratio of net investment income (loss) to average net assets

 

(1.81

)%

(2.04

)%

(1.84

)%

(1.70

)%

(1.66

)%

Portfolio turnover rate

 

48.45

%

86.89

%

62.37

%

73.54

%

83.72

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

106



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Small Cap Growth Fund

 

 

 

Class C

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

4.72

 

$

3.95

 

$

7.29

 

$

5.78

 

$

4.81

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment loss(i)

 

(0.10

)

(0.08

)

(0.11

)

(0.11

)

(0.09

)

Net realized and unrealized gain (loss) on investments

 

1.33

 

0.85

 

(3.23

)

1.62

 

1.06

 

Total from investment operations

 

1.23

 

0.77

 

(3.34

)

1.51

 

0.97

 

Net asset value, end of period

 

$

5.95

 

$

4.72

 

$

3.95

 

$

7.29

 

$

5.78

 

Total return (ii)

 

26.1

%

19.8

%

(45.8

)%

26.1

%

20.2

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

23,386

 

$

20,255

 

$

18,798

 

$

46,939

 

$

17,580

 

Ratio of gross expenses to average net assets

 

2.25

%

2.41

%

2.13

%

2.16

%

2.12

%

Ratio of expense reimbursements to average net assets

 

0.00

%

0.00

%

0.00

%

0.00

%

0.00

%

Ratio of net expenses to average net assets

 

2.25

%

2.41

%

2.13

%

2.16

%

2.12

%

Ratio of net investment income (loss) to average net assets

 

(1.91

)%

(2.01

)%

(1.84

)%

(1.72

)%

(1.66

)%

Portfolio turnover rate

 

48.45

%

86.89

%

62.37

%

73.54

%

83.72

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

107


 


 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Growth Opportunities Fund

 

 

 

Class A

 

Class C

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

From
3/3/2008
(commencement
of
operations) to
10/31/2008(i)

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

From
3/3/2008
(commencement
of
operations) to
10/31/2008(i)

 

Net asset value, beginning of period

 

$

7.94

 

$

6.55

 

$

10.00

 

$

7.84

 

$

6.51

 

$

10.00

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net investment loss(ii)

 

(0.11

)

(0.08

)

(0.06

)

(0.18

)

(0.12

)

(0.09

)

Net realized and unrealized gain (loss) on investments

 

2.40

 

1.47

 

(3.39

)

2.36

 

1.45

 

(3.40

)

Total from investment operations

 

2.29

 

1.39

 

(3.45

)

2.18

 

1.33

 

(3.49

)

Net asset value, end of period

 

$

10.23

 

$

7.94

 

$

6.55

 

$

10.02

 

$

7.84

 

$

6.51

 

Total return (iii)

 

28.8

%

21.2

%

(34.5

)%

27.8

%

20.4

%

(34.9

)%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

8,186

 

$

5,394

 

$

2,266

 

$

2,304

 

$

1,454

 

$

895

 

Ratio of gross expenses to average net assets

 

2.32

%

2.93

%

3.14

%

3.16

%

3.73

%

3.88

%

Ratio of expense reimbursements to average net assets

 

(0.82

)%

(1.43

)%

(1.64

)%

(0.91

)%

(1.48

)%

(1.63

)%

Ratio of net expenses to average net assets

 

1.50

%

1.50

%

1.50

%

2.25

%

2.25

%

2.25

%

Ratio of net investment income (loss) to average net assets

 

(1.24

)%

(1.10

)%

1.11

%

(2.00

)%

(1.85

)%

(1.85

)%

Portfolio turnover rate

 

64.25

%

63.94

%

27.80

%

64.25

%

63.94

%

27.80

%

 

See Notes to Financial Statements.

 


(i) Ratios have been annualized; total return and portfolio turnover rate have not been annualized.

(ii) Amount was computed based on average shares outstanding during the period.

(iii) Does not reflect the effect of sales charges, if applicable.

 

108



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Growth Opportunities Fund

 

 

 

Class I

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

From
3/3/2008
(commencement
of
operations) to
10/31/2008(i)

 

Net asset value, beginning of period

 

$

7.96

 

$

6.55

 

$

10.00

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

Net investment loss(ii)

 

(0.09

)

(0.06

)

(0.05

)

Net realized and unrealized gain (loss) on investments

 

2.42

 

1.47

 

(3.40

)

Total from investment operations

 

2.33

 

1.41

 

(3.45

)

Net asset value, end of period

 

$

10.29

 

$

7.96

 

$

6.55

 

Total return (iii)

 

29.3

%

21.5

%

(34.5

)%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

2,799

 

$

1,737

 

$

1,259

 

Ratio of gross expenses to average net assets

 

2.73

%

2.84

%

3.05

%

Ratio of expense reimbursements to average net assets

 

(1.48

)%

(1.59

)%

(1.80

)%

Ratio of net expenses to average net assets

 

1.25

%

1.25

%

1.25

%

Ratio of net investment income (loss) to average net assets

 

(0.99

)%

(0.85

)%

(0.83

)%

Portfolio turnover rate

 

64.25

%

63.94

%

27.80

%

 

See Notes to Financial Statements.

 


(i) Ratios have been annualized; total return and portfolio turnover rate have not been annualized.

(ii) Amount was computed based on average shares outstanding during the period.

(iii) Does not reflect the effect of sales charges, if applicable.

 

109


 


 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Health Sciences Fund

 

 

 

Class A

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

15.76

 

$

13.65

 

$

19.94

 

$

18.17

 

$

16.24

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment loss(i)

 

(0.10

)

(0.08

)

(0.09

)

(0.08

)

(0.07

)

Net realized and unrealized gain (loss) on investments

 

1.76

 

2.19

 

(4.71

)

2.72

 

2.35

 

Total from investment operations

 

1.66

 

2.11

 

(4.80

)

2.64

 

2.28

 

Distributions from net realized gains

 

 

 

(1.49

)

(0.87

)

(0.35

)

Net asset value, end of period

 

$

17.42

 

$

15.76

 

$

13.65

 

$

19.94

 

$

18.17

 

Total return (ii)

 

10.5

%

15.5

%

(26.0

)%

15.3

%

14.3

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

156,438

 

$

166,555

 

$

180,210

 

$

193,165

 

$

116,165

 

Ratio of gross expenses to average net assets

 

1.33

%

1.41

%

1.31

%

1.35

%

1.35

%

Ratio of expense reimbursements to average net assets

 

0.00

%

0.00

%

0.00

%

0.00

%

0.00

%

Ratio of net expenses to average net assets

 

1.33

%

1.41

%

1.31

%

1.35

%

1.35

%

Ratio of net investment income (loss) to average net assets

 

(0.58

)%

(0.59

)%

(0.54

)%

(0.42

)%

(0.40

)%

Portfolio turnover rate

 

75.15

%

174.56

%

202.86

%

183.27

%

168.87

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

110



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Health Sciences Fund

 

 

 

Class B

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

14.78

 

$

12.92

 

$

19.10

 

$

17.56

 

$

15.83

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment loss(i)

 

(0.23

)

(0.20

)

(0.21

)

(0.20

)

(0.19

)

Net realized and unrealized gain (loss) on investments

 

1.66

 

2.06

 

(4.48

)

2.61

 

2.27

 

Total from investment operations

 

1.43

 

1.86

 

(4.69

)

2.41

 

2.08

 

Distributions from net realized gains

 

 

 

(1.49

)

(0.87

)

(0.35

)

Net asset value, end of period

 

$

16.21

 

$

14.78

 

$

12.92

 

$

19.10

 

$

17.56

 

Total return (ii)

 

9.7

%

14.4

%

(26.6

)%

14.5

%

13.3

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

16,675

 

$

17,039

 

$

16,677

 

$

22,605

 

$

22,995

 

Ratio of gross expenses to average net assets

 

2.15

%

2.29

%

2.06

%

2.10

%

2.10

%

Ratio of expense reimbursements to average net assets

 

0.00

%

0.00

%

0.00

%

0.00

%

0.00

%

Ratio of net expenses to average net assets

 

2.15

%

2.29

%

2.06

%

2.10

%

2.10

%

Ratio of net investment income (loss) to average net assets

 

(1.41

)%

(1.48

)%

(1.29

)%

(1.16

)%

(1.15

)%

Portfolio turnover rate

 

75.15

%

174.56

%

202.86

%

183.27

%

168.87

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

111



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Health Sciences Fund

 

 

 

Class C

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

14.80

 

$

12.92

 

$

19.09

 

$

17.56

 

$

15.82

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment loss(i)

 

(0.22

)

(0.18

)

(0.21

)

(0.20

)

(0.19

)

Net realized and unrealized gain (loss) on investments

 

1.65

 

2.06

 

(4.47

)

2.60

 

2.28

 

Total from investment operations

 

1.43

 

1.88

 

(4.68

)

2.40

 

2.09

 

Distributions from net realized gains

 

 

 

(1.49

)

(0.87

)

(0.35

)

Net asset value, end of period

 

$

16.23

 

$

14.80

 

$

12.92

 

$

19.09

 

$

17.56

 

Total return (ii)

 

9.7

%

14.6

%

(26.6

)%

14.4

%

13.4

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

64,825

 

$

68,378

 

$

70,255

 

$

69,618

 

$

45,947

 

Ratio of gross expenses to average net assets

 

2.12

%

2.19

%

2.06

%

2.10

%

2.12

%

Ratio of expense reimbursements to average net assets

 

0.00

%

0.00

%

0.00

%

0.00

%

(0.01

)%

Ratio of net expenses to average net assets

 

2.12

%

2.19

%

2.06

%

2.10

%

2.11

%

Ratio of net investment income (loss) to average net assets

 

(1.37

)%

(1.38

)%

(1.30

)%

(1.16

)%

(1.15

)%

Portfolio turnover rate

 

75.15

%

174.56

%

202.86

%

183.27

%

168.87

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

112


 


 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Balanced Fund

 

 

 

Class A

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

19.50

 

$

16.97

 

$

24.71

 

$

21.15

 

$

20.29

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment income(i)

 

0.42

 

0.37

 

0.35

 

0.29

 

0.23

 

Net realized and unrealized gain (loss) on investments

 

1.86

 

2.57

 

(7.76

)

3.57

 

0.84

 

Total from investment operations

 

2.28

 

2.94

 

(7.41

)

3.86

 

1.07

 

Dividends from net investment income

 

(0.40

)

(0.41

)

(0.33

)

(0.30

)

(0.21

)

Net asset value, end of period

 

$

21.38

 

$

19.50

 

$

16.97

 

$

24.71

 

$

21.15

 

Total return (ii)

 

11.8

%

17.9

%

(30.4

)%

18.5

%

5.3

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

41,160

 

$

35,465

 

$

31,102

 

$

35,789

 

$

43,224

 

Ratio of gross expenses to average net assets

 

1.46

%

1.52

%

1.33

%

1.33

%

1.32

%

Ratio of expense reimbursements to average net assets

 

(0.09

)%

(0.09

)%

(0.09

)%

(0.08

)%

0.00

%

Ratio of net expenses to average net assets

 

1.37

%

1.43

%

1.24

%

1.25

%

1.32

%

Ratio of net investment income (loss) to average net assets

 

2.08

%

2.14

%

1.60

%

1.26

%

1.15

%

Portfolio turnover rate

 

72.11

%

100.18

%

78.04

%

139.18

%

271.30

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

113



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Balanced Fund

 

 

 

Class B

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

19.18

 

$

16.61

 

$

24.16

 

$

20.66

 

$

19.81

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment income(i)

 

0.25

 

0.21

 

0.18

 

0.12

 

0.08

 

Net realized and unrealized gain (loss) on investments

 

1.84

 

2.54

 

(7.60

)

3.50

 

0.82

 

Total from investment operations

 

2.09

 

2.75

 

(7.42

)

3.62

 

0.90

 

Dividends from net investment income

 

(0.19

)

(0.18

)

(0.13

)

(0.12

)

(0.05

)

Net asset value, end of period

 

$

21.08

 

$

19.18

 

$

16.61

 

$

24.16

 

$

20.66

 

Total return (ii)

 

10.9

%

16.8

%

(30.9

)%

17.6

%

4.5

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

10,380

 

$

14,408

 

$

20,762

 

$

53,928

 

$

67,170

 

Ratio of gross expenses to average net assets

 

2.24

%

2.41

%

2.07

%

2.07

%

2.07

%

Ratio of expense reimbursements to average net assets

 

(0.09

)%

(0.09

)%

(0.09

)%

(0.08

)%

0.00

%

Ratio of net expenses to average net assets

 

2.15

%

2.32

%

1.98

%

1.99

%

2.07

%

Ratio of net investment income (loss) to average net assets

 

1.26

%

1.29

%

0.81

%

0.53

%

0.40

%

Portfolio turnover rate

 

72.11

%

100.18

%

78.04

%

139.18

%

271.30

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

114



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Balanced Fund

 

 

 

Class C

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

19.19

 

$

16.66

 

$

24.26

 

$

20.75

 

$

19.90

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment income(i)

 

0.27

 

0.23

 

0.18

 

0.12

 

0.08

 

Net realized and unrealized gain (loss) on investments

 

1.83

 

2.54

 

(7.63

)

3.52

 

0.82

 

Total from investment operations

 

2.10

 

2.77

 

(7.45

)

3.64

 

0.90

 

Dividends from net investment income

 

(0.27

)

(0.24

)

(0.15

)

(0.13

)

(0.05

)

Net asset value, end of period

 

$

21.02

 

$

19.19

 

$

16.66

 

$

24.26

 

$

20.75

 

Total return (ii)

 

11.0

%

16.9

%

(30.9

)%

17.6

%

4.5

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

11,259

 

$

11,316

 

$

11,057

 

$

17,079

 

$

22,357

 

Ratio of gross expenses to average net assets

 

2.17

%

2.32

%

2.07

%

2.06

%

2.07

%

Ratio of expense reimbursements to average net assets

 

(0.09

)%

(0.09

)%

(0.09

)%

(0.08

)%

0.00

%

Ratio of net expenses to average net assets

 

2.08

%

2.23

%

1.98

%

1.98

%

2.07

%

Ratio of net investment income (loss) to average net assets

 

1.36

%

1.35

%

0.84

%

0.53

%

0.41

%

Portfolio turnover rate

 

72.11

%

100.18

%

78.04

%

139.18

%

271.30

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

115


 


 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Convertible Fund

 

 

 

Class A(i)

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

18.04

 

$

15.03

 

$

28.45

 

$

28.43

 

$

26.67

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment income(ii)

 

0.57

 

0.64

 

0.58

 

0.70

 

0.66

 

Net realized and unrealized gain (loss) on investments

 

3.47

 

3.14

 

(11.38

)

1.61

 

2.22

 

Total from investment operations

 

4.04

 

3.78

 

(10.80

)

2.31

 

2.88

 

Dividends from net investment income

 

(0.25

)

(0.53

)

(0.85

)

(1.16

)

(1.12

)

Distributions from net realized gains

 

 

 

(1.77

)

(1.13

)

 

Return of capital

 

 

(0.24

)

 

 

 

Net asset value, end of period

 

$

21.83

 

$

18.04

 

$

15.03

 

$

28.45

 

$

28.43

 

Total return (iii)

 

22.4

%

26.3

%

(40.7

)%

9.4

%

11.8

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

27,551

 

$

24,674

 

$

33,598

 

$

63,624

 

$

63,573

 

Ratio of gross expenses to average net assets

 

1.45

%

1.72

%

1.27

%

1.09

%

1.20

%

Ratio of expense reimbursements to average net assets

 

(0.21

)%

(0.42

)%

0.00

%

0.00

%

0.00

%

Ratio of net expenses to average net assets

 

1.24

%

1.30

%

1.27

%

1.09

%

1.20

%

Ratio of net investment income (loss) to average net assets

 

2.83

%

4.08

%

2.46

%

2.51

%

2.41

%

Portfolio turnover rate

 

121.23

%

130.33

%

98.38

%

134.32

%

96.37

%

 

See Notes to Financial Statements.

 


(i) Commenced operations on January 9, 2009.  Financial highlights prior to January 9, 2009 are that of its predecessor fund, Castle Convertible Fund, Inc.

(ii) Amount was computed based on average shares outstanding during the period.

(iii) Does not reflect the effect of sales charges, if applicable.

 

116



 

THE ALGER FUNDS

Financial Highlights for a share outstanding throughout the period

 

Alger Money Market Fund

 

 

 

Year ended
10/31/2010

 

Year ended
10/31/2009

 

Year ended
10/31/2008

 

Year ended
10/31/2007

 

Year ended
10/31/2006

 

Net asset value, beginning of period

 

$

1.00

 

$

1.00

 

$

1.00

 

$

1.00

 

$

1.00

 

INCOME FROM INVESTMENT OPERATIONS:

 

 

 

 

 

 

 

 

 

 

 

Net investment income(i)

 

0.00

 

0.00

 

0.02

 

0.04

 

0.04

 

Dividends from net investment income

 

0.00

 

0.00

 

(0.02

)

(0.04

)

(0.04

)

Net asset value, end of period

 

$

1.00

 

$

1.00

 

$

1.00

 

$

1.00

 

$

1.00

 

Total return (ii)

 

0.0

%

0.1

%

1.9

%

4.3

%

3.8

%

RATIOS/SUPPLEMENTAL DATA:

 

 

 

 

 

 

 

 

 

 

 

Net assets, end of period (000’s omitted)

 

$

40,720

 

$

45,304

 

$

56,395

 

$

54,207

 

$

55,068

 

Ratio of gross expenses to average net assets

 

0.92

%

0.96

%

0.84

%

0.88

%

0.90

%

Ratio of expense reimbursements to average net assets

 

(0.84

)%

(0.60

)%

0.00

%

0.00

%

0.00

%

Ratio of net expenses to average net assets

 

0.08

%

0.36

%

0.84

%

0.88

%

0.90

%

Ratio of net investment income (loss) to average net assets

 

0.02

%

0.08

%

1.93

%

4.20

%

3.78

%

 

See Notes to Financial Statements.

 


(i) Amount was computed based on average shares outstanding during the period.

(ii) Does not reflect the effect of sales charges, if applicable.

 

117


 


 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS

 

NOTE 1 — General:

 

The Alger Funds (the “Trust”) is a diversified, open-end registered investment company organized as a business trust under the laws of the Commonwealth of Massachusetts. The Trust operates as a series company currently issuing an unlimited number of shares of beneficial interest in ten funds — Alger Capital Appreciation Fund, Alger Large Cap Growth Fund, Alger Mid Cap Growth Fund, Alger SMid Cap Growth Fund, Alger Small Cap Growth Fund, Alger Growth Opportunities Fund, Alger Health Sciences Fund, Alger Balanced Fund, Alger Convertible Fund, and Alger Money Market Fund (collectively, the “Funds” or individually, each a “Fund”). The Alger Capital Appreciation Fund, Alger Large Cap Growth Fund, Alger Mid Cap Growth Fund, Alger SMid Cap Growth Fund, Alger Small Cap Growth Fund, Alger Growth Opportunities Fund and Alger Health Sciences Fund normally invest primarily in equity securities and each has an investment objective of long-term capital appreciation. The Alger Balanced Fund’s and Alger Convertible Fund’s investment objectives are current income and long-term capital appreciation which they seek to achieve through investing in equity and fixed income securities. The Alger Money Market Fund’s investment objective is current income which it seeks to achieve by investing in short-term instruments.

 

Each Fund, other than the Alger Money Market Fund, offers one or more the following share classes: Class A, B, C, and I. Class A shares are generally subject to an initial sales charge while Class B and C shares are generally subject to a deferred sales charge. Class B shares will automatically convert to Class A shares eight years after the end of the calendar month in which the order to purchase was accepted. The conversion is completed without the imposition of any sales charges or other fees. Class I shares are sold to institutional investors without an initial or deferred sales charge. Each class has identical rights to assets and earnings, except that each share class bears the cost of its plan of distribution and transfer agency and sub-transfer agency services.

 

NOTE 2 — Significant Accounting Policies:

 

(a) Investment Valuation: The Fund values its financial instruments at fair value using independent dealers or pricing services under policies approved by the Board. Investments of the Funds are valued on each day the New York Stock Exchange (the “NYSE”) is open, as of the close of the NYSE (normally 4:00 p.m. Eastern time).

 

Equity securities and option contracts for which such information is readily available are valued at the last reported sales price or official closing price as reported by an independent pricing service on the primary market or exchange on which they are traded. In the absence of reported sales, securities are valued at a price within the bid and ask price or, in the absence of a recent bid or ask price, the equivalent as obtained from one or more of the major market makers for the securities to be valued.

 

Debt securities generally trade in the over-the-counter market.  Securities with remaining maturities of more than sixty days at the time of acquisition are valued on the basis of last available bid prices or current market quotations provided by dealers or pricing services. In determining the value of a particular investment, pricing services may use certain

 

118



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

information with respect to transactions in such investments, quotations from dealers, pricing matrixes, market transactions in comparable investments, various relationships observed in the market between investments and calculated yield measures based on valuation technology commonly employed in the market for such investments. Asset-backed and mortgage-backed securities are valued by independent pricing services using models that consider estimated cash flows of each tranche of the security, establish a benchmark yield and develop an estimated tranche specific spread to the benchmark yield based on the unique attributes of the tranche.

 

The investments in the Alger Money Market Fund are valued under the amortized cost method which approximates current market value in accordance with Rule 2a-7 of the 1940 Act.  Under this method securities are valued at cost when purchased and thereafter, a constant proportionate amortization of any discount or premium is recorded until the maturity of the security.  The Fund seeks to maintain its net asset value per share at $1.00 although there is no assurance that it will be able to do so on a continuing basis.

 

Securities for which market quotations are not readily available are valued at fair value, as determined in good faith pursuant to procedures established by the Board of Trustees.

 

Securities in which the Funds invest may be traded in foreign markets that close before the close of the NYSE. Developments that occur between the close of the foreign markets and the close of the NYSE may result in adjustments to the closing prices to reflect what the investment manager, pursuant to policies established by the Board of Trustees, believes to be the fair value of these securities as of the close of the NYSE. The Funds may also fair value securities in other situations, for example, when a particular foreign market is closed but the Funds are open.

 

Financial Accounting Standards Board Accounting Standards Codification 820 — Fair Value Measurements and Disclosures (“ASC 820”) defines fair value as the price that the Funds would receive upon selling an investment in a timely transaction to an independent buyer in the principal or most advantageous market of the investment. ASC 820 established a three-tier hierarchy to maximize the use of observable market data and minimize the use of unobservable inputs and to establish classification of fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability and may be observable or unobservable. Observable inputs are based on market data obtained from sources independent of the Funds. Unobservable inputs are inputs that reflect the Funds’ own assumptions based on the best information available in the circumstances. The three-tier hierarchy of inputs is summarized in the three broad Levels listed below.

 

·          Level 1 — quoted prices in active markets for identical investments

·          Level 2 — significant other observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)

·          Level 3 — significant unobservable inputs (including the Funds’ own assumptions in determining the fair value of investments)

 

The Funds’ valuation techniques are consistent with the market approach whereby prices and other relevant information generated by market transactions involving identical or

 

119



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

comparable assets are used to measure fair value. Inputs for Level 1 include exchange listed prices and broker quotes in an active market.  Inputs for Level 2 include the last trade price in the case of a halted security, a broker quote in an inactive market, an exchange listed price which has been adjusted for fair value factors, and prices of closely related securities.  Additional Level 2 inputs include an evaluated price which is based upon a compilation of observable market information such as spreads for fixed income and preferred securities.  Inputs for Level 3 include derived prices from unobservable market information which can include cash flows and other information obtained from a company’s financial statements, or from market indicators such as benchmarks and indices.

 

(b) Cash and Cash Equivalents: Cash and cash equivalents include U.S. dollars and short-term securities maturing in sixty days or less.  Such short-term securities are valued at amortized cost which approximates market value.

 

(c) Securities Transactions and Investment Income: Securities transactions are recorded on a trade date basis. Realized gains and losses from securities transactions are recorded on the identified cost basis. Dividend income is recognized on the ex-dividend date and interest income is recognized on the accrual basis.

 

Premiums and discounts on debt securities purchased are amortized or accreted over the lives of the respective securities.

 

(d) Foreign Currency Translations: The books and records of the Funds are maintained in U.S. dollars. Foreign currencies, investments and other assets and liabilities are translated into U.S. dollars at the prevailing rates of exchange on the valuation date. Purchases and sales of investment securities and income and expenses are translated into U.S. dollars at the prevailing exchange rates on the respective dates of such transactions.

 

Net realized gains and losses on foreign currency transactions represent net gains and losses from the disposition of foreign currencies, currency gains and losses realized between the trade dates and settlement dates of security transactions, and the difference between the amount of net investment income accrued and the U.S. dollar amount actually received. The effects of changes in foreign currency exchange rates on investments in securities are included in realized and unrealized gain or loss on investments in the Statements of Operations.

 

(e) Option Contracts: When a Fund writes an option, an amount equal to the premium received by the Fund is recorded as a liability and is subsequently adjusted to the current fair value of the option written. Premiums received from writing options that expire unexercised are treated by the Fund on the expiration date as realized gains from investments. The difference between the premium and the amount paid on effecting a closing purchase transaction, including brokerage commissions, is also treated as a realized gain, or, if the premium is less than the amount paid for the closing purchase transaction, as a realized loss. If a call option is exercised, the premium is added to the proceeds from the sale of the underlying security in determining whether the Fund has realized a gain or loss. If a put option is exercised, the premium reduces the cost basis of the securities purchased by the Fund. The Fund as writer of an option bears the market risk of an unfavorable change in the price of the security underlying the written option.

 

120



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

The Funds may also purchase put and call options. Purchasing put and call options tends to decrease the Fund’s exposure to the underlying instrument. The Fund pays a premium which is included in the Funds’ Statement of Assets and Liabilities as an investment and subsequently marked to market to reflect the current value of the option. Premiums paid for purchasing options which expire are treated as realized losses. The risk associated with purchasing put and call options is limited to the premium paid. Premiums paid for purchasing options which are exercised or closed are added to the amounts paid or offset against the proceeds on the underlying security to determine the realized gain or loss.

 

(f) Lending of Fund Securities: The Funds may lend their securities to financial institutions, provided that the market value of the securities loaned will not at any time exceed one third of the Fund’s total assets, as defined. The Funds earn fees on the securities loaned. In order to protect against the risk of failure by the borrower to return the securities loaned or any delay in the delivery of such securities, the loan is collateralized by cash, letters of credit or U.S. Government securities that are maintained in an amount equal to at least 100 percent of the current market value of the loaned securities. The market value of the loaned securities is determined at the close of business of the Funds and any required additional collateral is delivered to the Funds on the next business day. There were no securities on loan during the year ended October 31, 2010.

 

(g) Dividends to Shareholders: Dividends payable to shareholders are recorded on the ex-dividend date.

 

The Alger Money Market Fund declares dividends daily from net investment income and such dividends are paid monthly. The Alger Convertible Fund declares and pays dividends from net investment income quarterly. The dividends from net investment income of the other Funds are declared and paid annually.

 

With respect to all Funds, dividends from net realized gains, offset by any loss carryforward, are declared and paid annually after the end of the fiscal year in which earned.

 

Each class is treated separately in determining the amounts of dividends of net investment income payable to holders of its shares.

 

The characterization of distributions to shareholders for financial reporting purposes is determined in accordance with federal income tax rules. Therefore, the source of the Funds’ distributions may be shown in the accompanying financial statements as either from, or in excess of, net investment income, net realized gain on investment transactions, or return of capital, depending on the type of book/tax differences that may exist. Capital accounts within the financial statements are adjusted for permanent book/tax differences. Reclassifications result primarily from the differences in tax treatment of net operating losses, foreign currency transactions and premium/discount of debt securities. The reclassifications are done annually at fiscal year end and have no impact on the net asset value of the Fund and are designed to present the Fund’s capital accounts on a tax basis.

 

(h) Federal Income Taxes: It is each Fund’s policy to comply with the requirements of the Internal Revenue Code Subchapter M applicable to regulated investment companies and to distribute all of its taxable income to its shareholders. Provided the Funds maintain

 

121



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

such compliance, no federal income tax provision is required. Each Fund is treated as a separate entity for the purpose of determining such compliance.

 

Financial Accounting Standards Board Accounting Standards Codification 740 — Income Taxes (“ASC 740”) requires the Funds to measure and recognize in their financial statements the benefit of a tax position taken (or expected to be taken) on an income tax return if such position will more likely than not be sustained upon examination based on the technical merits of the position.  No tax years are currently under investigation.  The Funds file income tax returns in the U.S. Federal jurisdiction, as well as the New York State and New York City jurisdictions.  Based upon their review of tax positions for the Funds’ open tax years of 2007-2010 in these jurisdictions, the Funds have determined that ASC 740 did not have a material impact on the Funds’ financial statements for the year ended October 31, 2010.

 

(i) Allocation Methods: The Trust accounts separately for the assets, liabilities and operations of each Fund. Expenses directly attributable to each Fund are charged to that Fund’s operations; expenses which are applicable to all Funds are allocated among them based on net assets. Income, realized and unrealized gains and losses, and expenses of each Fund, other than the Alger Money Market Fund and Alger Convertible Fund, are allocated among the Fund’s classes based on relative net assets, with the exception of distribution fees and transfer agency fees.

 

(j) Estimates: These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, which require using estimates and assumptions that affect the reported amounts therein.

 

NOTE 3 — Investment Advisory Fees and Other Transactions with Affiliates:

 

(a) Investment Advisory and Administration Fees: Fees incurred by each Fund, pursuant to the provisions of its Investment Advisory Agreement and its Administration Agreement with Fred Alger Management, Inc. (Alger Management), are payable monthly and computed based on the value of the average daily net assets of each Fund, at the following rates:

 

 

 

Advisory Fee

 

Administration
Fee

 

Alger Capital Appreciation Fund

 

.81

%

.0275

%

Alger Large Cap Growth Fund

 

.71

 

.0275

 

Alger Mid Cap Growth Fund

 

.76

 

.0275

 

Alger SMid Cap Growth Fund

 

.81

 

.0275

 

Alger Small Cap Growth Fund

 

.81

 

.0275

 

Alger Growth Opportunities Fund

 

.85

 

.0275

 

Alger Health Sciences Fund

 

.81

 

.0275

 

Alger Balanced Fund

 

.71

 

.0275

 

Alger Convertible Fund

 

.71

 

.0275

 

Alger Money Market Fund

 

.46

 

.0275

 

 

Alger Management has established an expense cap for several share classes, whereby it reimburses the share classes if annualized operating expenses (excluding interest, taxes,

 

122



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

brokerage, and extraordinary expenses) exceed the rates, based on average daily net assets, listed below:

 

 

 

A

 

Class
C

 

I

 

Fees Waived /
Reimbursed for the
Year Ended
October 31, 2010

 

Alger Growth Opportunities Fund*

 

1.50

%

2.25

%

1.25

%

$

105,761

 

Alger Convertible Fund*

 

1.24

 

N/A

 

N/A

 

54,341

 

 


*   Expense caps effective through February 28, 2011

 

As part of the settlement with the New York Attorney General (see Note 10—Litigation), Alger Management has agreed to reduce its advisory fee through November 30, 2011, to 0.62% for the Alger Balanced Fund. For the year ended October 31, 2010, Alger Management reimbursed the Alger Balanced Fund $55,463.

 

Alger Management has voluntarily reimbursed the Alger Money Market Fund $356,302 for the year ended October 31, 2010.

 

(b) Distribution Fees:

 

Class A Shares: The Class A shares of each Fund, other than the Alger Money Market Fund, have adopted a distribution plan pursuant to which each Fund pays Fred Alger & Company, Incorporated, the Fund’s distributor (the “Distributor” or “Alger Inc.”) and an affiliate of Alger Management, a fee at the annual rate of 0.25% of the respective average daily net assets of the Class A shares of the designated Fund to compensate Alger Inc. for its activities and expenses incurred in distributing the Class A shares. Fees charged may be more or less than the expenses incurred by Alger Inc.

 

Class B Shares: The Trust has adopted an Amended and Restated Plan of Distribution pursuant to which Class B shares of each Fund, other than the Alger Money Market Fund, Alger Growth Opportunities Fund and Alger Convertible Fund, reimburse Alger Inc. for costs and expenses incurred by Alger Inc. in connection with advertising, marketing and selling the Class B shares, and shareholder servicing, not to exceed an annual rate of 1% of the respective average daily net assets of the Class B shares of the designated Funds. If in any month, the costs incurred by Alger Inc. relating to the Class B shares are in excess of the distribution fees charged to the Class B shares of the Funds, the excess may be carried forward, with interest, and sought to be reimbursed in future periods. As of October 31, 2010, such excess carried forward was $20,641,640, $16,842,949, $10,888,316, $606,867, $15,048,786, $1,392,359, and $4,037,630 for Class B shares of the Alger Capital Appreciation Fund, Alger Large Cap Growth Fund, Alger Mid Cap Growth Fund, Alger SMid Cap Growth Fund, Alger Small Cap Growth Fund, Alger Health Sciences Fund and Alger Balanced Fund, respectively. Contingent deferred sales charges imposed on redemptions of Class B shares will reduce the amount of distribution expenses for which reimbursement may be sought. See Note 3(c) below.

 

Class C Shares: The Trust has adopted a Distribution Plan pursuant to which Class C shares of each Fund, other than the Alger Money Market Fund and the Alger Convertible Fund, pay the Alger Inc. a fee at the annual rate of 1% of the respective average daily net assets of the Class C shares of the designated Fund to compensate the Alger Inc. for its

 

123



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

activities and expenses incurred in distributing the Class C shares and shareholder servicing. The fees charged may be more or less than the expenses incurred by Alger Inc.

 

Class I Shares: The Trust has adopted a Distribution Plan pursuant to which Class I shares of the Alger SMid Cap Growth Fund and Alger Growth Opportunities Fund each pay Alger Inc. a fee at the annual rate of 0.25% of the average daily net assets of its Class I shares to compensate Alger Inc. for its activities and expenses incurred in distributing the Class I shares and shareholder servicing. The fees charged may be more or less than the expenses incurred by Alger Inc.

 

(c) Sales Charges: Purchases and sales of shares of the Funds, other than the Alger Money Market Fund, may be subject to initial sales charges or contingent deferred sales charges. The contingent deferred sales charges are used by Alger Inc. to offset distribution expenses previously incurred. Sales charges do not represent expenses of the Trust. For the year ended October 31, 2010, the initial sales charges and contingent deferred sales charges imposed, all of which were retained by Alger Inc., were as follows:

 

 

 

Initial Sales
Charges

 

Contingent
Deferred Sales
Charges

 

Alger Capital Appreciation Fund

 

$

7,274

 

$

91,468

 

Alger Large Cap Growth Fund

 

3,586

 

32,481

 

Alger Mid Cap Growth Fund

 

7,494

 

41,740

 

Alger SMid Cap Growth Fund

 

588

 

34,712

 

Alger Small Cap Growth Fund

 

2,382

 

27,522

 

Alger Growth Opportunities Fund

 

352

 

200

 

Alger Health Sciences Fund

 

1,571

 

62,766

 

Alger Balanced Fund

 

725

 

20,663

 

Alger Convertible Fund

 

826

 

 

Alger Money Market Fund

 

 

41,121

 

 

(d) Brokerage Commissions: During the year ended October 31, 2010, the Alger Capital Appreciation Fund, Alger Large Cap Growth Fund, Alger Mid Cap Growth Fund, Alger SMid Cap Growth Fund, Alger Small Cap Growth Fund, Alger Growth Opportunities Fund, Alger Health Sciences Fund and Alger Balanced Fund paid Alger Inc. commissions of $1,730,280, $141,333, $720,286, $506,369, $212,241, 9,555, $184,672 and $10,255 respectively, in connection with securities transactions.

 

(e) Shareholder Administrative Fees and Expenses: The Trust has entered into a shareholder administrative services agreement with Alger Management, to compensate Alger Management on a per account basis for its liaison and administrative oversight of Boston Financial Data Services, Inc. (“BFDS”) the transfer agent, and other related services. Effective June 1, 2010 the Fund compensates Alger Management at the annual rate of 0.0165% of their respective average daily net assets for the Class A, Class B shares and C shares and 0.01% of the daily net assets of the Class I shares for these services. From November 1, 2009 through October 31, 2010, the Alger Capital Appreciation Fund, Alger Large Cap Growth Fund, Alger Mid Cap Growth Fund, Alger SMid Cap Growth Fund, Alger Small Cap Growth Fund, Alger Growth Opportunities Fund, Alger Health Sciences Fund, Alger Balanced Fund, Alger Convertible Fund and Alger Money Market Fund

 

124



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

incurred fees of $175,151, $79,794, $81,021, $124,715, $103,976, $1,975, $50,600, $20,225, $4,520 and $13,049 respectively, for these services provided by Alger Management, which are included in the transfer agent fees and expenses in the Statement of Operations.

 

Alger Management makes payments to intermediaries that provide omnibus account services, sub-accounting services and/or networking services.  Fees paid by Alger Management to intermediaries that provide omnibus account services or sub-accounting are charged back to the Fund, subject to certain limitations, as approved by the Trust’s Board of Trustees.  For the year ended October 31, 2010, Alger Management charged back to the Alger Capital Appreciation Fund, Alger Large Cap Growth Fund, Alger Mid Cap Growth Fund, Alger SMid Cap Growth Fund, Alger Small Cap Growth Fund, Alger Growth Opportunities Fund, Alger Health Sciences Fund, Alger Balanced Fund, Alger Convertible Fund and Alger Money Market Fund $143,710, $25,646, $91,366, $48,954, $54,547, $1,686, $34,632, $8,709, $255 and $279 respectively, for these services, which are included in the transfer agent fees and expenses in the Statement of Operations.

 

(f) Trustee Fees: From November 1, 2009 through February 8, 2010 each Fund paid each trustee who is not affiliated with Alger Management or its affiliates $500 for each meeting attended, to a maximum of $2,000 per annum, plus travel expenses incurred for attending the meeting. The chairman of the Board of Trustees received an additional annual fee of $10,000 paid, pro rata, by all funds managed by Alger Management. Additionally, each member of the audit committee received an additional $50 for each audit committee meeting attended, to a maximum of $200 per annum.

 

Effective February 9, 2010 each Fund pays each trustee who is not affiliated with Alger Management or its affiliates $750 for each meeting attended, to a maximum of $3,000 per annum, plus travel expenses incurred for attending the meeting. The chairman of the Board of Trustees receives an additional annual fee of $15,000 which is paid, pro rata, by all funds managed by Alger Management. Additionally, each member of the audit committee receives an additional $75 for each audit committee meeting attended, to a maximum of $300 per annum.

 

(g) Interfund Loans: The Funds, along with other funds advised by Alger Management, may borrow money from and lend money to each other for temporary or emergency purposes. To the extent permitted under its investment restrictions, each fund may lend uninvested cash in an amount up to 15% of its net assets to other funds, and each fund may borrow in an amount up to 10% of its net assets from other funds. If a fund has borrowed from other funds and has aggregate borrowings from all sources that exceed 10% of the fund’s total assets, such fund will secure all of its loans from other funds. The interest rate charged on interfund loans is equal to the average of the overnight time deposit rate and bank loan rate available to the funds.

 

During the year ended October 31, 2010, Alger Mid Cap Growth Fund, Alger Small Cap Growth Fund, Alger Health Sciences Fund and Alger Balanced Fund incurred interfund loan interest expenses of $195, $620, $310 and $121, respectively.  During the year ended October 31, 2010 Alger Capital Appreciation Fund, Alger SMid Cap Growth Fund and Alger Small Cap Growth Fund earned interfund loan interest income of $8,659, $943 and $72, respectively.

 

125


 


 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

(h) Other Transactions With Affiliates: Certain officers of the Trust are directors and officers of Alger Management and the Distributor. At October 31, 2010 Alger Management and its affiliates owned the following share classes:

 

 

 

Share Class

 

 

 

A

 

B

 

C

 

I

 

Alger Capital Appreciation Fund

 

131,582

 

 

 

 

Alger Large Cap Growth Fund

 

79,753

 

 

 

 

Alger Mid Cap Growth Fund

 

88,108

 

 

 

 

Alger SMid Cap Growth Fund

 

342,944

 

 

40,757

 

6,493

 

Alger Small Cap Growth Fund

 

167,292

 

 

 

 

Alger Growth Opportunities Fund

 

10,000

 

 

10,000

 

180,000

 

Alger Convertible Fund

 

 

 

 

 

Alger Money Market Fund

 

98,631

 

 

 

 

 

NOTE 4 — Securities Transactions:

 

The following summarizes the securities transactions by the Trust, other than U.S. Government and short-term securities, for the year ended October 31, 2010:

 

 

 

PURCHASES

 

SALES

 

Alger Capital Appreciation Fund

 

$

1,637,063,268

 

$

1,608,204,052

 

Alger Large Cap Growth Fund

 

172,799,387

 

171,121,183

 

Alger Mid Cap Growth Fund

 

607,223,601

 

676,565,351

 

Alger SMid Cap Growth Fund

 

497,176,525

 

406,279,256

 

Alger Small Cap Growth Fund

 

161,015,628

 

224,756,611

 

Alger Growth Opportunities Fund

 

8,638,911

 

6,718,919

 

Alger Health Sciences Fund

 

182,603,336

 

233,122,385

 

Alger Balanced Fund

 

43,053,497

 

48,483,411

 

Alger Convertible Fund

 

30,665,701

 

31,865,170

 

 

Written call and put options activity for the year ended October 31, 2010, was as follows:

 

 

 

NUMBER OF
CONTRACTS

 

PREMIUMS
RECEIVED

 

Alger Mid Cap Growth Fund

 

 

 

 

 

Call Options outstanding at October 31, 2009

 

 

$

 

Call Options written

 

1,239

 

558,347

 

Call Options closed

 

 

 

Call Options expired

 

 

 

Call Options exercised

 

 

 

Call Options outstanding at October 31, 2010

 

1,239

 

$

558,347

 

 

126



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

 

 

NUMBER OF
CONTRACTS

 

PREMIUMS
RECEIVED

 

Alger Mid Cap Growth Fund

 

 

 

 

 

Put Options outstanding at October 31, 2009

 

 

$

 

Put Options written

 

6,839

 

1,363,869

 

Put Options closed

 

6,145

 

1,043,256

 

Put Options expired

 

 

 

Put Options exercised

 

 

 

Put Options outstanding at October 31, 2010

 

694

 

$

320,613

 

 

As of October 31, 2010, Alger Mid Cap Growth Fund had portfolio securities valued at $12,256,374, segregated as collateral for written options.

 

NOTE 5 — Borrowing:

 

The Funds may borrow from their custodian on an uncommitted basis. Each Fund pays the custodian a market rate of interest, generally based upon the London Inter-Bank Offer Rate.  The Funds may also borrow from other funds advised by Alger Management, as discussed in Note 3(g).  For the year ended October 31, 2010, the Funds had the following borrowings:

 

 

 

AVERAGE DAILY
BORROWING

 

WEIGHTED AVERAGE
INTEREST RATE

 

Alger Large Cap Growth Fund

 

$

3,101

 

2.24

%

Alger Mid Cap Growth Fund

 

21,275

 

1.35

 

Alger Small Cap Growth Fund

 

56,826

 

1.22

 

Alger Growth Opportunities Fund

 

8,388

 

2.35

 

Alger Health Sciences Fund

 

26,654

 

1.20

 

Alger Balanced Fund

 

14,792

 

1.43

 

Alger Convertible Fund

 

4,364

 

2.26

 

 

The highest amount borrowed during the year ended October 31, 2010 for each Fund were as follows:

 

 

 

Highest Borrowing

 

Alger Large Cap Growth Fund

 

466,454

 

Alger Mid Cap Growth Fund

 

1,730,000

 

Alger Small Cap Growth Fund

 

3,250,000

 

Alger Growth Opportunities Fund

 

765,419

 

Alger Health Sciences Fund

 

2,745,000

 

Alger Balanced Fund

 

765,000

 

Alger Convertible Fund

 

269,403

 

 

NOTE 6 — Share Capital:

 

(a)  The Trust has an unlimited number of authorized shares of beneficial interest of $.001 par value which are presently divided into ten series. Each series, other than the Money Market Fund, is divided into separate classes. The transactions of shares of beneficial interest were as follows:

 

127



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

 

 

FOR THE YEAR ENDED
OCTOBER 31, 2010

 

FOR THE YEAR ENDED
OCTOBER 31, 2009

 

 

 

SHARES

 

AMOUNT

 

SHARES

 

AMOUNT

 

Alger Capital Appreciation Fund

 

 

 

 

 

 

 

 

 

Class A:

 

 

 

 

 

 

 

 

 

Shares sold

 

17,624,771

 

$

222,549,208

 

18,205,583

 

$

184,720,544

 

Shares converted from Class B

 

748,608

 

9,438,178

 

1,378,120

 

12,702,430

 

Shares converted from Class C

 

24,530

 

308,266

 

2,734

 

30,306

 

Shares redeemed

 

(15,767,334

)

(199,594,791

)

(15,602,079

)

(145,772,085

)

Net increase

 

2,630,575

 

$

32,700,861

 

3,984,358

 

$

51,681,195

 

Class B:

 

 

 

 

 

 

 

 

 

Shares sold

 

505,173

 

$

5,722,227

 

825,412

 

$

6,806,700

 

Shares converted to Class A

 

(834,124

)

(9,438,178

)

(1,520,404

)

(12,702,430

)

Shares redeemed

 

(943,619

)

(10,705,592

)

(1,312,855

)

(10,658,178

)

Net decrease

 

(1,272,570

)

$

(14,421,543

)

(2,007,847

)

$

(16,553,908

)

Class C:

 

 

 

 

 

 

 

 

 

Shares sold

 

3,159,180

 

$

36,032,493

 

2,899,263

 

$

26,269,748

 

Shares converted to Class A

 

(27,275

)

(308,266

)

(3,025

)

(30,306

)

Shares redeemed

 

(2,270,957

)

(25,691,042

)

(2,272,680

)

(18,672,178

)

Net increase

 

860,948

 

$

10,033,185

 

623,558

 

$

7,567,264

 

 

 

 

 

 

 

 

 

 

 

Alger Large Cap Growth Fund

 

 

 

 

 

 

 

 

 

Class A:

 

 

 

 

 

 

 

 

 

Shares sold

 

4,014,545

 

$

42,288,474

 

1,385,187

 

$

11,227,564

 

Shares converted from Class B

 

1,172,975

 

12,294,141

 

1,524,290

 

12,303,387

 

Shares converted from Class C

 

14,055

 

145,376

 

10,743

 

99,600

 

Dividends reinvested

 

10,899

 

114,502

 

 

 

Shares redeemed

 

(2,828,593

)

(29,743,313

)

(5,930,371

)

(45,580,901

)

Net increase (decrease)

 

2,383,881

 

$

25,099,180

 

(3,010,151

)

$

(21,950,350

)

Class B:

 

 

 

 

 

 

 

 

 

Shares sold

 

1,296,437

 

$

12,063,303

 

1,675,569

 

$

12,058,815

 

Shares converted to Class A

 

(1,305,897

)

(12,294,141

)

(1,687,497

)

(12,303,387

)

Shares redeemed

 

(640,602

)

(6,049,579

)

(1,346,898

)

(9,567,872

)

Net decrease

 

(650,062

)

$

(6,280,417

)

(1,358,826

)

$

(9,812,444

)

Class C:

 

 

 

 

 

 

 

 

 

Shares sold

 

205,697

 

$

1,928,660

 

371,444

 

$

2,672,806

 

Shares converted to Class A

 

(15,695

)

(145,376

)

(11,926

)

(99,600

)

Shares redeemed

 

(571,144

)

(5,361,913

)

(964,119

)

(6,794,498

)

Net decrease

 

(381,142

)

$

(3,578,629

)

(604,601

)

$

(4,221,292

)

 

128



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

 

 

FOR THE YEAR ENDED
OCTOBER 31, 2010

 

FOR THE YEAR ENDED
OCTOBER 31, 2009

 

 

 

SHARES

 

AMOUNT

 

SHARES

 

AMOUNT

 

Alger Mid Cap Growth Fund

 

 

 

 

 

 

 

 

 

Class A:

 

 

 

 

 

 

 

 

 

Shares sold

 

5,002,168

 

$

29,299,085

 

11,387,965

 

$

47,629,358

 

Shares converted from Class B

 

1,522,280

 

8,930,639

 

2,375,070

 

10,031,935

 

Shares converted from Class C

 

29,297

 

169,625

 

14,067

 

70,908

 

Shares redeemed

 

(14,635,522

)

(86,165,891

)

(19,067,813

)

(79,479,384

)

Net decrease

 

(8,081,777

)

$

(47,766,542

)

(5,290,711

)

$

(21,747,183

)

Class B:

 

 

 

 

 

 

 

 

 

Shares sold

 

1,262,723

 

$

6,153,711

 

2,190,240

 

$

7,852,196

 

Shares converted to Class A

 

(1,796,724

)

(8,930,639

)

(2,779,895

)

(10,031,935

)

Shares redeemed

 

(2,017,388

)

(9,978,420

)

(3,951,256

)

(13,806,255

)

Net decrease

 

(2,551,389

)

$

(12,755,348

)

(4,540,911

)

$

(15,985,994

)

Class C:

 

 

 

 

 

 

 

 

 

Shares sold

 

599,134

 

$

2,983,067

 

1,341,351

 

$

4,767,074

 

Shares converted to Class A

 

(34,721

)

(169,625

)

(16,565

)

(70,908

)

Shares redeemed

 

(2,184,620

)

(10,858,871

)

(3,453,313

)

(12,245,478

)

Net decrease

 

(1,620,207

)

$

(8,045,429

)

(2,128,527

)

$

(7,549,312

)

 

 

 

 

 

 

 

 

 

 

Alger SMid Cap Growth Fund

 

 

 

 

 

 

 

 

 

Class A:

 

 

 

 

 

 

 

 

 

Shares sold

 

17,961,233

 

$

237,452,740

 

18,378,759

 

$

181,345,508

 

Shares converted from Class B

 

58,112

 

747,265

 

38,964

 

361,464

 

Shares converted from Class C

 

787

 

9,309

 

488

 

5,454

 

Shares redeemed

 

(11,378,855

)

(149,344,463

)

(15,379,146

)

(149,422,355

)

Net increase

 

6,641,277

 

$

88,864,851

 

3,039,065

 

$

32,290,071

 

Class B:

 

 

 

 

 

 

 

 

 

Shares sold

 

152,121

 

$

1,901,812

 

138,144

 

$

1,314,242

 

Shares converted to Class A

 

(62,055

)

(747,265

)

(41,164

)

(361,464

)

Shares redeemed

 

(136,010

)

(1,669,272

)

(132,622

)

(1,142,851

)

Net decrease

 

(45,944

)

$

(514,725

)

(35,642

)

$

(190,073

)

Class C:

 

 

 

 

 

 

 

 

 

Shares sold

 

1,369,189

 

$

17,036,805

 

1,394,945

 

$

13,760,118

 

Shares converted to Class A

 

(835

)

(9,309

)

(518

)

(5,454

)

Shares redeemed

 

(977,874

)

(12,103,058

)

(1,111,767

)

(9,732,741

)

Net increase

 

390,480

 

$

4,924,438

 

282,660

 

$

4,021,923

 

Class I:

 

 

 

 

 

 

 

 

 

Shares sold

 

8,024,708

 

$

107,276,321

 

7,747,564

 

$

75,676,547

 

Shares redeemed

 

(7,630,132

)

(100,440,276

)

(2,236,238

)

(21,716,031

)

Net increase

 

394,576

 

$

6,836,045

 

5,511,326

 

$

53,960,516

 

 

129


 


 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

 

 

FOR THE YEAR ENDED
OCTOBER 31, 2010

 

FOR THE YEAR ENDED
OCTOBER 31, 2009

 

 

 

SHARES

 

AMOUNT

 

SHARES

 

AMOUNT

 

Alger Small Cap Growth Fund

 

 

 

 

 

 

 

 

 

Class A:

 

 

 

 

 

 

 

 

 

Shares sold

 

11,855,205

 

$

72,139,305

 

16,305,604

 

$

73,333,549

 

Shares converted from Class B

 

684,515

 

4,179,282

 

824,346

 

3,672,169

 

Shares converted from Class C

 

11,764

 

74,803

 

6,685

 

34,299

 

Shares redeemed

 

(21,696,621

)

(131,673,600

)

(22,723,504

)

(97,326,825

)

Net decrease

 

(9,145,137

)

$

(55,280,210

)

(5,586,869

)

$

(20,286,808

)

Class B:

 

 

 

 

 

 

 

 

 

Shares sold

 

403,603

 

$

2,105,289

 

565,209

 

$

2,276,868

 

Shares converted to Class A

 

(768,558

)

(4,179,282

)

(916,602

)

(3,672,169

)

Shares redeemed

 

(580,707

)

(3,158,668

)

(977,566

)

(3,614,260

)

Net decrease

 

(945,662

)

$

(5,232,661

)

(1,328,959

)

$

(5,009,561

)

Class C:

 

 

 

 

 

 

 

 

 

Shares sold

 

636,563

 

$

3,372,768

 

1,052,393

 

$

4,558,262

 

Shares converted to Class A

 

(13,202

)

(74,803

)

(7,456

)

(34,299

)

Shares redeemed

 

(983,036

)

(5,340,133

)

(1,517,222

)

(5,754,948

)

Net decrease

 

(359,675

)

$

(2,042,168

)

(472,285

)

$

(1,230,985

)

 

 

 

 

 

 

 

 

 

 

Alger Growth Opportunities Fund

 

 

 

 

 

 

 

 

 

Class A:

 

 

 

 

 

 

 

 

 

Shares sold

 

534,282

 

$

5,013,204

 

526,665

 

$

3,365,742

 

Shares converted from Class C

 

 

 

141

 

1,085

 

Shares redeemed

 

(413,602

)

(3,791,764

)

(193,712

)

(1,270,573

)

Net increase

 

120,680

 

$

1,221,440

 

333,094

 

$

2,096,254

 

Class C:

 

 

 

 

 

 

 

 

 

Shares sold

 

75,286

 

$

696,278

 

84,518

 

$

542,665

 

Shares converted to Class A

 

 

 

(143

)

(1,085

)

Shares redeemed

 

(30,929

)

(273,307

)

(36,286

)

(240,177

)

Net increase

 

44,357

 

$

422,971

 

48,089

 

$

301,403

 

Class I:

 

 

 

 

 

 

 

 

 

Shares sold

 

89,096

 

$

854,676

 

35,174

 

$

250,129

 

Shares redeemed

 

(35,217

)

(322,312

)

(8,997

)

(62,056

)

Net increase

 

53,879

 

$

532,364

 

26,177

 

$

188,073

 

 

130



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

 

 

FOR THE YEAR ENDED
OCTOBER 31, 2010

 

FOR THE YEAR ENDED
OCTOBER 31, 2009

 

 

 

SHARES

 

AMOUNT

 

SHARES

 

AMOUNT

 

Alger Health Sciences Fund

 

 

 

 

 

 

 

 

 

Class A:

 

 

 

 

 

 

 

 

 

Shares sold

 

1,936,294

 

$

33,520,971

 

3,212,074

 

$

44,506,921

 

Shares converted from Class B

 

27,702

 

480,553

 

44,023

 

624,171

 

Shares converted from Class C

 

 

 

2,599

 

40,666

 

Shares redeemed

 

(3,555,686

)

(60,636,659

)

(5,893,975

)

(81,128,767

)

Net decrease

 

(1,591,690

)

$

(26,635,135

)

(2,635,279

)

$

(35,957,009

)

Class B:

 

 

 

 

 

 

 

 

 

Shares sold

 

95,551

 

$

1,577,344

 

166,564

 

$

2,204,670

 

Shares converted to Class A

 

(29,619

)

(480,553

)

(46,693

)

(624,171

)

Shares redeemed

 

(190,020

)

(3,050,561

)

(258,319

)

(3,397,543

)

Net decrease

 

(124,088

)

$

(1,953,770

)

(138,448

)

$

(1,817,044

)

Class C:

 

 

 

 

 

 

 

 

 

Shares sold

 

450,769

 

$

7,365,282

 

627,556

 

$

8,251,572

 

Shares converted to Class A

 

 

 

(2,765

)

(40,666

)

Shares redeemed

 

(1,078,523

)

(17,287,188

)

(1,442,911

)

(18,754,042

)

Net decrease

 

(627,754

)

$

(9,921,906

)

(818,120

)

$

(10,543,136

)

 

 

 

 

 

 

 

 

 

 

Alger Balanced Fund

 

 

 

 

 

 

 

 

 

Class A:

 

 

 

 

 

 

 

 

 

Shares sold

 

340,329

 

$

6,963,543

 

246,008

 

$

4,122,100

 

Shares converted from Class B

 

184,828

 

3,732,800

 

329,864

 

5,496,675

 

Shares converted from Class C

 

2,897

 

59,227

 

 

 

Dividends reinvested

 

26,221

 

523,904

 

30,967

 

490,828

 

Shares redeemed

 

(447,072

)

(9,067,679

)

(621,272

)

(10,578,490

)

Net increase (decrease)

 

107,203

 

$

2,211,795

 

(14,433

)

$

(468,887

)

Class B:

 

 

 

 

 

 

 

 

 

Shares sold

 

64,735

 

$

1,301,373

 

82,809

 

$

1,377,884

 

Shares converted to Class A

 

(186,892

)

(3,732,800

)

(334,411

)

(5,496,675

)

Dividends reinvested

 

5,720

 

113,324

 

11,333

 

178,147

 

Shares redeemed

 

(142,247

)

(2,851,742

)

(258,840

)

(4,276,855

)

Net decrease

 

(258,684

)

$

(5,169,845

)

(499,109

)

$

(8,217,499

)

Class C:

 

 

 

 

 

 

 

 

 

Shares sold

 

88,892

 

$

1,759,848

 

82,048

 

$

1,429,069

 

Shares converted to Class A

 

(2,936

)

(59,227

)

 

 

Dividends reinvested

 

6,108

 

120,748

 

7,267

 

114,171

 

Shares redeemed

 

(146,127

)

(2,946,175

)

(163,286

)

(2,650,191

)

Net decrease

 

(54,063

)

$

(1,124,806

)

(73,971

)

$

(1,106,951

)

 

 

 

 

 

 

 

 

 

 

Alger Convertible Fund(a)

 

 

 

 

 

 

 

 

 

Class A:

 

 

 

 

 

 

 

 

 

Shares sold

 

55,558

 

$

1,107,361

 

12,055

 

$

188,802

 

Dividends reinvested

 

7,862

 

156,535

 

23,639

 

367,127

 

Shares redeemed

 

(169,269

)

(3,435,041

)

(903,742

)

(13,227,110

)

Net decrease

 

(105,849

)

$

(2,171,145

)

(868,048

)

$

(12,671,181

)

 

131



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

 

 

FOR THE YEAR ENDED
OCTOBER 31, 2010

 

FOR THE YEAR ENDED
OCTOBER 31, 2009

 

 

 

SHARES

 

AMOUNT

 

SHARES

 

AMOUNT

 

Alger Money Market Fund(b)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares sold

 

22,933,306

 

$

22,933,306

 

24,321,637

 

$

24,417,274

 

Dividends reinvested

 

8,560

 

8,560

 

37,204

 

37,204

 

Shares redeemed

 

(27,525,599

)

(27,525,597

)

(35,546,105

)

(35,546,004

)

Net decrease

 

(4,583,733

)

$

(4,583,731

)

(11,187,264

)

$

(11,091,526

)

 


(a)

Initially offered January 9, 2009.

(b)

Dollar amount of shares sold for the year ended October 31, 2009, includes a reimbursement by Alger Management of $95,120 for losses on portfolio investments incurred in previous fiscal years.

 

During the year ended October 31, 2010, shares redeemed for the Alger SMid Cap Growth Fund included a redemption-in-kind of 4,184,110 Class I shares valued at $54,811,845.

 

(b) Redemption Fee: The Funds may impose a 2.00% redemption fee on Fund shares redeemed (including shares redeemed by exchange) within 30 days after such shares were acquired. The fees retained by the Funds are included as paid-in capital on the Statement of Assets and Liabilities and were as follows:

 

 

 

FOR THE YEAR ENDED
OCTOBER 31, 2010

 

FOR THE YEAR ENDED
OCTOBER 31, 2009

 

Alger Capital Appreciation Fund

 

$

14,322

 

$

13,769

 

Alger Large Cap Growth Fund

 

7,112

 

2,377

 

Alger Mid Cap Growth Fund

 

1,394

 

9,176

 

Alger SMid Cap Growth Fund

 

18,150

 

34,354

 

Alger Small Cap Growth Fund

 

13,675

 

14,317

 

Alger Growth Opportunities Fund

 

1,133

 

637

 

Alger Health Sciences Fund

 

1,017

 

10,433

 

Alger Balanced Fund

 

2,055

 

4,831

 

Alger Convertible Fund

 

8

 

40,426

 

 

NOTE 7 — Income Tax Information:

 

The tax character of distributions paid during the year ended October 31, 2010 and the year ended October 31, 2009 were as follows:

 

132


 


 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

 

 

FOR THE YEAR ENDED
OCTOBER 31, 2010

 

FOR THE YEAR ENDED
OCTOBER 31, 2009

 

Alger Capital Appreciation Fund

 

 

 

 

 

Distributions paid from:

 

 

 

 

 

Ordinary Income

 

 

 

Long-term capital gain

 

 

 

Return of capital

 

 

 

Total distributions paid

 

 

 

 

 

 

 

 

 

Alger Large Cap Growth Fund

 

 

 

 

 

Distributions paid from:

 

 

 

 

 

Ordinary Income

 

$

146,931

 

 

Long-term capital gain

 

 

 

Return of capital

 

 

 

Total distributions paid

 

$

146,931

 

 

 

 

 

 

 

 

Alger Mid Cap Growth Fund

 

 

 

 

 

Distributions paid from:

 

 

 

 

 

Ordinary Income

 

 

 

Long-term capital gain

 

 

 

Return of capital

 

 

 

Total distributions paid

 

 

 

 

 

 

 

 

 

Alger SMid Cap Growth Fund

 

 

 

 

 

Distributions paid from:

 

 

 

 

 

Ordinary Income

 

 

 

Long-term capital gain

 

 

 

Return of capital

 

 

 

Total distributions paid

 

 

 

 

 

 

 

 

 

Alger Small Cap Growth Fund

 

 

 

 

 

Distributions paid from:

 

 

 

 

 

Ordinary Income

 

 

 

Long-term capital gain

 

 

 

Return of capital

 

 

 

Total distributions paid

 

 

 

 

 

 

 

 

 

Alger Growth Opportunities Fund

 

 

 

 

 

Distributions paid from:

 

 

 

 

 

Ordinary Income

 

 

 

Long-term capital gain

 

 

 

Return of capital

 

 

 

Total distributions paid

 

 

 

 

 

 

 

 

 

Alger Health Sciences Fund

 

 

 

 

 

Distributions paid from:

 

 

 

 

 

Ordinary Income

 

 

 

Long-term capital gain

 

 

 

Return of capital

 

 

 

Total distributions paid

 

 

 

 

133



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

 

 

FOR THE YEAR ENDED
OCTOBER 31, 2010

 

FOR THE YEAR ENDED
OCTOBER 31, 2009

 

Alger Balanced Fund

 

 

 

 

 

Distributions paid from:

 

 

 

 

 

Ordinary Income

 

1,000,163

 

$

1,107,292

 

Long-term capital gain

 

 

 

Return of capital

 

 

 

Total distributions paid

 

$

1,000,163

 

$

1,107,292

 

 

 

 

 

 

 

Alger Convertible Fund

 

 

 

 

 

Distributions paid from:

 

 

 

 

 

Ordinary Income

 

331,577

 

882,658

 

Long-term capital gain

 

 

 

Return of capital

 

 

409,485

 

Total distributions paid

 

$

331,577

 

$

1,292,143

 

 

 

 

 

 

 

Alger Money Market Fund

 

 

 

 

 

Distributions paid from:

 

 

 

 

 

Ordinary Income

 

9,567

 

40,712

 

Long-term capital gain

 

 

 

Return of capital

 

 

 

Total distributions paid

 

$

9,567

 

$

40,712

 

 

As of October 31, 2010 the components of accumulated gains losses on a tax basis were as follows:

 

Capital Appreciation Fund

 

 

 

Undistributed ordinary income

 

 

Undistributed long-term gains

 

 

Net accumulated earnings

 

 

Capital loss carryforwards

 

$

(168,090,996

)

Net unrealized appreciation

 

35,123,794

 

Total accumulated losses

 

$

(132,967,202

)

 

 

 

 

Large Cap Growth Fund

 

 

 

Undistributed ordinary income

 

700,060

 

Undistributed long-term gains

 

 

Net accumulated earnings

 

700,060

 

Capital loss carryforwards

 

(105,587,874

)

Net unrealized appreciation

 

21,338,742

 

Total accumulated losses

 

$

(83,549,072

)

 

 

 

 

Mid Cap Growth Fund

 

 

 

Undistributed ordinary income

 

 

Undistributed long-term gains

 

 

Net accumulated earnings

 

 

Capital loss carryforwards

 

(161,681,219

)

Net unrealized appreciation

 

12,012,964

 

Total accumulated losses

 

$

(149,668,255

)

 

134



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

SMid Cap Growth Fund

 

 

 

Undistributed ordinary income

 

 

Undistributed long-term gains

 

 

Net accumulated earnings

 

 

Capital loss carryforwards

 

(98,550,353

)

Net unrealized appreciation

 

112,918,749

 

Total accumulated gains

 

$

14,368,396

 

 

 

 

 

Small Cap Growth Fund

 

 

 

Undistributed ordinary income

 

 

Undistributed long-term gains

 

 

Net accumulated earnings

 

 

Capital loss carryforwards

 

(79,158,342

)

Net unrealized appreciation

 

45,691,946

 

Total accumulated losses

 

$

(33,466,396

)

 

 

 

 

Growth Opportunities Fund

 

 

 

Undistributed ordinary income

 

 

Undistributed long-term gains

 

 

Net accumulated earnings

 

 

Capital loss carryforwards

 

(688,053

)

Net unrealized appreciation

 

2,862,823

 

Total accumulated gains

 

$

2,174,770

 

 

 

 

 

Health Sciences Fund

 

 

 

Undistributed ordinary income

 

 

Undistributed long-term gains

 

 

Net accumulated earnings

 

 

Capital loss carryforwards

 

(17,569,785

)

Net unrealized appreciation

 

9,716,926

 

Total accumulated losses

 

$

(7,852,859

)

 

 

 

 

Balanced Fund

 

 

 

Undistributed ordinary income

 

873,761

 

Undistributed long-term gains

 

 

Net accumulated earnings

 

873,761

 

Capital loss carryforwards

 

(14,080,927

)

Net unrealized appreciation

 

3,346,551

 

Total accumulated losses

 

$

(9,860,615

)

 

 

 

 

Convertible Fund

 

 

 

Undistributed ordinary income

 

 

Undistributed long-term gains

 

 

Net accumulated earnings

 

 

Capital loss carryforwards

 

(15,009,468

)

Net unrealized appreciation

 

4,262,172

 

Total accumulated losses

 

$

(10,747,296

)

 

135



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

Money Market Fund

 

 

 

Undistributed ordinary income

 

 

Undistributed long-term gains

 

 

Net accumulated earnings

 

 

Capital loss carryforwards

 

(640

)

Net unrealized appreciation

 

 

Total accumulated losses

 

$

(640

)

 

At October 31, 2010, the Funds, for federal income tax purposes, had capital loss carryforwards which expire as set forth in the table below. These amounts may be applied against future net realized gains until the earlier of their utilization or expiration.

 

Expiration Dates

 

Alger Capital
Appreciation Fund

 

Alger Large Cap
Growth Fund

 

Alger Mid Cap
Growth Fund

 

Alger SMid Cap
Growth Fund

 

2011

 

 

$

21,526,122

 

 

 

2016

 

$

90,086,734

 

14,902,136

 

$

56,194,324

 

$

15,591,677

 

2017

 

78,004,262

 

69,159,616

 

105,486,895

 

82,958,676

 

Total

 

168,090,996

 

105,587,874

 

161,681,219

 

98,550,353

 

 

Expiration Dates

 

Alger Small Cap
Growth Fund

 

Alger Growth
Opportunities
Fund

 

Alger Health
Sciences Fund

 

Alger Balanced
Fund

 

2011

 

 

 

 

$

2,892,067

 

2016

 

$

26,656,278

 

 

$

6,173,975

 

358,746

 

2017

 

52,502,064

 

$

688,053

 

11,395,810

 

10,830,114

 

Total

 

79,158,342

 

688,053

 

17,569,785

 

14,080,927

 

 

Expiration Dates

 

Alger Convertible
Fund

 

Alger Money
Market Fund

 

 

 

 

 

2012

 

 

$

640

 

 

 

 

 

2016

 

$

5,276,856

 

 

 

 

 

 

2017

 

9,732,612

 

 

 

 

 

 

Total

 

15,009,468

 

640

 

 

 

 

 

 

The difference between book-basis and tax-basis unrealized appreciation (depreciation) is determined annually and is attributable primarily to the tax deferral of losses on wash sales, the tax treatment of premium/discount on debt securities, the tax treatment of partnerships investments, the realization of unrealized appreciation of Passive Foreign Investment Companies, and return of capital from Real Estate Investment Trust investments.

 

Permanent differences, primarily from net operating losses and real estate investment trusts and partnership investments sold by the Portfolios, resulted in the following reclassifications among the Portfolio’s components of net assets at October 31, 2010:

 

136



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

Capital Appreciation Fund

 

 

 

Undistributed net investment income

 

$

2,998,990

 

Accumulated net realized loss

 

$

116,148,298

 

Paid in capital

 

$

(119,147,288

)

 

 

 

 

Large Cap Growth Fund

 

 

 

Undistributed net investment income

 

$

(14,960

)

Accumulated net realized loss

 

$

104,071,575

 

Paid in capital

 

$

(104,056,615

)

 

 

 

 

Mid Cap Growth Fund

 

 

 

Undistributed net investment income

 

$

886,134

 

Accumulated net realized loss

 

$

530,213

 

Paid in capital

 

$

(1,416,347

)

 

 

 

 

SMid Cap Growth Fund

 

 

 

Undistributed net investment income

 

$

6,925,996

 

Accumulated net realized loss

 

$

(13,340,945

)

Paid in capital

 

$

6,414,949

 

 

 

 

 

Small Cap Growth Fund

 

 

 

Undistributed net investment income

 

$

4,057,788

 

Accumulated net realized loss

 

$

2,976,010

 

Paid in capital

 

$

(7,033,798

)

 

 

 

 

Growth Opportunities Fund

 

 

 

Undistributed net investment income

 

$

144,517

 

Accumulated net realized loss

 

$

1,376

 

Paid in capital

 

$

(145,893

)

 

 

 

 

Health Sciences Fund

 

 

 

Undistributed net investment income

 

$

2,223,900

 

Accumulated net realized loss

 

$

85,187

 

Paid in capital

 

$

(2,309,087

)

 

 

 

 

Balanced Fund

 

 

 

Undistributed net investment income

 

$

(11,905

)

Accumulated net realized loss

 

$

8,521,894

 

Paid in capital

 

$

(8,509,989

)

 

 

 

 

Convertible Fund

 

 

 

Undistributed net investment income

 

$

213,129

 

Accumulated net realized loss

 

$

207,816

 

Paid in capital

 

$

(420,945

)

 

 

 

 

Money Market Fund

 

 

 

Undistributed net investment income

 

 

Accumulated net realized loss

 

 

Paid in capital

 

 

 

137



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

NOTE 8 — Fair Value Measurements:

 

The major categories of securities and their respective fair value inputs are detailed in each Fund’s Schedule of Investments.  The following is a summary of the inputs used as of October 31, 2010 in valuing the Funds’ investments carried at fair value:

 

Alger Capital Appreciation Fund

 

TOTAL FUND

 

LEVEL 1

 

LEVEL 2

 

LEVEL 3

 

COMMON STOCKS

 

 

 

 

 

 

 

 

 

Consumer Discretionary

 

$

104,677,860

 

$

104,677,860

 

 

 

Consumer Staples

 

39,899,763

 

39,899,763

 

 

 

Energy

 

88,063,660

 

78,940,225

 

9,123,435

 

 

Exchange Traded Funds

 

8,253,391

 

8,253,391

 

 

 

Financials

 

43,750,327

 

43,750,327

 

 

 

Health Care

 

81,924,839

 

81,924,839

 

 

 

Industrials

 

127,351,215

 

127,351,215

 

 

 

Information Technology

 

289,460,882

 

289,460,882

 

 

 

Materials

 

42,121,975

 

42,121,975

 

 

 

TOTAL COMMON STOCKS

 

$

825,503,912

 

$

816,380,477

 

$

9,123,435

 

 

TOTAL INVESTMENTS IN SECURITIES

 

$

825,503,912

 

$

816,380,477

 

$

9,123,435

 

 

 

Alger Large Cap Growth Fund

 

TOTAL FUND

 

LEVEL 1

 

LEVEL 2

 

LEVEL 3

 

COMMON STOCKS

 

 

 

 

 

 

 

 

 

Consumer Discretionary

 

$

32,755,474

 

$

32,755,474

 

 

 

Consumer Staples

 

29,907,533

 

29,907,533

 

 

 

Energy

 

26,599,219

 

26,599,219

 

 

 

Financials

 

20,652,906

 

20,652,906

 

 

 

Health Care

 

34,403,897

 

34,403,897

 

 

 

Industrials

 

37,332,704

 

37,332,704

 

 

 

Information Technology

 

99,102,360

 

99,102,360

 

 

 

Materials

 

14,183,657

 

14,183,657

 

 

 

Telecommunication Services

 

1,694,934

 

1,694,934

 

 

 

Utilities

 

2,730,427

 

2,730,427

 

 

 

TOTAL COMMON STOCKS

 

$

299,363,111

 

$

299,363,111

 

 

 

TOTAL INVESTMENTS IN SECURITIES

 

$

299,363,111

 

$

299,363,111

 

 

 

 

Alger Mid Cap Growth Fund

 

TOTAL FUND

 

LEVEL 1

 

LEVEL 2

 

LEVEL 3

 

COMMON STOCKS

 

 

 

 

 

 

 

 

 

Consumer Discretionary

 

$

62,406,890

 

$

62,406,890

 

 

 

Consumer Staples

 

4,424,290

 

4,424,290

 

 

 

Energy

 

24,672,970

 

19,843,333

 

4,829,637

 

 

Financials

 

26,115,387

 

26,115,387

 

 

 

Health Care

 

45,186,804

 

45,186,804

 

 

 

Industrials

 

48,853,904

 

48,853,904

 

 

 

Information Technology

 

74,929,591

 

74,929,591

 

 

 

Materials

 

14,143,253

 

14,143,253

 

 

 

TOTAL COMMON STOCKS

 

$

300,733,089

 

$

295,903,452

 

$

4,829,637

 

 

 

138



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

Alger Mid Cap Growth Fund

 

TOTAL FUND

 

LEVEL 1

 

LEVEL 2

 

LEVEL 3

 

CONVERTIBLE CORPORATE BONDS

 

 

 

 

 

 

 

 

 

Telecommunication Services

 

$

3,770,553

 

 

$

3,770,553

 

 

CONVERTIBLE PREFERRED STOCK

 

 

 

 

 

 

 

 

 

Health Care

 

$

2,160,002

 

 

 

$

2,160,002

 

PURCHASED OPTIONS

 

 

 

 

 

 

 

 

 

Consumer Discretionary

 

$

457,140

 

$

457,140

 

 

 

Information Technology

 

$

107,800

 

$

107,800

 

 

 

Materials

 

$

405,990

 

$

405,990

 

 

 

TOTAL PURCHASED OPTIONS

 

$

970,930

 

$

970,930

 

 

 

TOTAL INVESTMENTS IN SECURITIES

 

$

307,634,574

 

$

296,874,382

 

$

8,600,190

 

$

2,160,002

 

SECURITIES SOLD SHORT

 

 

 

 

 

 

 

 

 

OPTIONS WRITTEN

 

 

 

 

 

 

 

 

 

Consumer Discretionary

 

$

757,890

 

$

757,890

 

 

 

Energy

 

$

91,440

 

$

91,440

 

 

 

Materials

 

435,138

 

435,138

 

 

 

TOTAL SECURITIES SOLD SHORT

 

$

1,284,468

 

$

1,284,468

 

 

 

 

Alger SMid Cap Growth Fund

 

TOTAL FUND

 

LEVEL 1

 

LEVEL 2

 

LEVEL 3

 

COMMON STOCKS

 

 

 

 

 

 

 

 

 

Consumer Discretionary

 

$

156,683,918

 

$

156,683,918

 

 

 

Consumer Staples

 

18,367,367

 

18,367,367

 

 

 

Energy

 

29,209,207

 

29,209,207

 

 

 

Financials

 

54,081,810

 

54,081,810

 

 

 

Health Care

 

133,320,359

 

133,320,359

 

 

 

Industrials

 

168,475,789

 

168,475,789

 

 

 

Information Technology

 

200,360,750

 

200,360,750

 

 

 

Materials

 

34,711,447

 

34,711,447

 

 

 

Telecommunication Services

 

19,347,719

 

19,347,719

 

 

 

Utilities

 

9,801,596

 

9,801,596

 

 

 

TOTAL COMMON STOCKS

 

$

824,359,962

 

$

824,359,962

 

 

 

TOTAL INVESTMENTS IN SECURITIES

 

$

824,359,962

 

$

824,359,962

 

 

 

 

Alger Small Cap Growth Fund

 

TOTAL FUND

 

LEVEL 1

 

LEVEL 2

 

LEVEL 3

 

COMMON STOCKS

 

 

 

 

 

 

 

 

 

Consumer Discretionary

 

$

65,427,742

 

$

65,427,742

 

 

 

Consumer Staples

 

9,302,699

 

9,302,699

 

 

 

Energy

 

14,004,013

 

14,004,013

 

 

 

Financials

 

11,921,111

 

11,921,111

 

 

 

Health Care

 

59,815,508

 

59,815,508

 

 

 

Industrials

 

65,318,094

 

65,318,094

 

 

 

Information Technology

 

85,002,664

 

85,002,664

 

 

 

Materials

 

15,589,055

 

15,589,055

 

 

 

Telecommunication Services

 

4,942,429

 

4,942,429

 

 

 

Utilities

 

3,956,952

 

3,956,952

 

 

 

TOTAL COMMON STOCKS

 

$

335,280,267

 

$

335,280,267

 

 

 

TOTAL INVESTMENTS IN SECURITIES

 

$

335,280,267

 

$

335,280,267

 

 

 

 

139



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

Alger Growth Opportunities Fund

 

TOTAL FUND

 

LEVEL 1

 

LEVEL 2

 

LEVEL 3

 

COMMON STOCKS

 

 

 

 

 

 

 

 

 

Consumer Discretionary

 

$

2,371,641

 

$

2,371,641

 

 

 

Consumer Staples

 

440,823

 

440,823

 

 

 

Energy

 

516,897

 

516,897

 

 

 

Financials

 

903,980

 

903,980

 

 

 

Health Care

 

2,120,700

 

2,120,700

 

 

 

Industrials

 

2,270,143

 

2,270,143

 

 

 

Information Technology

 

3,362,111

 

3,362,111

 

 

 

Materials

 

558,697

 

558,697

 

 

 

Telecommunication Services

 

141,925

 

141,925

 

 

 

Utilities

 

123,655

 

123,655

 

 

 

TOTAL COMMON STOCKS

 

$

12,810,572

 

$

12,810,572

 

 

 

TOTAL INVESTMENTS IN SECURITIES

 

$

12,810,572

 

$

12,810,572

 

 

 

 

Alger Health Sciences Fund

 

TOTAL FUND

 

LEVEL 1

 

LEVEL 2

 

LEVEL 3

 

COMMON STOCKS

 

 

 

 

 

 

 

 

 

Consumer Staples

 

$

5,945,688

 

$

5,945,688

 

 

 

Health Care

 

213,349,878

 

213,349,878

 

 

 

Industrials

 

1,469,982

 

1,469,982

 

 

 

TOTAL COMMON STOCKS

 

$

220,765,548

 

$

220,765,548

 

 

 

CONVERTIBLE PREFERRED STOCK

 

 

 

 

 

 

 

 

 

Health Care

 

$

1,689,998

 

 

 

$

1,689,998

 

TOTAL INVESTMENTS IN SECURITIES

 

$

222,455,546

 

$

220,765,548

 

 

$

1,689,998

 

 

Alger Balanced Fund

 

TOTAL FUND

 

LEVEL 1

 

LEVEL 2

 

LEVEL 3

 

COMMON STOCKS

 

 

 

 

 

 

 

 

 

Consumer Discretionary

 

$

3,114,565

 

$

3,114,565

 

 

 

Consumer Staples

 

3,190,476

 

3,190,476

 

 

 

Energy

 

3,087,716

 

3,087,716

 

 

 

Exchange Traded Funds

 

612,148

 

612,148

 

 

 

Financials

 

3,200,207

 

3,200,207

 

 

 

Health Care

 

3,156,414

 

3,156,414

 

 

 

Industrials

 

3,509,352

 

3,509,352

 

 

 

Information Technology

 

7,706,113

 

7,706,113

 

 

 

Materials

 

1,380,044

 

1,380,044

 

 

 

Telecommunication Services

 

198,067

 

198,067

 

 

 

TOTAL COMMON STOCKS

 

$

29,155,102

 

$

29,155,102

 

 

 

CONVERTIBLE CORPORATE BONDS

 

 

 

 

 

 

 

 

 

Energy

 

$

167,062

 

 

$

167,062

 

 

Financials

 

252,813

 

 

252,813

 

 

Information Technology

 

629,250

 

 

629,250

 

 

Materials

 

420,875

 

 

420,875

 

 

Telecommunication Services

 

218,625

 

 

218,625

 

 

Utilities

 

345,937

 

 

345,937

 

 

TOTAL CONVERTIBLE CORPORATE BONDS

 

$

2,034,562

 

 

$

2,034,562

 

 

 

140



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

Alger Balanced Fund

 

TOTAL FUND

 

LEVEL 1

 

LEVEL 2

 

LEVEL 3

 

CONVERTIBLE PREFERRED STOCK

 

 

 

 

 

 

 

 

 

Financials

 

$

294,600

 

$

294,600

 

 

 

Utilities

 

225,720

 

225,720

 

 

 

TOTAL CONVERTIBLE PREFERRED STOCK

 

$

520,320

 

$

520,320

 

 

 

CORPORATE BONDS

 

 

 

 

 

 

 

 

 

Consumer Discretionary

 

$

2,223,303

 

 

$

2,223,303

 

 

Consumer Staples

 

429,872

 

 

429,872

 

 

Energy

 

1,607,397

 

 

1,607,397

 

 

Financials

 

5,051,347

 

 

5,051,347

 

 

Health Care

 

2,188,660

 

 

2,188,660

 

 

Industrials

 

1,441,246

 

 

1,441,246

 

 

Information Technology

 

2,170,786

 

 

2,170,786

 

 

Materials

 

533,790

 

 

533,790

 

 

Telecommunication Services

 

465,651

 

 

465,651

 

 

Utilities

 

912,147

 

 

912,147

 

 

TOTAL CORPORATE BONDS

 

$

17,024,199

 

 

$

17,024,199

 

 

MANDATORY CONVERTIBLE PREFERRED STOCK

 

 

 

 

 

 

 

 

 

Financials

 

$

358,266

 

$

358,266

 

 

 

PREFERRED STOCKS

 

 

 

 

 

 

 

 

 

Financials

 

$

666,950

 

$

666,950

 

 

 

COLLATERALIZED MORTGAGE OBLIGATIONS

 

 

 

 

 

 

 

 

 

Asset Backed Securities

 

$

535,510

 

 

$

535,510

 

 

ASSET BACKED SECURITIES

 

 

 

 

 

 

 

 

 

Financials

 

$

332,894

 

 

$

332,894

 

 

Utilities

 

201,064

 

 

201,064

 

 

TOTAL ASSET BACKED SECURITIES

 

$

533,958

 

 

$

533,958

 

 

U.S. GOVERNMENT & AGENCY MORTGAGE BACKED OBLIGATIONS

 

 

 

 

 

 

 

 

 

Collateralized Mortgage Backed Obligations

 

$

1,803,506

 

 

$

1,803,506

 

 

Federal National Mortgage Association

 

375,944

 

 

375,944

 

 

TOTAL U.S. GOVERNMENT & AGENCY MORTGAGE BACKED OBLIGATIONS

 

$

2,179,450

 

 

$

2,179,450

 

 

U.S. GOVERNMENT & AGENCY OBLIGATIONS (EXCLUDING MORTGAGE-BACKED)

 

 

 

 

 

 

 

 

 

Federal Farm Credit Bank

 

$

534,426

 

 

$

534,426

 

 

Federal Home Loan Bank

 

297,121

 

 

297,121

 

 

Federal National Mortgage Association

 

1,360,562

 

 

1,360,562

 

 

U.S. Treasury Notes

 

5,101,170

 

 

5,101,170

 

 

TOTAL U.S. GOVERNMENT & AGENCY OBLIGATIONS (EXCLUDING MORTGAGE-BACKED)

 

$

7,293,279

 

 

$

7,293,279

 

 

TOTAL INVESTMENTS IN SECURITIES

 

$

60,301,596

 

$

30,700,638

 

$

29,600,958

 

 

 

Alger Convertible Fund

 

TOTAL FUND

 

LEVEL 1

 

LEVEL 2

 

LEVEL 3

 

COMMON STOCKS

 

 

 

 

 

 

 

 

 

Energy

 

$

870,433

 

$

870,433

 

 

 

Industrials

 

160,200

 

160,200

 

 

 

TOTAL COMMON STOCKS

 

$

1,030,633

 

$

1,030,633

 

 

 

 

141



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

Alger Convertible Fund

 

TOTAL FUND

 

LEVEL 1

 

LEVEL 2

 

LEVEL 3

 

CONVERTIBLE CORPORATE BONDS

 

 

 

 

 

 

 

 

 

Consumer Discretionary

 

$

3,221,218

 

 

$

3,221,218

 

 

Consumer Staples

 

338,250

 

 

338,250

 

 

Energy

 

1,878,875

 

 

1,878,875

 

 

Financials

 

1,980,313

 

 

1,980,313

 

 

Health Care

 

2,246,999

 

 

2,246,999

 

 

Industrials

 

1,226,888

 

 

1,226,888

 

 

Information Technology

 

4,035,093

 

 

4,035,093

 

 

Materials

 

1,664,000

 

 

1,664,000

 

 

Telecommunication Services

 

444,500

 

 

444,500

 

 

Utilities

 

345,938

 

 

345,938

 

 

TOTAL CONVERTIBLE CORPORATE BONDS

 

$

17,382,074

 

 

$

17,382,074

 

 

CONVERTIBLE PREFERRED STOCK

 

 

 

 

 

 

 

 

 

Financials

 

$

1,153,000

 

$

780,850

 

$

372,150

 

 

Health Care

 

262,904

 

262,904

 

 

 

Materials

 

860,400

 

542,500

 

317,900

 

 

Utilities

 

282,150

 

282,150

 

 

 

TOTAL CONVERTIBLE PREFERRED STOCK

 

$

2,558,454

 

$

1,868,404

 

$

690,050

 

 

CORPORATE BONDS

 

 

 

 

 

 

 

 

 

Information Technology

 

$

645,000

 

 

$

645,000

 

 

MANDATORY CONVERTIBLE PREFERRED STOCK

 

 

 

 

 

 

 

 

 

Energy

 

$

741,934

 

$

741,934

 

 

 

Financials

 

370,620

 

370,620

 

 

 

Utilities

 

522,500

 

522,500

 

 

 

TOTAL MANDATORY CONVERTIBLE PREFERRED STOCK

 

$

1,635,054

 

$

1,635,054

 

 

 

PREFERRED STOCKS

 

 

 

 

 

 

 

 

 

Financials

 

$

3,300,374

 

$

3,047,374

 

$

253,000

 

 

TOTAL INVESTMENTS IN SECURITIES

 

$

26,551,589

 

$

7,581,465

 

$

18,970,124

 

 

 

Alger Money Market Fund

 

TOTAL FUND

 

LEVEL 1

 

LEVEL 2

 

LEVEL 3

 

U.S. GOVERNMENT & AGENCY OBLIGATIONS (EXCLUDING MORTGAGE-BACKED)

 

 

 

 

 

 

 

 

 

Federal Agriculture Mortgage Corporation

 

$

8,998,661

 

 

$

8,998,661

 

 

Federal Home Loan Bank

 

$

12,999,140

 

 

$

12,999,140

 

 

TOTAL U.S. GOVERNMENT & AGENCY OBLIGATIONS (EXCLUDING MORTGAGE-BACKED)

 

$

21,997,801

 

 

$

21,997,801

 

 

SHORT-TERM INVESTMENTS

 

 

 

 

 

 

 

 

 

Time Deposits

 

$

18,739,556

 

 

$

18,739,556

 

 

TOTAL INVESTMENTS IN SECURITIES

 

$

40,737,357

 

 

$

40,737,357

 

 

 

142



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

 

 

FAIR VALUE 
MEASUREMENTS 
USING SIGNIFICANT
UNOBSERVABLE 
INPUTS (LEVEL3)

 

Alger Health Sciences Fund

 

Trading Securities

 

Opening balance at November 1, 2009

 

$

 —

 

Net realized and unrealized gain (loss) on investments, foreign currency and options

 

 

 

Purchases, issuances, and settlements

 

$

1,689,998

 

Transfers in and/ or out of level 3

 

 

 

Closing balance at October 31, 2010

 

1,689,998

 

The amount of net realized and unrealized gain (loss) on investments, foreign currency and options for the period attributable to change in unrealized appreciation (depreciation) relating to investments still held at October 31, 2010

 

$

 —

 

 

Alger Mid Cap Growth Fund

 

Trading Securities

 

Opening balance at November 1, 2009

 

$

 —

 

Net realized and unrealized gain (loss) on investments, foreign currency and options

 

 

 

Purchases, issuances, and settlements

 

2,160,002

 

Transfers in and/ or out of level 3

 

 

 

Closing balance at October 31, 2010

 

2,160,002

 

The amount of net realized and unrealized gain (loss) on investments, foreign currency and options for the period attributable to change in unrealized appreciation (depreciation) relating to investments still held at October 31, 2010

 

$

 —

 

 

NOTE 9 — Derivatives:

 

Financial Accounting Standards Board Accounting Standards Codification 815 — Derivatives and Hedging (“ASC 815”) requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative agreements.

 

Forward currency contracts—In connection with portfolio purchases and sales of securities denominated in foreign currencies, the Funds may enter into forward currency contracts. Additionally, each Fund may enter into such contracts to economically hedge certain other foreign currency denominated investments. These contracts are valued at the current cost of covering or offsetting such contracts, and the related realized and unrealized foreign exchange gains and losses are included in the statement of operations. In the event that counterparties fail to settle these currency contracts or the related foreign security trades, a Fund could be exposed to foreign currency fluctuations.

 

Options—The Funds seek to capture the majority of the returns associated with equity market investments. To meet this investment goal, the Funds invest in a broadly diversified portfolio of common stocks, while also buying and selling call and put options on equities and equity indices.  The Funds purchase call options to increase their exposure to stock market risk and also provide diversification of risk.  The Funds purchase put options in order to protect from significant market declines that may occur over a short period of time. The Funds will write covered call and cash secured put options to generate cash flows while reducing the volatility of the Funds’ portfolio.  The cash flows may be an important source of the Funds’ return, although written call options may

 

143



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

reduce the Funds’ ability to profit from increases in the value of the underlying security or equity portfolio.  The value of a call option generally increases as the price of the underlying stock increases and decreases as the stock decreases in price.  Conversely, the value of a put option generally increases as the price of the underlying stock decreases and decreases as the stock increases in price The combination of the diversified stock portfolio and the purchase and sale of options is intended to provide the Funds with the majority of the returns associated with equity market investments but with reduced volatility and returns that are augmented with the cash flows from the sale of options.  During the year ended October 31, 2010, written equity and index put options were used in accordance with this objective.

 

The fair values of derivative instruments as of October 31, 2010 are as follows:

 

Alger Mid Cap Growth Fund

 

ASSET DERIVATIVES 2010

 

LIABILITY DERIVATIVES 2010

 

Derivatives not accounted 
for as hedging instruments

 

Balance Sheet 
Location

 

Fair Value

 

Balance Sheet 
Location

 

Fair Value

 

Purchased Put Options

 

Investments in securities, at value

 

$

863,130

 

 

 

Purchased Call Options

 

Investments in securities, at value

 

107,800

 

 

 

Written Put Options

 

 

 

Written options outstanding, at value

 

$

188,768

 

Written Call Options

 

 

 

Written options outstanding, at value

 

1,095,700

 

Total

 

 

 

$

970,930

 

 

 

$

1,284,468

 

 

For the year ended October 31, 2010, the Alger Mid Cap Growth Fund had option purchases of $6,946,078 and option sales of $9,284,786, and the Health Sciences Fund had option purchases of $574,652 and option sales of $28,729.  The effect of derivative instruments on the Statement of Operations for the year ended October 31, 2010 is as follows:

 

Net realized gain on investments and options

 

Alger Mid Cap Growth Fund

 

Derivatives not accounted for as hedging instruments

 

Options

 

Purchased Put Options

 

$

1,852,563

 

Written Put Options

 

(436,279

)

Total

 

$

1,873,345

 

 

Alger Health Sciences Fund

 

Derivatives not accounted for as hedging instruments

 

Options

 

Purchased Put Options

 

$

(545,923

)

Total

 

$

(545,923

)

 

144



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

Net change in unrealized appreciation (depreciation) on investments, options

 

Alger Mid Cap Growth Fund

 

Derivatives not accounted for as hedging instruments under Statement 133

 

Options

 

Purchased Options

 

$

(1,654,786

)

Written Options

 

(405,508

)

Total

 

$

(2,060,294

)

 

NOTE 10 — Litigation:

 

In October 2006, Alger Management, the Distributor and Alger Shareholder Services, Inc. entered into a settlement with the office of the New York State Attorney General, and in January 2007, the Manager and Distributor entered into a settlement with the Securities and Exchange Commission (the “SEC”) in connection with practices in the mutual fund industry identified as “market timing” and “late trading.” As part of these settlements, without admitting or denying liability, the firms consented to the payment of $30 million to reimburse fund shareholders; a fine of $10 million; and certain other remedial measures including a reduction in management fees of $1 million per year for five years. The $40 million was paid into an SEC Fair Fund for distribution to investors.

 

On August 31, 2005, the West Virginia Securities Commissioner (the “WVSC”), in an ex parte Summary Order to Cease and Desist and Notice of Right to Hearing, concluded that the Manager and the Distributor had violated the West Virginia Uniform Securities Act (the “WVUSA”), and ordered the Manager and the Distributor to cease and desist from further violations of the WVUSA by engaging in the market-timing-related conduct described in the order. The ex parte order provided notice of their right to a hearing with respect to the violations of law asserted by the WVSC. Other firms unaffiliated with the Manager were served with similar orders. The Manager and the Distributor intend to request a hearing for the purpose of seeking to vacate or modify the order.

 

In addition, in 2003 and 2004 several purported class actions and shareholder derivative suits were filed against various parties in the mutual fund industry, including the Manager, certain mutual funds managed by the Manager (the “Alger Mutual Funds”), and certain current and former Alger Mutual Fund trustees and officers, alleging wrongful conduct related to market-timing and late-trading by mutual fund shareholders. These cases were transferred to the U.S. District Court of Maryland by the Judicial Panel on Multidistrict Litigation for consolidated pre-trial proceedings under the caption number 1:04-MD-15863 (JFM). After a number of the claims in the Alger lawsuits, including all claims against Alger Mutual Funds and their independent trustees, were dismissed by the court, the Alger-related class and derivative suits were settled.  A Final Judgment and Order approving the settlement was entered on October 25, 2010.  No appeals from the Final Judgment and Order were filed within the allotted time limit. The settlement was paid by insurance, and had no financial impact on the Alger Mutual Funds.

 

145



 

THE ALGER FUNDS

NOTES TO FINANCIAL STATEMENTS (Continued)

 

NOTE 11 — Acquisition of the Castle Convertible Fund, Inc.:

 

On January 9, 2009, the Alger Convertible Fund (the “Fund”) commenced operations by acquiring all the net assets of Castle Convertible Fund, Inc. (the “Acquired Fund”) pursuant to a plan of reorganization approved by the Acquired Fund’s shareholders on October 22, 2008. The acquisition was accomplished by a tax-free exchange of shares of the Fund, valued at $33,879,112, for 2,236,000 shares of Acquired Fund outstanding on January 9, 2009. The Acquired Fund’s net assets of $33,879,112, including $10,406,449 of unrealized depreciation, were combined with those of the Fund.  The combined net assets of the Fund and Acquired Fund were $33,879,112 immediately after the acquisition.

 

NOTE 12 — Recent Accounting Pronouncements:

 

On January 21, 2010, the FASB issued Accounting Standards Update (ASU) 2010-06. The ASU amends ASC 820 to add new requirements for disclosures about transfers into and out of Levels 1 and 2 and separate disclosures about purchases, sales, issuances, and settlements relating to Level 3 measurements.  It also clarifies existing fair value disclosures about the level of disaggregation and about inputs and valuation techniques used to measure fair value.  The application of ASU 2010-06 is required for fiscal years and interim periods beginning after December 15, 2009.  The implications of ASU 2010-06 is not expected to have a material impact on the financial statements of the Funds.

 

NOTE 13 — Subsequent Events:

 

Management of each Fund has evaluated events that have occurred subsequent to October 31, 2010.  No such events have been identified which require recognition and disclosure.

 

146



 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Shareholders and Board of Trustees of

The Alger Funds:

 

We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of The Alger Funds (the “Funds”) comprising the Alger Capital Appreciation Fund, Alger Large Cap Growth Fund, Alger Mid Cap Growth Fund, Alger SMid Cap Growth Fund, Alger Small Cap Growth Fund, Alger Growth Opportunities Fund, Alger Health Sciences Fund, Alger Balanced Fund, Alger Convertible Fund and Alger Money Market Fund as of October 31, 2010, and the related statements of operations for the year then ended, the statements of changes in net assets for each of the two years in the period then ended, and the financial highlights for each of the two years in the period then ended. These financial statements and financial highlights are the responsibility of the Funds’ management. Our responsibility is to express an opinion on these financial statements and financial highlights based on our audits. The Funds’ financial highlights for the respective periods ended October 31, 2008 were audited by other auditors, whose reports dated December 16, 2008, expressed unqualified opinions on such financial highlights.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement. The Funds are not required to have, nor were we engaged to perform, an audit of their internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Funds’ internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. Our procedures included confirmation of securities owned as of October 31, 2010, by correspondence with the custodian and brokers; where replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the financial statements and financial highlights referred to above, present fairly, in all material respects, the financial position of each of the portfolios constituting The Alger Funds as of October 31, 2010, the results of their operations for the year then ended, and the changes in their net assets and the financial highlights for each of the two years in the period then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Deloitte & Touche LLP

New York, New York

December 27, 2010

 

147



 

THE ALGER FUNDS

ADDITIONAL INFORMATION (Unaudited)

 

Shareholder Expense Example

 

As a shareholder of the Fund, you incur two types of costs: transaction costs, if applicable, including sales charges (loads) and redemption fees; and ongoing costs, including management fees, distribution (12b-1) fees, if applicable, and other fund expenses. This example is intended to help you understand your ongoing costs (in dollars) of investing in the Fund and to compare these costs with the ongoing costs of investing in other mutual funds.

 

The example below is based on an investment of $1,000 invested at the beginning of the six-month period starting May 1, 2010 and ending October 31, 2010.

 

Actual Expenses

 

The first line for each class of shares in the table below provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you would have paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line under the heading entitled “Expenses Paid During the Period” to estimate the expenses you paid on your account during this period.

 

Hypothetical Example for Comparison Purposes

 

The second line for each class of shares in the table below provides information about hypothetical account values and hypothetical expenses based on the Fund’s actual expense ratios for each class of shares and an assumed rate of return of 5% per year before expenses, which is not the Fund’s actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds.

 

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs, such as sales charges (loads) and redemption fees. Therefore, the second line under each class of shares in the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.

 

148



 

 

 

 

 

Beginning
Account
Value
May 1, 2009

 

Ending
Account
Value
October 31, 2010

 

Expenses
Paid During
the Six Months
Ended
October 31,
2010(a)

 

Ratio of
Expenses to
Average
Net Assets
For the
Six Months
Ended
October 31,
2010(b)

 

Alger Capital Appreciation Fund

 

 

 

 

 

 

 

 

 

Class A

 

Actual

 

$

1,000.00

 

$

1,007.47

 

$

6.66

 

1.32

%

 

 

Hypothetical(c)

 

1,000.00

 

1,018.57

 

6.70

 

1.32

 

Class B

 

Actual

 

1,000.00

 

1,003.33

 

11.10

 

2.20

 

 

 

Hypothetical(c)

 

1,000.00

 

1,014.13

 

11.16

 

2.20

 

Class C

 

Actual

 

1,000.00

 

1,003.32

 

10.58

 

2.09

 

 

 

Hypothetical(c)

 

1,000.00

 

1,014.65

 

10.64

 

2.09

 

 

 

 

 

 

 

 

 

 

 

 

 

Alger Large Cap Growth Fund

 

 

 

 

 

 

 

 

 

Class A

 

Actual

 

$

1,000.00

 

$

1,017.18

 

$

7.04

 

1.38

%

 

 

Hypothetical(c)

 

1,000.00

 

1,018.23

 

7.04

 

1.38

 

Class B

 

Actual

 

1,000.00

 

1,014.10

 

10.15

 

2.00

 

 

 

Hypothetical(c)

 

1,000.00

 

1,015.12

 

10.16

 

2.00

 

Class C

 

Actual

 

1,000.00

 

1,013.11

 

10.54

 

2.08

 

 

 

Hypothetical(c)

 

1,000.00

 

1,014.73

 

10.55

 

2.08

 

 

 

 

 

 

 

 

 

 

 

 

 

Alger Mid Cap Growth Fund

 

 

 

 

 

 

 

 

 

Class A

 

Actual

 

$

1,000.00

 

$

1,017.52

 

$

7.00

 

1.38

%

 

 

Hypothetical(c)

 

1,000.00

 

1,018.27

 

7.00

 

1.38

 

Class B

 

Actual

 

1,000.00

 

1,013.16

 

10.78

 

2.12

 

 

 

Hypothetical(c)

 

1,000.00

 

1,014.50

 

10.79

 

2.12

 

Class C

 

Actual

 

1,000.00

 

1,013.21

 

11.17

 

2.20

 

 

 

Hypothetical(c)

 

1,000.00

 

1,014.11

 

11.17

 

2.20

 

 

 

 

 

 

 

 

 

 

 

 

 

Alger SMid Cap Growth Fund

 

 

 

 

 

 

 

 

 

Class A

 

Actual

 

$

1,000.00

 

$

1,009.76

 

$

6.70

 

1.32

%

 

 

Hypothetical(c)

 

1,000.00

 

1,018.54

 

6.73

 

1.32

 

Class B

 

Actual

 

1,000.00

 

1,005.21

 

10.93

 

2.16

 

 

 

Hypothetical(c)

 

1,000.00

 

1,014.30

 

10.98

 

2.16

 

Class C

 

Actual

 

1,000.00

 

1,005.95

 

10.75

 

2.13

 

 

 

Hypothetical(c)

 

1,000.00

 

1,014.48

 

10.80

 

2.13

 

Class I

 

Actual

 

1,000.00

 

1,010.40

 

6.08

 

1.20

 

 

 

Hypothetical(c)

 

1,000.00

 

1,019.16

 

6.11

 

1.20

 

 

 

 

 

 

 

 

 

 

 

 

 

Alger Small Cap Growth Fund

 

 

 

 

 

 

 

 

 

Class A

 

Actual

 

$

1,000.00

 

$

1,001.49

 

$

7.09

 

1.40

%

 

 

Hypothetical(c)

 

1,000.00

 

1,018.12

 

7.15

 

1.40

 

Class B

 

Actual

 

1,000.00

 

998.32

 

10.82

 

2.15

 

 

 

Hypothetical(c)

 

1,000.00

 

1,014.37

 

10.91

 

2.15

 

Class C

 

Actual

 

1,000.00

 

996.65

 

11.31

 

2.25

 

 

 

Hypothetical(c)

 

1,000.00

 

1,013.87

 

11.41

 

2.25

 

 

149



 

 

 

 

 

Beginning
Account
Value
May 1, 2009

 

Ending
Account
Value
October 31, 2010

 

Expenses
Paid During
the Six Months
Ended
October 31,
2010(a)

 

Ratio of
Expenses to
Average
Net Assets
For the
Six Months
Ended
October 31,
2010(b)

 

Alger Growth Opportunities Fund

 

 

 

 

 

 

 

 

 

Class A

 

Actual

 

$

1,000.00

 

$

1,027.11

 

$

7.68

 

1.50

%

 

 

Hypothetical(c)

 

1,000.00

 

1,017.63

 

7.64

 

1.50

 

Class C

 

Actual

 

1,000.00

 

1,023.49

 

11.50

 

2.25

 

 

 

Hypothetical(c)

 

1,000.00

 

1,013.84

 

11.44

 

2.25

 

Class I

 

Actual

 

1,000.00

 

1,029.00

 

6.41

 

1.25

 

 

 

Hypothetical(c)

 

1,000.00

 

1,018.89

 

6.38

 

1.25

 

 

 

 

 

 

 

 

 

 

 

 

 

Alger Health Sciences Fund

 

 

 

 

 

 

 

 

 

Class A

 

Actual

 

$

1,000.00

 

$

960.84

 

$

6.59

 

1.33

%

 

 

Hypothetical(c)

 

1,000.00

 

1,018.49

 

6.78

 

1.33

 

Class B

 

Actual

 

1,000.00

 

957.50

 

10.63

 

2.15

 

 

 

Hypothetical(c)

 

1,000.00

 

1,014.35

 

10.94

 

2.15

 

Class C

 

Actual

 

1,000.00

 

956.96

 

10.46

 

2.12

 

 

 

Hypothetical(c)

 

1,000.00

 

1,014.52

 

10.76

 

2.12

 

 

 

 

 

 

 

 

 

 

 

 

 

Alger Balanced Fund

 

 

 

 

 

 

 

 

 

Class A

 

Actual

 

$

1,000.00

 

$

1,021.50

 

$

6.96

 

1.37

%

 

 

Hypothetical(c)

 

1,000.00

 

1,018.32

 

6.95

 

1.37

 

Class B

 

Actual

 

1,000.00

 

1,017.37

 

10.95

 

2.15

 

 

 

Hypothetical(c)

 

1,000.00

 

1,014.35

 

10.93

 

2.15

 

Class C

 

Actual

 

1,000.00

 

1,017.92

 

10.60

 

2.08

 

 

 

Hypothetical(c)

 

1,000.00

 

1,014.70

 

10.58

 

2.08

 

 

 

 

 

 

 

 

 

 

 

 

 

Alger Convertible Fund

 

 

 

 

 

 

 

 

 

Class A

 

Actual

 

$

1,000.00

 

$

1,032.67

 

$

6.35

 

1.24

%

 

 

Hypothetical(c)

 

1,000.00

 

1,018.95

 

6.31

 

1.24

 

 

 

 

 

 

 

 

 

 

 

 

 

Alger Money Market Fund

 

 

 

 

 

 

 

 

 

 

 

Actual

 

$

1,000.00

 

$

1,000.11

 

$

0.38

 

0.08

%

 

 

Hypothetical(c)

 

1,000.00

 

1,024.82

 

0.39

 

0.08

 

 


(a)

Expenses are equal to the annualized expense ratio of the respective share class, multiplied by the average account value over the period, multiplied by 184/365 (to reflect the one-half year period).

(b)

Annualized.

(c)

5% annual return before expenses.

 

150



 

Tax Information

 

In accordance with subchapter M of the Internal Revenue Code of 1986, as amended, for the year ended October 31, 2010, 59.65%, and 100.00% of the Alger Balanced Fund, and Alger Large Cap Growth Fund’s ordinary dividend qualified for the dividends received deduction for corporations.  For the year ended October 31, 2010, certain dividends paid by the Funds may be subject to a maximum rate of 15%, as provided by the Jobs and Growth Tax Relief Reconciliation Act of 2003.  Of the distributions paid during the fiscal year, the following represents the maximum amount that may be considered qualified dividend income:

 

Alger Balanced Fund

 

$

518,289

 

Alger Large Cap Growth Fund

 

$

3,755,896

 

Alger Convertible Fund

 

$

550,622

 

 

Shareholders should not use the above information to prepare their tax returns.  Since the Fund’s fiscal year is not the calendar year, another notification will be sent with respect to calendar year 2010.  Such notification, which will reflect the amount to be used by tax payers on their federal income tax returns, will be made in conjunction with Form 1099 DIV and will be mailed in January 2011.  Shareholders are advised to consult their own tax advisers with respect to the tax consequences of their investment in the Fund.

 

Trustees and Officers of the Fund

 

Information about the trustees and officers of the Fund is set forth below.  In the table the term “Alger Fund Complex” refers to the Fund, The Alger Portfolios, The Alger Institutional Funds, Alger China-U.S. Growth Fund and The Alger Funds II, each of which is a registered investment company managed by Fred Alger Management, Inc. (“Alger Management”).  Each Trustee serves until an event of termination, such as death or resignation, or until his successor is duly elected; each officer’s term of office is one year.  Unless otherwise noted, the address of each person named below is 111 Fifth Avenue, New York, NY 10003.

 

151



 

Name, Age, Position with the
Fund

 

Principal Occupations

 

Trustee
and/or
Officer
Since

 

Number of
Funds in
the Alger
Fund
Complex
which are
Overseen
by Trustee

INTERESTED TRUSTEE

 

 

 

 

 

 

 

 

 

 

 

 

 

Hilary M. Alger (49)

 

Director of Development, Pennsylvania Ballet since 2004; Associate Director of Development, College of Arts and Sciences and Graduate School, University of Virginia 1999-2003.

 

2003

 

27

 

 

 

 

 

 

 

NON-INTERESTED TRUSTEE

 

 

 

 

 

 

 

 

 

 

 

 

 

Charles F. Baird, Jr. (57)

 

Managing Partner of North Castle Partners, a private equity securities group; Chairman of Leiner Health Products, Enzymatic Therapy and Caleel & Hayden (skincare business); former Chairman of Elizabeth Arden Day Spas, Naked Juice, Equinox (fitness company) and EAS (manufacturer of nutritional products). Formerly Managing Director of AEA Investors, Inc.

 

2000

 

27

 

 

 

 

 

 

 

Roger P. Cheever (65)

 

Associate Vice President for Principal Gifts, and Senior Associate Dean for Development in the Faculty of Arts and Sciences at Harvard University; Formerly Deputy Director of the Harvard College Fund.

 

2000

 

27

 

 

 

 

 

 

 

Lester L. Colbert Jr. (76)

 

Private investor since 1988; Formerly Chairman of the Board, President and Chief Executive Officer of Xidex Corporation (manufacturer of computer information media).

 

2000

 

27

 

 

 

 

 

 

 

Stephen E. O’Neil (78)

 

Attorney. Private Investor since 1981. Formerly of Counsel to the law firm of Kohler & Barnes.

 

1986

 

27

 

 

 

 

 

 

 

David Rosenberg (48)

 

Associate Professor of Law since January 2006 (Assistant Professor 2000-2005), Zicklin School of Business, Baruch College, City University of New York.

 

2007

 

27

 

 

 

 

 

 

 

Nathan E. Saint-Amand M.D. (73)

 

Medical doctor in private practice; Member of the Board of the Manhattan Institute (non-profit policy research) since 1988; Formerly Co-Chairman, Special Projects Committee, Memorial Sloan Kettering.

 

1986

 

27

 

152



 

Name, Age, Position with the
Fund

 

Principal Occupations

 

Trustee
and/or
Officer
Since

 

Number of
Funds in
the Alger
Fund
Complex
which are
Overseen
by Trustee

OFFICERS

 

 

 

 

 

 

 

 

 

 

 

 

 

Dan C. Chung (48)
President

 

Chief Investment Officer and Director since 2001, and Chief Executive Officer since 2006, of Alger Management; President since 2003 of Alger Associates, Inc. (“Associates”); President and Director since 2003 of Fred Alger International Advisory S.A. (“International”); and President since 2003 and Director since 2001 of Analysts Resources, Inc. (“Resources”); Formerly Trustee of the Trust from 2001 to 2007.

 

2001

 

N/A

 

 

 

 

 

 

 

Michael D. Martins (45)
Treasurer

 

Senior Vice President of Alger Management; Assistant Treasurer since 2004.

 

2005

 

N/A

 

 

 

 

 

 

 

Hal Liebes (46)
Secretary

 

Executive Vice President, Chief Legal Officer, Chief Operating Officer and Secretary of Alger Management; Director since 2006 of International and Resources.

 

2005

 

N/A

 

 

 

 

 

 

 

Lisa A. Moss (45)
Assistant Secretary

 

Senior Vice President since 2009, and Vice President and Assistant General Counsel of Alger Management since June 2006. Formerly Director of Merrill Lynch Investment Managers, L.P. from 2005-2006.

 

2006

 

N/A

 

 

 

 

 

 

 

Anthony S. Caputo (55)
Assistant Treasurer

 

Employed by Alger Management since 1986, currently serving as Vice President.

 

2007

 

N/A

 

 

 

 

 

 

 

Sergio M. Pavone (49)
Assistant Treasurer

 

Employed by Alger Management since 2002, currently serving as Vice President.

 

2007

 

N/A

 

 

 

 

 

 

 

Barry J. Mullen (57)
Chief Compliance Officer

 

Senior Vice President and Director of Compliance of Alger Management since May 2006. Formerly Director of BlackRock, Inc. from 2004-2006.

 

2006

 

N/A

 

Ms. Alger is an “interested person” (as defined in the Investment Company Act) of the Fund because of her affiliations with Alger Management.  No Trustee is a director of any public company except as indicated under “Principal Occupations”.

 

The Statement of Additional Information contains additional information about the Fund’s Trustees and is available without charge upon request by calling (800) 992-3863.

 

Investment Management Agreement Renewal

 

At an in-person meeting held on September 14, 2010, the Trustees, including the Independent Trustees, unanimously approved renewal of the Investment Advisory

 

153



 

Agreement (the “Agreement”) between the Trust and Fred Alger Management, Inc. (“Alger Management”). The Independent Trustees were assisted in their review by independent legal counsel and met with such counsel in executive session separate from representatives of Alger Management.

 

In evaluating the Agreement, the Trustees drew on materials that they had requested and which were provided to them in advance of the meeting by Alger Management and by counsel. The materials covered, among other matters, (i) the nature, extent and quality of the services provided by Alger Management under the Agreement, (ii) the investment performance of each of the Trust’s portfolios (each a “Fund”), (iii) the costs to Alger Management of its services and the profits realized by Alger Management and Alger Inc. from their relationship with the Trust, and (iv) the extent to which economies of scale would be realized if and as the Funds grow and whether the fee levels in the Agreement reflect these economies of scale. These materials included an analysis of the Funds and Alger Management’s services by FUSE Research Network LLC (“FUSE”), an independent consulting firm having no other relationship with Alger Management, whose specialties include assistance to fund trustees and directors in their review of advisory contracts pursuant to section 15(c) of the 1940 Act. At the meeting, senior FUSE personnel provided a presentation to the Trustees based on the FUSE materials.

 

In deciding whether to approve renewal of the Agreement, the Trustees considered various factors, including those enumerated above. They also considered other direct and indirect benefits to Alger Management and its affiliates from their relationship with the Trust.

 

Nature, Extent and Quality of Services.  In considering the nature, extent and quality of the services provided by Alger Management pursuant to the Agreement, the Trustees relied on their prior experience as Trustees of the Trust, their familiarity with the personnel and resources of Alger Management and its affiliates, and the materials provided at the meeting.  They noted that under the Agreement Alger Management is responsible for managing the investment operations of the Funds.  They also noted that administrative, compliance, reporting and accounting services necessary for the conduct of the Trust’s affairs are provided under the separate Administration Agreement with Alger Management. The Trustees reviewed the background and experience of Alger Management’s senior investment management personnel, including the individuals currently responsible for the investment operations of the Funds. They also considered the resources, operational structures and practices of Alger Management in managing each Fund’s portfolio, as well as Alger Management’s overall investment management business.  They noted especially Alger Management’s history of expertise in managing portfolios of “growth” stocks and that, according to an analysis provided by FUSE, the characteristics of each equity Fund had been consistent with those of a fund that holds itself out to investors as growth-oriented. They also took notice of the ability of the fixed-income portfolio manager of Alger Balanced Fund, Alger Convertible Fund and Alger Money Market Fund to manage fixed-income instruments across the credit and credit quality spectra.  The Trustees concluded that Alger Management’s experience, resources and strength in the areas of importance to the Funds are considerable.  The Trustees

 

154



 

considered the level and depth of Alger Management’s ability to execute portfolio transactions to effect investment decisions, including those through Alger Inc.  The Trustees also considered the enhanced control and compliance environment at Alger Management and within the Trust.

 

Investment Performance of the Funds.  Drawing upon information provided at the meeting by Alger Management as well as FUSE and upon reports provided to the Trustees by Alger Management throughout the preceding year, the Trustees reviewed each Fund’s returns for the year-to-date (at 6/30/10), second-quarter, and 1-, 3-, 5-, and 10-year periods to the extent available (and its year-by-year returns), together with supplemental data through 8/31/10, and compared them with benchmark and peer-group data for the same periods. They noted that the performance for the near term (periods of 1 year or less through 6/30/10) of some of the Funds (Small Cap, Growth Opportunities, Convertible) generally surpassed (sometimes by a wide margin) or matched their peer group and benchmark, while others (Mid Cap, SMid Cap, Health Sciences) generally fell short (again, sometimes by a wide margin) of those measures, and the performance of still others (Large Cap, Capital Appreciation, Balanced) was mixed, the Balanced Fund generally matching or surpassing its peer group but falling short of its benchmark. In light of the exceptional recent conditions in the Money Market Fund’s investment universe, in which positive portfolio returns, if any, were generally difficult to achieve and maintain, the Trustees placed little weight on the near—term performance data for that Fund. Performance results for the longer (3- and 5- year) periods, to the extent available, were generally consistent with the near-term data, except that SMid Cap, Health Sciences and Capital Appreciation showed superior longer-term results. Representatives of Alger Management discussed with the Trustees measures that the firm was in the process of instituting to improve the performance of the Funds that had consistently fallen short of their peers and benchmarks.

 

Fund Fees and Expense Ratios; Profitability to Alger Management and its Affiliates.  The Trustees considered the profitability of the Investment Advisory Agreement to Alger Management and its affiliates, and the methodology used by Alger Management in determining such profitability.  The Trustees reviewed previously-provided data on each Fund’s profitability to Alger Management and its affiliates for the year ended June 30, 2010.  In addition, the Trustees reviewed each Fund’s management fee and expense ratio and compared them with a group of comparable funds. In order to assist the Trustees in this comparison, FUSE had provided the Trustees with comparative information with respect to fees paid, and expense ratios incurred, by similar funds. That information indicated that the fees of the Large Cap, Mid Cap, SMid Cap, Small Cap and Health Sciences Funds were near or below the median for the applicable FUSE reference group, while those of Capital Appreciation, Growth Opportunities, Convertible, Money Market, and Balanced Funds clearly exceeded those of the applicable reference group. All of the Funds’ expense ratios, except those of Health Sciences Fund, exceeded their peer median. The Trustees determined that such information should be taken into account in weighing the size of the fee against the nature, extent and quality of the services provided. The Trustees also considered fees paid to Alger Management by two other types of clients, specifically mutual funds for which Alger Management acted as sub-adviser and Alger Management’s institutional clients. The Trustees determined that in both cases the

 

155



 

fees were of doubtful relevance for purposes of comparison with those of the Funds because of the significant differences in services provided by Alger Management to those types of clients as opposed to the Funds, but that to the extent that meaningful comparison was practicable, the differences in services adequately explained the differences in the fees. After discussing with representatives of Alger Management and FUSE the methodologies used in computing the costs that formed the bases of the profitability calculations, the Trustees turned to the profitability data provided. After analysis and discussion, they concluded that, to the extent that Alger Management’s and its affiliates’ relationships with the Funds had been profitable to either or both of those entities, the profit margin in each case was not unacceptable.

 

Economies of Scale.  On the basis of their discussions with management and their analysis of information provided at the meeting, the Trustees determined that the nature of the Funds and their operations is such that Alger Management is likely to realize economies of scale in the management of each Fund at some point as it grows in size, but that adoption of breakpoints in one or more of the advisory fees, while possibly appropriate at a later date, could await further analysis of the sources and potential scale of the economies and the fee structure that would best reflect them.  Accordingly, the Trustees requested that Alger Management address this topic with the Trustees at future meetings.

 

Other Benefits to Alger Management.  The Trustees considered whether Alger Management benefits in other ways from its relationship with one or more of the Funds.  They noted that Alger Management maintains soft-dollar arrangements in connection with the Funds’ brokerage transactions (other than those of Alger Money Market Fund), reports on which are regularly supplied to the Trustees at their quarterly meetings and summaries of which, listing commissions by Fund for the twelve months through June 30, 2010, had been included in the materials supplied prior to the meeting. The Trustees also noted that Alger Inc. provides a substantial portion of the Funds’ equity brokerage and receives shareholder servicing fees from the Funds (other than Alger Money Market Fund) as well. The Trustees had been provided with information regarding, and had considered, the brokerage and shareholder servicing fee benefits in connection with their review of the profitability to Alger Management and its affiliates of their relationships with the Funds. As to other benefits received, the Trustees decided that none were so significant as to render Alger Management’s fees excessive.

 

Conclusions and Determinations. At the conclusion of these discussions, each of the Independent Trustees expressed the opinion that he had been furnished with sufficient information to make an informed business decision with respect to renewal of the Investment Advisory Agreement.  Based on its discussions and considerations as described above, the Board made the following conclusions and determinations:

 

·                  The Board concluded that the nature, extent and quality of the services provided to each Fund by Alger Management are adequate and appropriate.

 

·                  The Board determined that the Funds’ overall performance was acceptable.

 

156


 

 


 

·                  The Board concluded that each advisory fee paid to Alger Management was reasonable in light of comparative performance and expense and advisory fee information, costs of the services provided and profits to be realized and benefits derived or to be derived by Alger Management from the relationship with the Fund.

 

·                  The Board determined that there were not at this time significant economies of scale to be realized by Alger Management in managing the Funds’ assets but that, to the extent that material economies of scale should be realized in the future, the Board would seek to ensure that they were shared with the applicable Fund.

 

The Board considered these conclusions and determinations and, without any one factor being dispositive, determined with respect to each Fund that renewal of the Investment Advisory Agreement was in the best interests of the Fund and its shareholders.

 

Privacy Policy

 

Your Privacy Is Our Priority

 

At Fred Alger & Company, Incorporated (“Alger Inc.”) we value the confidence you have placed in us. In trusting us with your assets, you provide us with personal and financial data. Alger is committed to maintaining the confidentiality of the personal nonpublic information (“personal information”) entrusted to us by our customers. Your privacy is very important to us, and we are dedicated to safeguarding your personal information as we serve your financial needs.

 

Our Privacy Policy

 

We believe you should know about Alger’s Privacy Policy and how we collect and protect your personal information. This Privacy Policy (“Policy”) describes our practices and policy for collecting, sharing and protecting the personal information of our prospective, current and former customers. The Policy is applicable to Alger and its affiliate, Fred Alger Management, Inc., as well as the following funds:  The Alger Funds, The Alger Institutional Funds, The Alger Portfolios, Alger China-U.S. Growth Fund and The Alger Funds II. We are proud of our Policy and hope you will take a moment to read about it.

 

Information We Collect

 

The type of personal information we collect and use varies depending on the Alger products or services you select.

 

We collect personal information that enables us to serve your financial needs, develop and offer new products and services, and fulfill legal and regulatory requirements. Depending on the products or services you request, we obtain personal information about you from the following sources:

 

·                  Information, such as your name, address and social security number, provided on applications and other forms we receive from you or your representative;

 

157



 

·                  Information from your communications with Alger employees or from your representative, which may be provided to us by telephone, in writing or through Internet transactions; and

·                  Information about your transactions, such as the purchase and redemption of fund shares, account balances and parties to the transactions, which we receive from our affiliates or other third parties.

 

Sharing of Personal Information

 

We may share your personal information with our affiliates so that they may process and service your transactions.

 

However, Alger never sells customer lists to any third party. Further, we do not disclose personal information to nonaffiliated third parties, except as required by law or as permitted by law to service your account, such as follows:

 

·                  To third-party service providers that assist us in servicing your accounts (e.g. securities clearinghouses);

·                  To governmental agencies and law enforcement officials (e.g. valid subpoenas, court orders); and

·                  To financial institutions that perform marketing services on our behalf or with whom we have joint marketing agreements that provide for the confidentiality of personal information.

 

Our Security Practices

 

We protect your personal information by maintaining physical, electronic and procedural safeguards. When you visit Alger’s Internet sites your information is protected by our systems that utilize 128-bit data encryption, Secure Socket Layer (SSL) protocol, user names, passwords and other precautions. We have implemented safeguards to ensure that access to customer information is limited to employees, such as customer service representatives, who require such information to carry out their job responsibilities. Our employees are aware of their strict responsibility to respect the confidentiality of your personal information.

 

Thank you for choosing to invest with Alger. We value your relationship with us and assure you we will abide by our policy to protect your information.

 

Proxy Voting Policies

 

A description of the policies and procedures the Trust uses to determine how to vote proxies relating to portfolio securities and the proxy voting record is available, without charge, by calling (800) 992-3863 or online on the Funds’ website at http://www.alger.com or on the SEC’s website at http://www.sec.gov.

 

158



 

Fund Holdings

 

The Funds’ most recent month end portfolio holdings are available approximately sixty days after month end on the Funds’ website at www.alger.com. The Funds also file their complete schedule of portfolio holdings with the SEC for the first and third quarter of each fiscal year on Form N-Q. The Funds’ Forms N-Q are available online on the SEC’s website at http://www.sec.gov or may be reviewed and copied at the SEC’s Public Reference Room in Washington, D.C. Information regarding the operation of the SEC’s Public Reference Room may be obtained by calling 1-800-SEC-0330. A copy of the most recent quarterly holdings may also be obtained from the Funds by calling (800) 992-3863.

 

159



 

THE ALGER FUNDS

 

111 Fifth Avenue

New York, NY 10003

(800) 992-3863

www.alger.com

 

Investment Manager

 

Fred Alger Management, Inc.

111 Fifth Avenue

New York, NY 10003

 

Distributor

 

Fred Alger & Company, Incorporated

111 Fifth Avenue

New York, NY 10003

 

Transfer Agent and Dividend Disbursing Agent

 

Boston Financial Data Services, Inc.

P.O. Box 8480

Boston, MA 02266

 

This report is submitted for the general information of the shareholders of The Alger Funds. It is not authorized for distribution to prospective investors unless accompanied by an effective Prospectus for the Trust, which contains information concerning the Trust’s investment policies, fees and expenses as well as other pertinent information.

 



 

(This page has been intentionally left blank.)

 



 

(This page has been intentionally left blank.)

 



 

(This page has been intentionally left blank.)

 



 

(This page has been intentionally left blank.)

 



 

(This page has been intentionally left blank.)

 



 

 

 

AFAR

 


 

 


 

ITEM 2.  CODE OF ETHICS.

 

(a)   The Registrant has adopted a code of ethics (the “Code of Ethics”) that applies to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions.

 

(b)         Not applicable.

 

(c)          The Registrant has amended its Code of Ethics during the period covered by the shareholder report presented in Item 1 hereto whereby the code further clarifies instances when exceptions may be granted by the Chief Compliance Officer or the General Counsel.

 

(d)         The Registrant has not granted a waiver or an implicit waiver from a provision of its Code of Ethics during the period covered by the shareholder report presented in Item 1 hereto.

 

(e)          Not applicable.

 

(f)            The Registrant’s Code of Ethics is attached as an Exhibit hereto.

 

ITEM 3.  AUDIT COMMITTEE FINANCIAL EXPERT.

 

The Board of Trustees of the Registrant determined that Stephen E. O’Neil is an audit committee financial expert (within the meaning of that phrase specified in the instructions to Form N-CSR) on the Registrant’s audit committee. Mr. O’Neil is an “independent” trustee — i.e., he is not an interested person of the Registrant as defined in the Investment Company Act of 1940, nor has he accepted directly or indirectly any consulting, advisory or other compensatory fee from the Registrant, other than in his capacity as Trustee.

 

ITEM 4.  PRINCIPAL ACCOUNTANT FEES AND SERVICES.

 

a) Audit Fees:

 

October 31, 2010

 

$

243,000

 

October 31, 2009

 

$

243,000

 

 

b) Audit-Related Fees: NONE

 

c) Tax Fees for tax advice, tax compliance and tax planning:

 

October 31, 2010

 

$

67,032

 

October 31, 2009

 

$

53,650

 

 

d) All Other Fees:

 

October 31, 2010

 

$

6,000

 

October 31, 2009

 

$

6,000

 

 

Other fees include a review and consent for Registrants registration statement filing and a review of the semi-annual financial statements.

 

e) 1) Audit Committee Pre-Approval Policies And Procedures:

 

Audit and non-audit services provided by the Registrant’s independent registered public accounting firm (the “Auditors”) on behalf the Registrant must be pre-approved by the Audit Committee. Non-audit services provided by the Auditors on behalf of the Registrant’s Investment Adviser or any entity controlling, controlled by, or under common control with the Investment Adviser must be pre-approved by the Audit Committee if such non-audit services directly relate to the operations or financial reporting of the Registrant.

 



 

2) All fees in item 4(b) through 4(d) above were approved by the Registrants’ Audit Committee.

 

f) Not Applicable

 

g) Non-Audit Fees:

 

October 31, 2010

 

$189,420 and €73,916

 

October 31, 2009

 

$145,700

 

 

h) The audit committee of the board of trustees has considered whether the provision of the non-audit services that were rendered to the registrant’s investment adviser and any entity controlling, controlled by, or under common control, with the adviser that provides ongoing services to the registrant that were not approved pursuant to (c)(7)(ii) of Rule 2-01 of Regulation S-X is compatible with maintaining the principle accountant’s independence.

 

ITEM 5.  AUDIT COMMITTEE OF LISTED REGISTRANTS.

 

Not applicable

 

ITEM 6.  INVESTMENTS.

 

Not applicable

 

ITEM 7. DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES.

 

Not applicable

 

ITEM 8.  PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES.

 

Not applicable

 

ITEM 9.  PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS.

 

Not applicable

 

ITEM 10.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

 

None

 

ITEM 11.  CONTROLS AND PROCEDURES.

 

(a) The Registrant’s principal executive officer and principal financial officer have concluded that the Registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended) are effective based on their evaluation of the disclosure controls and procedures as of a date within 90 days of the filing date of this document.

 

(b) No changes in the Registrant’s internal control over financial reporting occurred during the Registrant’s second fiscal half-year that materially affected, or are

 



 

reasonably likely to materially affect, the Registrant’s internal control over financial reporting.

 

ITEM 12. EXHIBITS.

 

(a) (1) Code of Ethics as Exhibit 99.CODE ETH

 

(a) (2) Certifications of principal executive officer and principal financial officer as required by rule 30a-2(a) under the Investment Company Act of 1940 are attached as Exhibit 99.CERT

 

(b) Certifications of principal executive officer and principal financial officer as required by rule 30a-2(b) under the Investment Company Act of 1940 are attached as Exhibit 99.906CERT

 


 


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

The Alger Funds

 

 

By:

/s/Dan C. Chung

 

 

 

 

Dan C. Chung

 

 

 

President

 

 

Date:  December 16, 2010

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

By:

/s/Dan C. Chung

 

 

 

 

Dan C. Chung

 

 

 

President

 

 

Date:  December 16, 2010

 

 

By:

/s/Michael D. Martins

 

 

 

 

Michael D. Martins

 

 

 

Treasurer

 

 

Date:  December 16, 2010